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ABSTRACT	  
	  Characterization	  of	  the	  Hydrogen	  Peroxide	  Stress	  Responses	  of	  Bifidobacterium	  
longum	  and	  Bifidobacterium	  animalis	  subsp.	  lactis	  	  	  by	  	  Taylor	  S.	  Oberg,	  Doctor	  of	  Philosophy	  Utah	  State	  University	  2013	  	  Major	  Professor:	  Dr.	  Jeffery	  R.	  Broadbent	  Department:	  Nutrition,	  Dietetics	  and	  Food	  Science	  	   Consumer	  interest	  in	  probiotic	  bifidobacteria	  is	  increasing,	  but	  industry	  efforts	  to	  secure	  high	  cell	  viability	  are	  undermined	  by	  the	  sensitivity	  of	  these	  anaerobes	  to	  oxidative	  stress	  during	  food	  production	  or	  storage.	  	  In	  this	  study,	  we	  examined	  the	  physiological	  and	  transcriptional	  stress	  responses	  of	  three	  strains	  of	  
Bifidobacterium	  longum	  and	  three	  strains	  of	  Bifidobacterium	  animalis	  subsp.	  lactis	  to	  hydrogen	  peroxide	  (H2O2).	  	  Intrinsic	  and	  inducible	  H2O2	  resistance	  was	  determined	  for	  each	  strain,	  and	  results	  showed	  B.	  longum	  subsp.	  infantis	  ATCC	  15697	  had	  the	  highest	  level	  of	  intrinsic	  H2O2	  resistance.	  	  Inducible	  H2O2	  resistance	  was	  detected	  in	  four	  strains,	  B.	  longum	  strains	  NCC2705	  and	  D2957,	  B.	  animalis	  subsp.	  lactis	  strains	  RH-­‐1	  and	  BL-­‐04.	  We	  then	  examined	  the	  transcriptional	  responses	  of	  B.	  animalis	  subsp.	  lactis	  strains,	  BL-­‐04	  and	  DSM10140,	  and	  B.	  longum	  strains	  NCC2705	  and	  D2957	  to	  H2O2	  
 iv	  exposure.	  Transcriptional	  analysis	  was	  performed	  on	  cells	  exposed	  to	  a	  sub-­‐lethal	  H2O2	  concentration	  for	  5,	  20,	  or	  60	  min	  compared	  to	  an	  untreated	  control.	  	  B.	  




Characterization	  of	  the	  Hydrogen	  Peroxide	  Stress	  Responses	  of	  
Bifidobacterium	  longum	  and	  Bifidobacterium	  animalis	  subsp.	  lactis	  
 Taylor	  S.	  Oberg	  	  	   Probiotics	  are	  living	  organisms	  which	  exert	  a	  beneficial	  health	  effect	  when	  consumed	  in	  sufficient	  numbers.	  	  	  Consumer	  interest	  in	  probiotics	  has	  increased	  dramatically	  in	  recent	  years	  prompting	  an	  increase	  in	  production	  and	  development	  of	  functional	  foods.	  	  One	  major	  problem	  is	  the	  decreased	  viability	  of	  probiotic	  bacteria	  during	  functional	  food	  production	  and	  storage	  and	  subsequent	  digestion	  due	  to	  environmental	  stresses.	  	  The	  most	  common	  probiotic	  strains	  belong	  to	  the	  genus	  Lactobacillus	  or	  Bifidobacterium.	  	  Due	  to	  the	  anaerobic	  nature	  of	  these	  bacteria,	  they	  lack	  the	  required	  defense	  mechanisms	  for	  oxidative	  stress	  inherent	  in	  aerobic	  microorganisms.	  	  This	  study	  examined	  the	  oxidative	  stress	  responses	  of	  six	  strains	  of	  Bifidobacterium,	  which	  are	  commonly	  used	  as	  probiotics	  in	  functional	  foods	  	   The	  first	  phase	  of	  the	  study	  investigated	  the	  innate	  and	  inducible	  hydrogen	  peroxide	  (H2O2)	  stress	  response	  of	  Bifidobacterium	  longum	  strains	  NCC2705	  and	  D2957,	  Bifidobacterium	  longum	  ssp.	  infantis	  ATCC	  15697,	  and	  Bifidobacterium	  
animalis	  ssp.	  lactis	  strains	  BL-­‐04,	  DSM10140	  and	  RH-­‐1.	  	  Strains	  were	  screened	  for	  survival	  at	  increasing	  concentrations	  of	  H2O2	  and	  lethal	  and	  sublethal	  concentrations	  were	  determined	  for	  each.	  	  In	  the	  second	  phase,	  B.	  animalis	  ssp.	  
lactis	  strains	  BL-­‐04	  and	  DSM10140	  and	  B.	  longum	  strains	  NCC2705	  and	  D2957	  were	  
 vi	  treated	  with	  a	  sublethal	  H2O2	  concentration	  and	  RNA	  samples	  were	  collected	  for	  transcriptome	  analysis	  after	  5	  min	  and	  either	  20	  or	  60	  min.	  	  Statistical	  analysis	  was	  performed	  to	  identify	  genes	  that	  increased	  or	  decreased	  in	  expression	  during	  H2O2	  treatment	  compared	  to	  control	  cells.	  	  Results	  showed	  that	  survival	  was	  species	  and	  strain	  dependent	  and	  that	  strains	  which	  naturally	  survived	  higher	  H2O2	  concentrations	  had	  a	  larger	  number	  of	  differentially	  expressed	  genes	  early	  on	  during	  H2O2	  exposure.	  	  Some	  of	  the	  protective	  genetic	  systems	  that	  were	  activated	  during	  H2O2	  stress	  are	  mechanisms	  which	  perform	  basic	  cellular	  functions	  under	  normal	  conditions	  such	  as	  deoxuynucleotide	  synthesis.	  	  Under	  stress	  conditions,	  these	  systems	  can	  be	  used	  to	  detoxify	  oxidative	  free	  radicals.	  	  Also	  a	  number	  of	  genes	  involved	  in	  sugar	  transport	  and	  energy	  production	  for	  the	  cell	  showed	  increased	  expression,	  which	  reveals	  the	  increased	  energy	  needs	  of	  the	  cells	  during	  oxidative	  stress.	  During	  testing,	  it	  was	  found	  that	  two	  B.	  animalis	  ssp.	  lactis	  strains,	  BL-­‐04	  and	  DSM10140,	  had	  differing	  levels	  of	  survival	  and	  gene	  expression	  during	  H2O2	  exposure	  despite	  having	  almost	  identical	  genome	  sequences.	  	  It	  was	  determined	  that	  one	  possible	  cause	  of	  the	  differences	  was	  a	  genetic	  deletion	  in	  a	  gene	  that	  allows	  the	  cell	  to	  incorporate	  extracellular	  fatty	  acids	  into	  the	  cell	  membrane	  instead	  of	  synthesizing	  them.	  Results	  from	  this	  project	  have	  increased	  the	  understanding	  of	  oxidative	  stress	  responses	  in	  bifidobacteria	  and	  highlighted	  possible	  methods	  to	  increase	  bacterial	  survival	  during	  food	  manufacture,	  storage,	  and	  human	  digestion.	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CHAPTER	  1	  
INTRODUCTION	  AND	  OBJECTIVES	  
	  Food	  or	  food	  ingredients	  with	  “bioactive”	  properties	  have	  increased	  in	  popularity	  among	  consumers	  over	  the	  last	  few	  years.	  	  These	  functional	  foods	  are	  defined	  by	  their	  ability	  to	  impact	  human	  health	  in	  a	  manner	  that	  is	  not	  based	  only	  on	  their	  nutritional	  value.	  	  As	  such,	  probiotic	  bacteria	  represent	  one	  of	  the	  most	  promising	  categories	  of	  bioactive	  food	  ingredients	  (1).	  	  The	  term	  “probiotic”	  commonly	  refers	  to	  “living	  organisms	  which,	  when	  ingested	  at	  sufficient	  numbers,	  exert	  a	  beneficial	  effect	  on	  the	  host	  organism	  beyond	  inherent	  general	  nutrition”	  (2).	  Currently,	  species	  of	  Lactobacillus	  and	  Bifidobacterium	  are	  the	  most	  widely	  used	  probiotic	  bacteria	  added	  to	  commercial	  products	  (3).	  	  Though	  they	  are	  relatively	  minor	  components	  of	  the	  normal	  gastrointestinal	  microbiota	  in	  human	  adults,	  bifidobacteria	  are	  thought	  to	  promote	  or	  provide	  several	  health	  related	  functions,	  including	  host	  resistance	  to	  infectious	  microbes,	  anti-­‐carcinogenic	  activities,	  and	  improved	  nutritional	  efficiency	  (4).	  	  Although	  many	  species	  of	  bifidobacteria	  are	  used	  as	  probiotics,	  the	  two	  most	  important	  commercial	  species	  are	  Bifidobacterium	  animalis	  subsp.	  lactis	  and	  Bifidobacterium	  longum.	  Researchers	  have	  suggested	  that	  probiotic	  bacteria	  should	  generally	  satisfy	  several	  criteria,	  including	  the	  ability	  to	  maintain	  high	  viability	  during	  the	  technological	  processes	  used	  to	  prepare	  and	  deliver	  the	  bacterium,	  and	  the	  ability	  to	  survive	  passage	  through	  the	  upper	  GI	  tract	  for	  adherence	  and	  colonization	  of	  the	  large	  intestine	  (5,	  6,	  7).	  	  Although	  no	  conclusive	  data	  is	  available	  on	  a	  minimal	  
  
2	  effective	  dose	  of	  probiotics	  in	  humans,	  results	  from	  several	  clinical	  trials	  suggest	  a	  direct	  dose-­‐effect	  correlation	  (8,	  9,	  10).	  	  As	  a	  result,	  the	  current	  WHO	  definition	  of	  probiotics	  emphasizes	  the	  need	  for	  administration	  of	  the	  probiotics	  in	  “adequate	  amounts”	  (11).	  	  Thus,	  successful	  application	  of	  probiotic	  bifidobacteria	  in	  foods	  is	  not	  only	  dependent	  upon	  scientific	  research	  that	  demonstrates	  their	  efficacy	  in	  providing	  human	  health	  benefits,	  but	  also	  on	  the	  development	  of	  technologies	  to	  ensure	  their	  survival	  in	  high	  numbers	  during	  food	  processing	  and	  maintaining	  those	  high	  numbers	  during	  storage.	  Industrially,	  bifidobacteria	  are	  usually	  preserved	  or	  distributed	  in	  liquid,	  spray-­‐dried,	  frozen,	  or	  lyophilized	  forms	  (12,	  13).	  	  Most	  of	  the	  currently	  used	  culture	  preservation	  and	  production	  methods	  subject	  cells	  to	  stress	  conditions,	  such	  as	  freezing,	  drying,	  nutrient	  starvation,	  and	  concentration	  stress,	  that	  serve	  to	  diminish	  cell	  viability	  (13).	  	  Difficulties	  also	  arise	  with	  probiotic	  bifidobacteria	  applications	  due	  to	  the	  fact	  that	  cells	  are	  typically	  exposed	  to	  stress	  conditions	  during	  the	  manufacturing	  process	  of	  most	  food-­‐based	  delivery	  systems	  (14).	  	  At	  present,	  yogurt	  or	  fermented	  milks	  are	  the	  most	  common	  vehicle	  foods	  for	  delivery	  of	  probiotic	  bifidobacteria,	  but	  regardless	  of	  the	  vehicle	  food,	  efforts	  to	  secure	  and	  maintain	  high	  numbers	  of	  viable	  bifidobacteria	  in	  the	  product	  are	  commonly	  impeded	  by	  the	  intrinsic	  properties	  of	  the	  food	  such	  as	  dehydration	  (low	  Aw),	  high	  or	  low	  temperature,	  low	  pH,	  and	  elevated	  oxygen	  or	  NaCl	  levels,	  all	  of	  which	  are	  deleterious	  to	  bifidobacteria	  (14-­‐17).	  	  To	  address	  this	  problem,	  processors	  may	  
  
3	  employ	  very	  large	  inocula	  or	  add	  specific	  growth	  promoters	  or	  protectants	  (14,	  18,	  19).	   Understanding	  the	  requirements	  for	  preservation	  methods	  that	  promote	  high	  cell	  viability	  and	  retained	  metabolic	  activity	  among	  probiotic	  bacteria	  can	  present	  a	  formidable	  challenge.	  	  Fortunately,	  some	  species	  and	  strains	  are	  intrinsically	  more	  resistant	  to	  environmental	  stresses	  than	  are	  others,	  which	  indicate	  that	  this	  limitation	  can	  probably	  be	  overcome	  through	  a	  more	  fundamental	  understanding	  of	  bifidobacteria	  physiology	  and	  their	  molecular	  mechanisms	  for	  cell	  protection	  during	  environmental	  stress.	  	  For	  this	  reason,	  there	  has	  been	  a	  growing	  worldwide	  interest	  in	  bifidobacteria	  stress	  responses	  and	  their	  potential	  application	  to	  promote	  cell	  survival	  during	  processing,	  distribution,	  and	  consumption	  of	  probiotic	  foods	  (14,	  17,	  20).	  	  Outcomes	  from	  this	  research	  will	  provide	  a	  more	  complete	  and	  detailed	  understanding	  of	  how	  these	  Bifidobacterium	  respond	  to	  H2O2	  stress	  conditions	  encountered	  during	  food	  production	  or	  storage,	  and	  will	  identify	  potential	  strategies	  to	  enhance	  long-­‐term	  cell	  survival	  in	  bioactive	  foods.	  	  Research	  described	  in	  this	  dissertation	  addressed	  the	  following	  objectives:	  1. Characterize	  physiological	  stress	  responses	  among	  B.	  animalis	  subsp.	  lactis	  and	  B.	  longum	  strains	  to	  oxidative	  stress	  caused	  by	  exposure	  to	  H2O2.	  a. Determine	  the	  lethal	  and	  sublethal	  H2O2	  concentrations	  for	  each	  strain.	  b. Define	  the	  fatty-­‐acid	  composition	  change	  in	  the	  bacterial	  cell	  wall	  that	  occurs	  during	  the	  oxidative	  stress	  response.	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  2. Characterize	  the	  inducible	  stress	  response	  of	  B.	  lactis	  and	  B.	  longum	  to	  sublethal	  oxidative	  stress	  levels	  caused	  by	  exposure	  to	  H2O2.	  3. Use	  DNA	  microarray	  technology	  to	  identify	  and	  define	  similarities	  and	  differences	  in	  the	  transcriptional	  responses	  of	  specific	  strains	  from	  each	  species	  that	  display	  an	  intrinsic	  and	  inducible	  stress	  response	  to	  H2O2.	  	  Strains	  selected	  for	  use	  in	  this	  study	  represent	  cultures	  that	  are	  industrially	  important	  and	  had	  available	  genome	  sequence	  data	  to	  support	  DNA	  microarray	  studies.	  	  Previous	  studies	  have	  shown	  a	  varying	  degree	  of	  resistance	  in	  bifidobacteria	  and	  lactic	  acid	  bacteria	  at	  a	  wide	  range	  of	  H2O2	  concentrations	  tested	  in	  differing	  buffers	  (21-­‐26).	  	  To	  accomplish	  Objective	  1,	  strains	  were	  treated	  with	  a	  range	  of	  H2O2	  concentrations	  in	  a	  growth	  media	  instead	  of	  a	  buffer,	  allowing	  cells	  the	  opportunity	  for	  active	  metabolism	  during	  exposure.	  	  The	  concentration	  of	  H2O2	  in	  the	  medium	  was	  also	  measured	  during	  the	  exposure	  period	  to	  monitor	  possible	  degradation.	  	  This	  data	  were	  then	  used	  to	  define	  a	  lethal	  and	  sublethal	  H2O2	  concentration	  for	  each	  strain.	  The	  cell	  membrane	  composition	  plays	  an	  important	  role	  as	  the	  first	  line	  of	  defense	  against	  acid	  stress.	  	  A	  modified	  version	  of	  the	  MIDI	  laboratories	  protocol	  for	  cell	  membrane	  fatty	  acid	  analysis	  (27)	  was	  used	  to	  determine	  if	  the	  cell	  membrane	  fatty	  acid	  profile	  changes	  during	  H2O2	  exposure	  in	  bifidobacteria.	  In	  many	  bacteria,	  including	  species	  of	  bifidobacteria,	  it	  has	  also	  been	  shown	  that	  cell	  survival	  may	  be	  dramatically	  improved	  by	  deliberate	  induction	  of	  an	  adaptive	  or	  inducible	  stress	  response	  (28-­‐37).	  	  To	  accomplish	  objective	  2,	  strains	  
  
5	  were	  exposed	  to	  previously	  defined	  sublethal	  H2O2	  concentrations	  for	  set	  intervals,	  and	  these	  pretreated	  cells	  were	  then	  subjected	  to	  lethal	  concentrations	  of	  H2O2.	  	  An	  inducible	  stress	  response	  was	  defined	  as	  an	  increase	  in	  survival	  at	  lethal	  H2O2	  levels	  after	  pre-­‐exposure	  to	  sublethal	  H2O2	  concentrations	  compared	  to	  unexposed	  cells.	  	   DNA	  microarray	  technology	  has	  vastly	  improved	  the	  ability	  of	  researchers	  to	  determine	  the	  influence	  of	  gene	  expression	  in	  microbial	  adaptation	  to	  different	  environmental	  conditions.	  	  To	  accomplish	  objective	  3,	  DNA	  microarrays	  containing	  all	  of	  the	  unique	  open	  reading	  frames	  for	  both	  B.	  longum	  NCC2705	  and	  B.	  animalis	  subsp.	  lactis	  strains	  DSM10140	  and	  BL-­‐04	  were	  designed	  by	  our	  lab	  group	  and	  obtained	  from	  Affymetrix	  (Affymetrix,	  Santa	  Clara,	  CA).	  	  RNA	  was	  isolated	  from	  cells	  exposed	  to	  sublethal	  H2O2	  concentrations	  and	  used	  to	  generate	  cDNA	  for	  hybridization	  to	  the	  custom	  DNA	  microarrays.	  	  Raw	  data	  from	  the	  hybridization	  was	  analyzed	  using	  the	  Bioconductor	  packages	  in	  the	  open	  source	  statistical	  platform	  R	  (www.r-­‐project.org).	  	  Statistically	  differentially	  expressed	  genes	  were	  then	  grouped	  according	  to	  cellular	  function	  for	  comparison	  between	  strains.	  Although	  there	  has	  been	  much	  research	  performed	  on	  the	  stress	  responses	  of	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Functional	  foods	  Functional	  foods	  are	  foods	  or	  food	  ingredients	  with	  “bioactive”	  properties	  which	  are	  defined	  by	  their	  ability	  to	  impact	  human	  health	  in	  a	  manner	  that	  is	  not	  based	  only	  on	  their	  nutritional	  value.	  	  Consumer	  interest	  in	  such	  functional	  food	  products	  has	  increased	  dramatically	  over	  the	  last	  few	  years.	  	  As	  such,	  probiotic	  bacteria	  represent	  one	  of	  the	  most	  promising	  categories	  of	  bioactive	  food	  ingredients	  (1).	  	  The	  term	  “probiotic”	  commonly	  refers	  to	  “living	  organisms	  which,	  when	  ingested	  at	  sufficient	  numbers,	  exert	  a	  beneficial	  effect	  on	  the	  host	  organism	  beyond	  inherent	  general	  nutrition”	  (2).	  	  Currently,	  species	  of	  Lactobacillus	  and	  
Bifidobacterium	  are	  the	  most	  widely	  used	  probiotic	  bacteria	  added	  to	  commercial	  products	  (3).	  
	  
Bifidobacteria	  The	  Actinobacteria	  phylum	  is	  one	  of	  the	  largest	  taxonomic	  units	  among	  the	  
Eubacteria	  and	  is	  comprised	  primarily	  of	  Gram	  positive	  bacteria	  with	  a	  high	  guanine	  +	  cytosine	  (G+C)	  content	  	  (>51%).	  	  This	  phylum	  includes	  the	  Bifidobacteriales	  order,	  containing	  only	  one	  family,	  Bifidobacteriaceae,	  which	  consists	  of	  8	  genera	  with	  
Bifidobacterium	  as	  the	  only	  genus	  with	  multiple	  species	  (4,	  5).	  
Bifidobacterium	  species	  are	  Gram-­‐positive,	  non-­‐acid-­‐fast,	  non-­‐spore	  forming,	  non-­‐motile,	  catalase	  negative	  rods	  of	  irregular	  shape,	  and	  they	  are	  anaerobic	  
  
10	  chemoorganotrophs	  that	  metabolize	  a	  variety	  of	  carbohydrates	  through	  fermentation	  to	  produce	  organic	  acids	  but	  not	  gas	  (6).	  	  Bifidobacteria	  species	  have	  been	  isolated	  from	  multiple	  sources	  including	  food,	  sewage,	  insects,	  the	  human	  oral	  cavity,	  and	  the	  guts	  of	  both	  humans	  and	  animals	  (7).	  	  Some	  species	  have	  been	  isolated	  from	  both	  human	  and	  animal	  gut,	  showing	  the	  ability	  to	  grow	  in	  different	  hosts,	  whereas	  other	  species	  have	  only	  been	  isolated	  from	  the	  gut	  of	  certain	  animal	  species	  (eg.,	  rabbits,	  cows	  and	  chickens)	  demonstrating	  a	  highly	  specialized	  adaptation	  to	  specific	  ecological	  environments	  (8,	  9,	  10).	  	  This	  highly	  evolved	  adaptation	  to	  growth	  in	  the	  gut	  is	  illustrated	  by	  the	  fact	  that	  strains	  can	  ferment	  complex	  carbohydrates	  for	  growth	  that	  are	  not	  digestible	  by	  the	  host	  (11-­‐14).	  	  Genetic	  analysis	  has	  revealed	  numerous	  oligosaccharide	  transporters	  and	  glycosyl	  hydrolases	  that	  can	  account	  for	  up	  to	  10%	  of	  the	  genomic	  content	  of	  some	  strains	  (12,	  15,	  16).	  This	  specialization	  in	  ecological	  adaptation	  is	  illustrated	  by	  comparison	  of	  B.	  
longum	  subsp.	  infantis	  ATCC	  15697,	  a	  strain	  commonly	  isolated	  in	  human	  infants,	  and	  B.	  animalis	  subsp.	  lactis	  strain,	  which	  are	  commonly	  isolated	  from	  human	  adults.	  	  The	  genome	  of	  B.	  longum	  subsp.	  infantis	  ATCC	  15697	  contains	  genes	  encoding	  proteins	  involved	  in	  the	  breakdown	  and	  utilization	  of	  human	  milk	  oligosaccharides	  in	  breast	  milk,	  which	  are	  not	  found	  in	  the	  genomes	  of	  B.	  animalis	  subsp.	  lactis	  strains	  (13).	  	  Instead,	  B.	  animalis	  subsp.	  lactis	  strains	  contain	  a	  large	  number	  of	  genes	  involved	  in	  breakdown	  and	  metabolism	  of	  complex	  carbohydrates	  found	  in	  an	  adult-­‐type	  diet	  containing	  plant	  derived	  fibers	  (12,	  17).	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Energy	  production	  and	  fermentation	  Although	  a	  majority	  of	  the	  Bifidobacterium	  species	  can	  utalize	  complex	  carbohydrates,	  most	  strains	  will	  favor	  simple	  sugars	  over	  more	  complex	  sugars	  if	  they	  are	  available.	  	  Bifidobacterium	  species	  lack	  genes	  involved	  in	  the	  electron	  transport	  chain	  for	  oxidative	  phosphorylation	  and	  degrade	  hexose	  sugars	  by	  fermentation	  exclusively	  through	  the	  fructose-­‐6-­‐phosphate	  phosphoketolase	  (F6PK)	  pathway	  commonly	  known	  as	  the	  “bifid	  shunt”	  (6,	  18).	  	  The	  key	  enzyme	  in	  this	  pathway,	  F6PK,	  cleaves	  hexose	  phosphate	  to	  erythrose-­‐4-­‐phosphate	  then	  acetyl	  phosphate,	  which	  is	  converted	  to	  acetate	  by	  substrate	  level	  phosphorylation.	  	  Pentose	  phosphates	  are	  also	  generated	  from	  tetrose	  and	  hexose	  phosphates	  using	  transaldolase	  and	  transketolase,	  which	  are	  then	  degraded	  to	  acetyl	  phosphate	  and	  glyceraldehyde-­‐3-­‐phosphate,	  which	  is	  then	  oxidized	  to	  pyruvate	  via	  the	  Emden-­‐Myerhoff	  pathway.	  	  Pyruvate	  is	  then	  reduced	  to	  lactate	  to	  regenerate	  NAD+,	  giving	  a	  theoretical	  yield	  of	  3	  mol	  acetate	  and	  2	  mol	  of	  lactate	  for	  every	  2	  mol	  of	  glucose	  consumed	  (19,	  20).	  	  This	  pathway	  functions	  in	  bifidobacteria	  due	  to	  the	  fact	  that	  they	  lack	  several	  genes	  involved	  in	  glycolysis,	  including	  the	  key	  regulatory	  enzyme	  phosphofructokinase.	  	  
Probiotic	  health	  benefits	  	   Though	  they	  are	  relatively	  minor	  components	  of	  the	  normal	  gastrointestinal	  (GI)	  microbiota	  in	  human	  adults,	  bifidobacteria	  are	  thought	  to	  promote	  or	  provide	  several	  health	  related	  functions	  (21,	  22).	  	  Moreover,	  certain	  species	  of	  bifidobacteria	  are	  major	  components	  of	  the	  GI	  microbiota	  of	  healthy,	  breast-­‐fed	  infants,	  and	  recent	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  work	  suggests	  the	  composition	  of	  GI	  microbiota	  in	  infants	  and	  children	  may	  influence	  the	  development	  of	  diarrheal,	  inflammatory,	  and	  allergic	  diseases	  (23).	  The	  relationship	  between	  bifidobacteria	  and	  human	  health	  has	  intrigued	  physicians	  and	  microbiologists	  for	  over	  100	  years	  (24),	  and	  stimulated	  consumer	  interest	  in	  bioactive	  foods	  that	  contain	  bifidobacteria	  as	  seen	  recently	  with	  new	  products	  on	  the	  market	  (25,	  26).	  	  Examples	  of	  probiotic	  effects	  documented	  with	  the	  consumption	  of	  bifidobacteria	  include	  a	  decrease	  in	  severity	  of	  the	  side	  effects	  associated	  with	  antibiotics	  use,	  a	  reduced	  incidence	  of	  infection	  in	  patients	  receiving	  irradiation	  therapy,	  a	  decrease	  in	  the	  duration	  of	  diarrhea	  due	  to	  various	  etiologies,	  improved	  lactose	  digestion,	  a	  reduced	  frequency	  of	  allergic	  reactions,	  and	  normalization	  of	  blood	  lipid	  composition	  (3,	  27,	  28,	  29,	  30).	  	  Recent	  clinical	  trials	  have	  shown	  that	  bifidobacteria	  can	  alleviate	  lactose	  malabsorption	  symptoms,	  increase	  bowel	  transit	  time	  and	  stool	  frequency	  in	  children	  and	  adults	  suffering	  constipation,	  be	  used	  as	  an	  effective	  treatment	  for	  ulcerative	  colitis,	  alleviate	  symptoms	  of	  irritable	  bowel	  syndrome,	  reduce	  the	  symptoms	  of	  stress	  induced	  GI	  disorders	  and	  stimulate	  the	  immune	  system	  of	  patients	  with	  HIV	  infection	  to	  increase	  the	  overall	  quality	  of	  life	  (31-­‐39).	  Although	  many	  species	  of	  bifidobacteria	  are	  used	  as	  probiotics,	  the	  two	  most	  important	  commercial	  species	  are	  Bifidobacterium	  animalis	  ssp.	  lactis	  and	  
Bifidobacterium	  longum.	  	  The	  ability	  of	  these	  and	  other	  species	  of	  bifidobacteria,	  to	  exert	  probiotic	  activities	  is	  thought	  to	  result	  from	  the	  combination	  of	  direct	  (e.g.,	  antagonism	  of	  pathogens	  via	  the	  production	  of	  antimicrobials	  or	  competition	  for	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  attachment	  sites)	  and	  indirect	  (e.g.,	  immuno-­‐stimulation)	  mechanisms	  (3,	  22,	  40).	  	  Researchers	  have	  suggested	  that	  to	  serve	  as	  an	  effective	  probiotic	  agent,	  these	  bacteria	  generally	  should	  satisfy	  several	  criteria	  including:	  (i)	  be	  able	  to	  exert	  a	  beneficial	  effect	  towards	  the	  host;	  (ii)	  be	  non-­‐pathogenic	  and	  non-­‐toxic;	  (iii)	  be	  able	  to	  survive	  passage	  through	  the	  upper	  GI	  tract;	  (iv)	  be	  able	  to	  adhere	  to	  and	  colonize	  the	  large	  intestine;	  (v)	  be	  derived	  from	  the	  same	  species	  as	  the	  intended	  host;	  (vi)	  show	  antimicrobial	  and	  /or	  immunomodulatory	  activity;	  and	  (vii)	  be	  able	  to	  maintain	  a	  high	  viability	  during	  the	  technology	  processes	  used	  to	  prepare	  and	  deliver	  the	  bacterium	  (41-­‐44).	  	  Although	  no	  conclusive	  data	  is	  available	  on	  a	  minimal	  effective	  dose	  of	  probiotics	  in	  humans,	  results	  from	  several	  clinical	  trials	  suggest	  a	  direct	  dose-­‐effect	  correlation	  (45,	  46,	  47).	  	  As	  a	  result,	  the	  current	  WHO	  definition	  of	  probiotics	  emphasizes	  the	  need	  for	  administration	  of	  the	  probiotics	  in	  “adequate	  amounts”	  (48).	  	  Thus,	  successful	  application	  of	  probiotic	  bifidobacteria	  in	  foods	  is	  not	  only	  dependent	  upon	  scientific	  research	  that	  demonstrates	  their	  efficacy	  in	  providing	  human	  health	  benefits,	  but	  also	  on	  the	  development	  of	  technologies	  to	  ensure	  their	  survival	  in	  high	  numbers	  during	  food	  processing	  and	  maintaining	  those	  high	  numbers	  during	  storage.	  	  While	  research	  efforts	  are	  currently	  underway	  to	  demonstrate	  the	  efficacy	  of	  bifidobacteria	  in	  promoting	  or	  providing	  various	  health	  benefits,	  knowledge	  of	  methods	  to	  enhance	  the	  survival	  of	  bifidobacteria	  in	  food-­‐based	  delivery	  systems	  remains	  fragmentary.	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Probiotic	  food	  production	  Industrially,	  bifidobacteria	  are	  usually	  preserved	  or	  distributed	  in	  liquid,	  spray-­‐dried,	  frozen,	  or	  lyophilized	  forms	  (49,	  50).	  	  Unfortunately,	  understanding	  the	  requirements	  for	  preservation	  methods	  that	  promote	  high	  cell	  viability	  and	  retained	  metabolic	  activity	  among	  probiotic	  bacteria	  can	  present	  a	  formidable	  challenge.	  	  This	  is	  because	  most	  culture	  preservation	  and	  production	  methods	  subject	  cells	  to	  stress	  conditions,	  such	  as	  freezing,	  drying,	  nutrient	  starvation,	  and	  concentration	  stress,	  that	  serve	  to	  diminish	  cell	  viability	  (50).	  	  As	  a	  result,	  problems	  in	  large-­‐scale	  cultivation	  and	  preservation	  of	  bifidobacteria	  continue	  to	  limit	  the	  commercial	  application	  of	  these	  cultures	  (51).	  Difficulties	  associated	  with	  probiotic	  strain	  production	  are	  further	  exacerbated	  by	  the	  fact	  that	  exposure	  to	  cellular	  stress	  conditions	  are	  also	  an	  integral	  feature	  of	  the	  manufacturing	  process	  for	  most	  food-­‐based	  delivery	  systems	  for	  bifidobacteria	  (51).	  	  At	  present,	  yogurt	  or	  fermented	  milks	  are	  the	  most	  common	  vehicle	  foods	  for	  delivery	  of	  probiotic	  bifidobacteria,	  but	  cheese,	  ice	  cream,	  infant	  formula,	  fruit	  juice,	  and	  other	  foods	  are	  also	  used	  to	  a	  lesser	  extent	  (51,	  52).	  	  Regardless	  of	  the	  vehicle	  food,	  efforts	  to	  secure	  and	  maintain	  high	  numbers	  of	  viable	  bifidobacteria	  in	  the	  product	  are	  commonly	  impeded	  by	  the	  intrinsic	  properties	  of	  the	  food	  such	  as	  dehydration	  (low	  Aw),	  high	  or	  low	  temperature,	  low	  pH,	  and	  elevated	  oxygen	  or	  NaCl	  levels,	  all	  of	  which	  are	  deleterious	  to	  bifidobacteria	  (52-­‐55).	  	  To	  address	  this	  problem,	  processors	  may	  employ	  very	  large	  inocula	  or	  add	  specific	  growth	  promoters	  or	  protectants	  (51,	  56,	  57).	  	  To	  function	  as	  an	  effective	  probiotic,	  
  
15	  strains	  must	  also	  be	  able	  to	  survive	  gastric	  stresses,	  primarily	  the	  low	  pH	  of	  the	  stomach	  and	  bile	  salt	  exposure	  in	  the	  small	  intestine	  (58,	  59).	  Micro-­‐encapsulation	  is	  another	  promising	  technology	  to	  enhance	  survival	  of	  bifidobacteria	  in	  foods.	  	  This	  process	  surrounds	  cells	  with	  various	  matrices,	  such	  as	  calcium	  alginate,	  pectin,	  or	  whey	  proteins,	  to	  protect	  them	  from	  adverse	  environments	  in	  the	  food	  and	  during	  transit	  through	  the	  upper	  GI	  tract	  (25,	  60).	  	  Though	  encapsulation	  can	  impart	  significant	  protection	  to	  some	  strains	  of	  bifidobacteria,	  wide	  differences	  in	  strain	  robustness	  continue	  to	  hamper	  industry	  efforts	  to	  secure	  high	  numbers	  of	  viable	  shelf-­‐stable	  probiotic	  bacteria	  in	  food	  products	  (51,	  60).	  Oxidative	  stresses	  pose	  a	  major	  hurdle	  in	  the	  application	  of	  bifidobacteria	  in	  functional	  foods	  due	  to	  their	  anaerobic	  nature.	  	  Oxygen	  toxicity	  results	  from	  cell	  exposure	  to	  activated	  oxygen	  compounds	  such	  as	  superoxide,	  hydrogen	  peroxide	  (H2O2),	  and	  hydroxyl	  radicals,	  which	  cause	  peptide	  breaks,	  oxidation	  of	  sulfhydryl	  groups	  in	  proteins,	  DNA	  damage	  and	  oxidation	  of	  membrane	  lipids	  (61).	  	  Although	  H2O2	  is	  the	  most	  stable	  of	  these	  molecules,	  dissociation	  and	  interaction	  with	  cellular	  components	  can	  form	  organic	  peroxides,	  which	  can	  initiate	  a	  chain	  reaction	  of	  oxidation	  (62).	  	  One	  common	  source	  of	  H2O2	  is	  from	  metabolic	  byproducts	  of	  the	  starter	  cultures	  used	  to	  manufacture	  yogurt,	  Lactobacillus	  delbrueckii	  ssp.	  bulgaricus	  and	  Streptococcus	  thermophilus,	  which	  have	  been	  shown	  to	  produce	  inhibitory	  concentrations	  of	  H2O2	  when	  grown	  under	  conditions	  such	  as	  those	  encountered	  during	  bioactive	  food	  production	  and	  storage	  (63).	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Acid	  stress	  responses	  of	  bifidobacteria	  One	  of	  the	  primary	  problems	  that	  cells	  negotiate	  during	  stress	  is	  protein	  damage	  resulting	  in	  misfolded	  and	  non-­‐functioning	  proteins.	  	  To	  overcome	  this	  problem,	  cells	  utilize	  molecular	  chaparones	  for	  proper	  protein	  folding	  and	  stabilization	  during	  stresses	  and,	  if	  the	  protein	  is	  damaged	  beyond	  repair,	  ATP	  dependent	  proteases	  hydrolyze	  proteins	  to	  prevent	  accumulation	  of	  non-­‐functioning	  proteins	  in	  the	  cell	  (64,	  65,	  66).	  	  Genetic	  analysis	  of	  B.	  animalis	  subsp.	  
lactis	  and	  B.	  longum	  strains	  reveal	  a	  small	  assortment	  of	  classical	  molecular	  chaparones	  and	  stress-­‐associated	  proteases	  (67,	  68).	  The	  detrimental	  effects	  of	  acid	  stress	  on	  bifidobacteria	  are	  caused	  by	  elevated	  proton	  concentrations.	  	  At	  low	  pH,	  undissociated	  organic	  acids	  can	  passively	  diffuse	  across	  the	  membrane,	  and	  once	  internalized,	  dissociate	  and	  acidify	  the	  cytoplasm,	  causing	  metabolic	  failure	  and	  eventually	  cellular	  death.	  	  Overall,	  bifidobacteria	  survive	  poorly	  at	  low	  pH,	  with	  the	  exception	  of	  B.	  animalis	  subsp.	  
lactis	  strains,	  which	  is	  why	  strains	  from	  this	  species	  are	  widely	  used	  in	  functional	  foods	  (69,	  70).	  	  Studies	  have	  shown	  that	  in	  anaerobic	  bacteria	  like	  bifidobacteria,	  the	  main	  cellular	  defense	  against	  low	  pH	  is	  the	  F0F1-­‐ATPase,	  which	  pumps	  protons	  across	  the	  cytoplasmic	  membrane	  at	  the	  expense	  of	  hydrolyzing	  ATP	  (71,	  72,	  73).	  	  This	  survival	  mechanism	  has	  been	  confirmed	  in	  B.	  animalis	  subsp.	  lactis	  and	  B.	  
longum	  strains	  through	  proteomic	  and	  transcriptomic	  data	  (74,	  75,	  76).	  	  This	  same	  data	  has	  shown	  that	  in	  addition	  to	  the	  classical	  stress	  response	  chaperones	  (eg.,	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  DnaK,	  DnaJ,	  GroEL,	  GroES),	  acid	  stress	  also	  caused	  the	  increase	  of	  proteins	  involved	  in	  the	  glycolytic	  pathway	  (75).	  	  Induction	  of	  genes	  involved	  in	  metabolism	  shows	  that	  the	  cells	  are	  rerouting	  metabolites	  to	  different	  branches,	  including	  the	  P6PK	  pathway,	  to	  modify	  energy	  production	  and	  redox	  equivalents.	  	  This	  underscores	  the	  increased	  energy	  needs	  for	  the	  cells	  during	  stress	  exposure	  for	  proton	  expulsion	  and	  protein	  synthesis.	  	  Research	  has	  also	  shown	  that	  low	  pH	  increases	  the	  amount	  of	  enzymes	  involved	  in	  branched	  chain	  amino	  acid	  biosynthesis	  as	  well	  as	  glutamine	  synthetase	  (75).	  	  Branched	  chain	  amino	  acid	  synthesis	  is	  coupled	  to	  the	  conversion	  of	  glutamine	  to	  glutamate	  liberating	  an	  ammonia	  ion,	  which	  acts	  as	  a	  cellular	  buffer	  (77,	  78).	  	  
Bile	  stress	  responses	  of	  bifidobacteria	  Human	  bile	  is	  a	  mixture	  of	  electrolytes,	  bile	  salts,	  phospholipids,	  cholesterol,	  bilirubin	  and	  proteins,	  which	  is	  secreted	  into	  the	  duodenum	  during	  digestion	  to	  facilitate	  emulsification	  and	  absorption	  of	  lipid	  soluble	  nutrients.	  	  A	  certain	  percentage	  of	  bile	  salts	  escape	  entero-­‐hepatic	  circulation	  and	  act	  as	  strong	  antimicrobials	  in	  the	  colon	  due	  to	  their	  strong	  detergent	  action,	  which	  damages	  cellular	  membranes	  and	  interrupts	  membrane	  functionality.	  	  Oxidative	  stress	  is	  a	  well-­‐known	  function	  of	  bile	  salt	  exposure	  in	  cells	  and	  has	  been	  shown	  to	  cause	  DNA	  damage	  and	  generate	  protein	  conformation	  modifications	  and	  increase	  protein	  turnover	  (79,	  80,	  81).	  	  Because	  of	  this,	  bile	  salt	  exposure	  to	  bifidobacteria	  will	  trigger	  oxidative	  stress	  mechanisms	  in	  response	  to	  bile	  such	  as	  the	  thioredoxin	  reductase	  system,	  along	  with	  the	  classic	  stress	  response	  chaperones	  (81,	  82).	  	  
  
18	  The	  cellular	  membrane	  is	  the	  first	  line	  of	  defense	  against	  cellular	  stress	  and	  bacterial	  cells	  have	  developed	  methods	  for	  rapid	  modification	  of	  the	  fatty	  acid	  moieties	  and	  head	  groups	  in	  response	  to	  stress.	  	  Research	  has	  shown	  that	  adding	  Tween	  80	  to	  the	  growth	  media	  of	  some	  LAB	  strains	  consequently	  increases	  their	  survival	  at	  low	  pH	  (83),	  and	  that	  bile	  stress	  induces	  modification	  of	  the	  membrane	  fatty	  acid	  composition	  in	  B.	  animalis	  subsp.	  lactis,	  which	  is	  accomplished	  through	  incorporation	  of	  fatty	  acids	  with	  different	  chain	  lengths,	  saturation,	  or	  post	  synthetic	  modification	  of	  existing	  fatty	  acids	  (84,	  85).	  	  In	  B.	  animalis	  subsp.	  lactis,	  bile	  salt	  exposure	  decreased	  the	  production	  of	  a	  long-­‐chain	  fatty	  acyl	  CoA	  ligase,	  which	  is	  used	  for	  incorporation	  of	  exogenous	  fatty	  acids	  into	  the	  cellular	  membrane	  (86).	  	  
Oxidative	  stress	  responses	  of	  bifidobacteria	  Oxidative	  stresses	  in	  bacteria	  are	  caused	  by	  reactive	  oxygen	  species	  such	  as	  the	  superoxide	  anion,	  H2O2,	  or	  hydroxyl	  radicals,	  which	  damage	  biomolecules	  through	  mechanisms	  such	  as;	  oxidation	  of	  sulfhydryl	  groups	  and	  peptide	  breaks	  in	  protein,	  fatty	  acid	  peroxidation	  and	  propagation,	  and	  DNA	  damage	  through	  depolymerization	  and	  depurination	  (87,	  88,	  89).	  Most	  bacteria	  possess	  classical	  oxidative	  defense	  mechanisms	  to	  detoxify	  oxidative	  free	  radicals	  such	  as	  super	  oxide	  dismutase,	  catalase	  and	  NADH	  peroxidases	  (90,	  91).	  	  Because	  of	  the	  anaerobic	  nature	  of	  bifidobacteria	  and	  their	  adaptation	  to	  the	  anaerobic	  environment	  of	  the	  gut,	  they	  lack	  these	  classical	  enzymes	  for	  oxygen	  radical	  detoxification.	  	  Genetic	  analyses	  of	  B.	  animalis	  subsp.	  
lactis	  and	  B.	  longum	  strains	  reveal	  that	  they	  contain	  genes	  for	  flavin	  proteins,	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  although	  they	  lack	  a	  gene	  for	  flavin	  reductase,	  as	  well	  as	  genes	  for	  a	  thioredoxin	  reductase-­‐thioredoxin	  system	  and	  a	  peroxiredoxin	  (67).	  	  Ferritin-­‐like	  iron	  binding	  proteins	  have	  also	  been	  identified	  as	  a	  protective	  mechanism	  against	  oxidative	  free	  radicals	  by	  sequestering	  iron	  to	  prevent	  free	  hydroxal	  radical	  formation	  (92).	  Molecular	  understanding	  of	  oxidative	  stress	  responses	  in	  bifidobacteria,	  particularly	  H2O2,	  is	  limited.	  	  Previous	  studies	  have	  investigated	  H2O2	  resistance	  in	  bifidobacteria	  and	  LAB,	  though	  due	  to	  experimental	  design,	  an	  increased	  understanding	  of	  the	  mechanism	  was	  not	  provided.	  	  This	  was	  partially	  due	  to	  a	  wide	  range	  of	  H2O2	  concentrations	  tested	  under	  static	  conditions	  in	  differing	  buffer	  solutions	  at	  very	  short	  or	  very	  long	  exposure	  times	  (93-­‐97). 	  
Inducible	  stress	  responses	  and	  crossprotection	  Several	  studies	  have	  shown	  that	  survival	  of	  many	  bacteria,	  including	  species	  of	  bifidobacteria,	  under	  stress	  conditions	  may	  be	  dramatically	  improved	  by	  deliberate	  induction	  of	  an	  adaptive	  or	  inducible	  stress	  response	  (98-­‐105).	  	  These	  bacterial	  stress	  responses	  are	  characterized	  by	  the	  transient	  induction	  of	  specific	  genes	  that	  encode	  for	  protective	  proteins	  (106).	  	  Although	  specific	  information	  on	  this	  topic	  in	  bifidobacteria	  is	  still	  quite	  limited,	  researchers	  have	  confirmed	  stress	  treatments	  are	  followed	  by	  the	  coordinated	  expression	  of	  gene	  products	  that	  include	  general	  and	  specific	  stress	  proteins	  (e.g.	  chaperones	  and	  ATP-­‐dependent	  proteases)	  and	  corresponding	  regulatory	  proteins	  (82,	  107,	  108,	  109,	  110).	  	   In	  the	  context	  of	  industrial	  or	  medical	  microbiology,	  one	  of	  the	  more	  significant	  facets	  of	  bacteria	  stress	  adaptation	  is	  the	  finding	  that	  stress	  responses	  
  
20	  induced	  under	  one	  set	  of	  conditions	  commonly	  provide	  cells	  with	  significant	  cross	  protection	  against	  other	  hostile	  yet	  seemingly	  unrelated	  environments	  (111).	  	  Recent	  studies	  have	  shown	  that	  the	  breadth	  and	  degree	  of	  environmental	  resistance	  or	  cross	  protection	  induced	  by	  a	  particular	  stress	  treatment	  can	  differ	  significantly	  between	  species	  and	  even	  strains	  (52,	  104,	  105,	  112,	  113,	  114,	  115).	  	  Although	  the	  knowledge	  that	  sublethal	  stress	  treatments	  can	  promote	  cell	  robustness	  is	  already	  exploited	  in	  the	  manufacture	  and	  use	  of	  probiotic	  cultures	  (55),	  a	  more	  detailed	  understanding	  of	  environmental	  adaptation	  specifically	  targeting	  bifidobacteria	  should	  reveal	  new	  strategies	  to	  improve	  the	  industrial	  stability,	  performance,	  and	  utility	  of	  these	  probiotic	  bacteria.	  Fortunately,	  some	  species	  and	  strains	  of	  bifidobacteria	  are	  intrinsically	  more	  resistant	  to	  environmental	  stresses	  than	  are	  others,	  which	  indicates	  that	  this	  limitation	  can	  probably	  be	  overcome	  through	  a	  more	  fundamental	  understanding	  of	  bifidobacteria	  physiology	  and	  their	  molecular	  mechanisms	  utilized	  during	  environmental	  stress	  response.	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  Interest	  in,	  and	  use	  of,	  bifidobacteria	  as	  a	  probiotic	  delivered	  in	  functional	  foods	  has	  increased	  dramatically	  in	  recent	  years.	  	  Due	  to	  their	  anaerobic	  nature,	  oxidative	  stress	  can	  pose	  a	  major	  challenge	  to	  maintaining	  viability	  of	  bifidobacteria	  during	  functional	  food	  storage.	  	  To	  better	  understand	  the	  oxidative	  stress	  response	  in	  two	  industrially	  important	  bifidobacteria	  species,	  we	  examined	  the	  response	  of	  three	  strains	  of	  Bifidobacterium	  longum	  and	  three	  strains	  of	  Bifidobacterium	  animalis	  subsp.	  lactis	  to	  hydrogen	  peroxide	  (H2O2).	  	  Each	  strain	  was	  exposed	  to	  a	  range	  of	  H2O2	  concentrations	  (0	  mM	  to	  10	  mM)	  to	  evaluate	  and	  compare	  intrinsic	  resistance	  to	  H2O2.	  	  Next,	  strains	  were	  tested	  for	  the	  presence	  of	  an	  inducible	  oxidative	  stress	  response	  by	  exposure	  to	  a	  sublethal	  H2O2	  concentration	  for	  20	  or	  60	  min	  followed	  by	  challenge	  at	  a	  lethal	  H2O2	  concentration.	  	  Results	  showed	  B.	  longum	  subsp.	  
infantis	  ATCC	  15697	  had	  the	  highest	  level	  of	  intrinsic	  H2O2	  resistance	  of	  all	  strains	  tested	  and	  B.	  animalis	  subs.	  lactis	  BL-­‐04	  had	  the	  highest	  resistance	  among	  B.	  lactis	  strains.	  	  Inducible	  H2O2	  resistance	  was	  detected	  in	  four	  strains,	  B.	  longum	  NCC2705,	  
B.	  longum	  D2957,	  B.	  lactis	  RH-­‐1	  and	  B.	  lactis	  BL-­‐04.	  	  Other	  strains	  showed	  either	  no	  
                                                1	  Reprinted	  from	  Oberg	  TS,	  Steele	  JL,	  Ingham	  SC,	  Smeianov	  VV,	  Briczinski	  EP,	  Abdalla	  A,	  Broadbent	  JR.	  2011.	  Intrinsic	  and	  inducible	  resistance	  to	  hydrogen	  peroxide	  in	  
Bifidobacterium	  species.	  J.	  Ind.	  Microbiol.	  Biotechnol.	  38:1947–1953	  with	  permission	  (Appendix	  B).	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  difference	  or	  increased	  sensitivity	  to	  H2O2	  after	  induction	  treatments.	  	  These	  data	  indicate	  that	  intrinsic	  and	  inducible	  resistance	  to	  hydrogen	  peroxide	  is	  strain	  specific	  in	  B.	  longum	  and	  B.	  lactis	  and	  suggest	  that	  for	  some	  strains,	  sublethal	  H2O2	  treatments	  might	  help	  increase	  cell	  resistance	  to	  oxidative	  damage	  during	  production	  and	  storage	  of	  probiotic	  containing	  foods.	  	  
INTRODUCTION	  
	  	   Foods	  and	  food	  ingredients	  with	  “bioactive”	  properties,	  which	  are	  defined	  by	  their	  ability	  to	  impact	  human	  health	  in	  a	  manner	  not	  based	  solely	  on	  their	  nutritional	  value,	  have	  increased	  in	  popularity	  among	  consumers	  in	  the	  last	  decade.	  One	  example	  involves	  “probiotic”	  bacteria,	  which	  are	  “living	  organisms	  that,	  when	  ingested	  at	  sufficient	  numbers,	  exert	  a	  beneficial	  effect	  on	  the	  host	  organism	  beyond	  inherent	  general	  nutrition”	  (12).	  	  Currently,	  species	  of	  Lactobacillus	  and	  
Bifidobacterium	  are	  the	  most	  widely	  used	  probiotic	  bacteria	  added	  to	  commercial	  bioactive	  products	  (33).	  	  Many	  species	  of	  bifidobacteria	  are	  used	  as	  probiotics,	  but	  two	  of	  the	  most	  important	  commercial	  species	  are	  Bifidobacterium	  longum	  and	  
Bifidobacterium	  animalis	  ssp.	  lactis	  (henceforth	  described	  as	  B.	  lactis).	  	   Although	  bifidobacteria	  are	  relatively	  minor	  components	  of	  the	  normal	  gastrointestinal	  (GI)	  microbiota	  in	  human	  adults,	  research	  indicates	  some	  strains	  can	  promote	  or	  provide	  several	  health	  related	  functions,	  including	  host	  resistance	  to	  infectious	  microbes,	  anti-­‐carcinogenic	  activities,	  and	  improved	  nutritional	  efficiency	  (2,	  41).	  	  Moreover,	  certain	  species	  of	  bifidobacteria	  are	  major	  components	  of	  the	  GI	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  microbiota	  in	  healthy,	  breast-­‐fed	  infants,	  and	  recent	  work	  suggests	  the	  composition	  of	  GI	  microbiota	  in	  infants	  and	  children	  may	  influence	  the	  development	  of	  diarrheal,	  inflammatory,	  and	  allergic	  diseases	  (31).	  No	  conclusive	  data	  are	  available	  on	  the	  minimal	  effective	  dose	  of	  probiotics	  in	  humans,	  but	  results	  from	  several	  clinical	  trials	  suggest	  a	  direct	  dose-­‐effect	  correlation	  (23,	  26,	  35).	  	  As	  a	  result,	  the	  current	  WHO	  definition	  of	  probiotics	  emphasizes	  the	  need	  for	  administration	  of	  the	  probiotics	  in	  “adequate	  amounts”	  (27).	  	  Thus,	  successful	  application	  of	  probiotic	  bifidobacteria	  in	  foods	  is	  not	  only	  dependent	  upon	  the	  functionality	  of	  the	  strain,	  but	  also	  on	  the	  development	  of	  technologies	  to	  ensure	  their	  survival	  in	  high	  numbers	  during	  food	  processing	  and	  maintaining	  those	  high	  numbers	  during	  storage.	  Challenges	  associated	  with	  probiotic	  delivery	  are	  exacerbated	  by	  the	  fact	  that	  these	  cells	  are	  commonly	  exposed	  to	  unfavorable	  environmental	  conditions	  during	  the	  manufacture	  or	  storage	  of	  most	  food-­‐based	  delivery	  systems	  for	  bifidobacteria	  (29).	  	  For	  example,	  efforts	  to	  secure	  and	  maintain	  high	  numbers	  of	  viable	  bifidobacteria	  in	  bioactive	  food	  products	  are	  commonly	  impeded	  by	  the	  intrinsic	  and	  extrinsic	  properties	  of	  the	  food	  such	  as	  dehydration	  (low	  aw),	  high	  or	  low	  temperature,	  low	  pH,	  high	  sodium	  chloride	  levels,	  or	  presence	  of	  oxygen,	  all	  of	  which	  may	  be	  deleterious	  to	  bifidobacteria	  (7,	  9,	  29,	  39).	  	  To	  address	  this	  problem,	  processors	  may	  employ	  very	  large	  inocula	  or	  add	  specific	  growth	  promoters	  or	  protectants	  (25,	  29,	  44).	  Additionally,	  the	  ability	  of	  bacteria	  to	  resist	  environmental	  extremes	  is	  generally	  affected	  by	  growth	  phase,	  with	  stationary-­‐phase	  cells	  showing	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  far	  greater	  resistance	  than	  mid-­‐log-­‐phase	  cells	  (45).	  	  As	  a	  result,	  industrial	  production	  of	  probiotic	  cultures	  is	  typically	  performed	  in	  large	  fermenters	  under	  rigid	  pH	  and	  temperature	  control,	  and	  cells	  are	  harvested	  at	  late-­‐log	  or	  early	  stationary-­‐phase	  growth	  to	  maximize	  cell	  biomass	  and	  vigor	  (22,	  30).	  	  Oxygen	  toxicity	  results	  from	  cell	  exposure	  to	  activated	  oxygen	  compounds	  such	  as	  superoxide,	  hydrogen	  peroxide	  (H2O2),	  and	  hydroxyl	  radicals,	  which	  induce	  peptide	  breaks,	  oxidation	  of	  sulfhydryl	  groups	  in	  proteins	  and	  oxidation	  of	  membrane	  lipids	  (6).	  	  Although	  H2O2	  is	  the	  most	  stable	  of	  these	  molecules,	  dissociation	  and	  interaction	  with	  cellular	  components	  can	  form	  organic	  peroxides,	  which	  can	  initiate	  a	  chain	  reaction	  of	  oxidation	  (13).	  	  Most	  bifidobacteria	  organisms	  lack	  genes	  for	  catalase	  and	  superoxide	  dismutase,	  which	  are	  used	  by	  many	  bacteria	  to	  detoxify	  H2O2	  and	  superoxide,	  respectively.	  Nonetheless,	  Bifiobacterium	  species	  have	  been	  shown	  to	  produce	  inhibitory	  levels	  of	  H2O2	  when	  incubated	  in	  the	  presence	  of	  oxygen	  (10).	  	  Moreover,	  bifidobacteria	  are	  commonly	  added	  to	  yogurt	  products	  and	  the	  starter	  cultures	  used	  to	  manufacture	  yogurt,	  Lactobacillus	  
delbrueckii	  ssp.	  bulgaricus	  and	  Streptococcus	  thermophilus	  have	  also	  been	  shown	  to	  produce	  inhibitory	  concentrations	  of	  H2O2	  when	  grown	  under	  conditions	  such	  as	  those	  encountered	  during	  bioactive	  food	  production	  and	  storage	  (40).	  Several	  studies	  have	  shown	  environmental	  stress	  resistance	  in	  many	  microorganisms,	  including	  some	  bifidobacteria,	  may	  be	  dramatically	  improved	  by	  deliberate	  induction	  of	  an	  adaptive	  or	  inducible	  stress	  response	  (4,	  5,	  8,	  11,	  15,	  22,	  30,	  37,	  42).	  	  These	  inducible	  stress	  responses	  are	  characterized	  by	  the	  transient	  
  
36	  induction	  of	  genes	  that	  encode	  general	  and	  specific	  stress	  proteins	  (e.g.	  chaperones	  and	  ATP-­‐dependent	  proteases)	  and	  corresponding	  regulatory	  proteins	  (3,	  16,	  21,	  32,	  34,	  46,	  47).	  	  	   The	  knowledge	  that	  sublethal	  stress	  treatments	  can	  promote	  cell	  robustness	  is	  already	  exploited	  in	  the	  manufacture	  and	  use	  of	  probiotic	  cultures	  (39),	  but	  a	  more	  detailed	  understanding	  of	  environmental	  adaptation	  by	  bifidobacteria	  to	  oxidative	  stress	  would	  likely	  reveal	  new	  strategies	  to	  improve	  the	  industrial	  stability,	  performance,	  and	  utility	  of	  these	  probiotics.	  Thus,	  the	  purpose	  of	  this	  research	  was	  to	  investigate	  the	  intrinsic	  and	  inducible	  H2O2	  stress	  resistance	  in	  several	  industrially	  important	  strains	  of	  B.	  longum	  and	  B.	  lactis.	  
	  
MATERIALS	  AND	  METHODS	  
	  
Bacterial	  strains	  and	  culture	  conditions	  Strains	  of	  B.	  longum	  and	  B.	  lactis	  selected	  for	  use	  in	  this	  study	  are	  listed	  in	  Table	  3-­‐1.	  	  Strains	  were	  maintained	  as	  glycerol	  freezer	  stocks	  at	  -­‐80oC,	  and	  working	  cultures	  were	  prepared	  by	  two	  successive	  transfers	  (1%	  innoculum,	  v/v)	  into	  peptonized	  milk	  media	  (MP5)	  (3%	  proteose	  peptone,	  1.4%	  glucose,	  1.7%	  yeast	  extract,	  0.1%	  Tween	  80,	  0.45%	  sodium	  chloride,	  0.05%	  cysteine	  HCl)	  with	  anaerobic	  incubation	  at	  37oC	  for	  18	  h.	  	  Batch	  cultures	  of	  each	  strain	  were	  prepared	  for	  H2O2	  resistance	  studies	  by	  a	  1%	  (v/v)	  inoculation	  of	  working	  cultures,	  diluted	  to	  an	  OD600	  of	  1.0	  in	  MP5	  media,	  into	  one	  liter	  of	  MP5	  media	  in	  a	  1	  L	  New	  Brunswick	  BioFlo	  III	  fermenter	  (New	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  Brunswik	  Scientific,	  Edison,	  New	  Jersey),	  with	  an	  agitation	  rate	  of	  100	  rpm	  and	  an	  incubation	  temperature	  of	  37oC.	  	  A	  gas	  mixture	  of	  5%	  carbon	  dioxide	  and	  95%	  nitrogen	  was	  continuously	  passed	  over	  the	  headspace	  of	  the	  fermenter	  to	  achieve	  anaerobic	  conditions,	  and	  the	  pH	  was	  maintained	  at	  6.5	  by	  automatic	  addition	  of	  15%	  (v/v)	  ammonium	  hydroxide.	  The	  cultures	  were	  incubated	  until	  the	  cells	  reached	  early	  stationary-­‐phase	  (approximately	  12	  h	  for	  the	  B.	  lactis	  strains	  and	  14	  h	  for	  the	  B.	  longum	  strains).	  	  
Table	  3-­1	  	  Bifidobacteria	  selected	  for	  this	  study.	  Species	  and	  strain	   Description	  (reference)	  
B.	  animalis	  ssp.	  lactis	   	  	  	  	  	  	  	  BL-­‐04	   Industrial	  probiotic	  strain	  [3]	  	  	  	  	  	  	  DSM	  10140	   Industrial	  probiotic	  and	  type	  strain	  [3]	  	  	  	  	  	  	  RH-­‐1	   Industrial	  probiotic	  strain	  
B.	  longum	   	  	  	  	  	  	  	  NCC2705	   Industrial	  probiotic	  strain;	  isolated	  from	  human	  infant	  [36]	  	  	  	  	  	  	  D2957	   Industrial	  probiotic	  strain	  








and	  the	  CFU/mL	  after	  1	  h	  (for	  each	  strain)	  were	  fitted	  into	  a	  least	  squares	  linear	  regression	  model	  with	  the	  95%	  confidence	  interval	  of	  the	  slopes	  used	  to	  determine	  significant	  differences	  between	  the	  strains	  (14).	  	   For	  inducible	  stress	  response	  testing,	  lethal	  stress	  treatments	  for	  each	  strain	  were	  defined	  as	  the	  minimum	  H2O2	  concentration	  at	  which	  there	  were	  no	  recoverable	  cells	  over	  the	  6-­‐h	  incubation	  period.	  	  Sublethal	  stress	  treatments	  for	  each	  strain	  were	  defined	  as	  the	  highest	  H2O2	  concentration	  that	  resulted	  in	  no	  more	  than	  a	  1	  log10	  decrease	  in	  cell	  numbers	  during	  the	  6-­‐h	  exposure	  (30).	  	  




withstand	  a	  particular	  lethal	  stress	  treatment	  after	  a	  sublethal	  H2O2	  exposure	  was	  expressed	  as	  a	  percent	  survival,	  which	  was	  calculated	  by	  dividing	  the	  log10	  CFU/mL	  of	  surviving	  cells	  after	  a	  30	  min	  lethal	  H2O2	  challenge	  by	  the	  log10	  CFU/mL	  of	  cells	  after	  a	  0	  min	  lethal	  H2O2	  exposure.	  	  To	  determine	  if	  the	  calculated	  percent	  survival	  was	  significant,	  means	  from	  the	  induced	  strain	  were	  compared	  to	  control	  means	  using	  a	  one-­‐tailed	  two-­‐sample	  t	  test	  without	  pooled	  variance	  with	  a	  =	  0.05	  (14).	  	  
RESULTS	  
	  	   Assays	  for	  intrinsic	  resistance	  to	  H2O2	  exposure	  among	  commercial	  strains	  of	  
B.	  longum	  and	  B.	  lactis	  showed	  B.	  longum	  ssp.	  infantis	  ATCC	  15697	  had	  significantly	  higher	  (p<0.05)	  intrinsic	  H2O2	  resistance	  than	  all	  the	  strains	  tested	  (Figure	  3-­‐1).	  	  B.	  
lactis	  BL-­‐04,	  B.	  longum	  NCC2705,	  and	  B.	  lactis	  RH-­‐1	  showed	  an	  intermediate	  level	  of	  intrinsic	  H2O2	  resistance,	  while	  B.	  longum	  D2957	  and	  B.	  lactis	  DSM10140	  showed	  the	  lowest	  intrinsic	  resistance	  to	  H2O2.	  	  The	  log10	  CFU	  data	  collected	  each	  hour	  over	  the	  6	  h	  incubation	  was	  used	  to	  define	  the	  sublethal	  and	  lethal	  H2O2	  concentrations	  for	  induction	  and	  challenge	  (Figure	  3-­‐2).	  	  The	  graphs	  in	  figure	  3-­‐2	  show	  a	  clear	  division	  among	  the	  concentrations	  of	  H2O2	  tested	  and	  based	  on	  the	  data,	  the	  sublethal	  concentration	  was	  determined	  to	  be	  1.25mM	  and	  the	  lethal	  concentrations	  were	  determined	  to	  be	  2.55mM	  and	  5.25mM	  for	  all	  strains.	  	  Experiments	  to	  screen	  




Fig.	  3-­1	  	  Linear	  regression	  plots	  of	  intrinsic	  H2O2	  resistance.	  	  X-­axis,	  measured	  H2O2	  concentration	  of	  media	  before	  inoculation.	  	  Y-­axis,	  log10	  CFU/mL	  after	  1	  h	  incubation.	  Graphs:	  a.	  	  B.	  infantis	  ATCC	  15697;	  b.	  B.	  longum	  NCC2705;	  c.	  B.	  




Fig.	  3-­2	  	  Graphs	  of	  intrinsic	  H2O2	  resistance	  during	  a	  6	  h	  exposure.	  	  X-­axis,	  time	  (h).	  	  Y-­axis,	  log10	  CFU/mL.	  Graphs:	  a.	  B.	  




strains	  displayed	  a	  decreased	  percent	  survival	  after	  the	  lethal	  challenge	  compared	  to	  control	  cells	  (Figure	  3-­‐3).	  	  These	  results	  show	  that	  some	  strains	  were	  unable	  to	  mount	  an	  inducible	  stress	  response	  under	  the	  conditions	  tested,	  and	  in	  some	  cases,	  cells	  that	  were	  exposed	  to	  sublethal	  H2O2	  were	  more	  sensitive	  to	  lethal	  H2O2	  concentrations	  than	  control	  cells.	  	  However,	  60	  min	  sublethal	  H2O2	  treatment	  with	  
B.	  longum	  NCC2705	  significantly	  (p<0.05)	  increased	  the	  survival	  of	  this	  strain	  at	  both	  lethal	  H2O2	  concentrations	  tested	  (Figure	  3-­‐4),	  and	  a	  significant	  (p<0.05)	  increase	  in	  survival	  was	  also	  recorded	  for	  B.	  longum	  NCC2705	  and	  B.	  longum	  D2957	  given	  a	  20	  min	  treatment	  followed	  by	  a	  lethal	  challenge	  at	  2.55	  mM	  H2O2	  (Figure	  3-­‐3A).	  Among	  the	  B.	  lactis	  strains,	  B.	  lactis	  RH-­‐1	  and	  B.	  lactis	  BL-­‐04	  cells	  given	  a	  20	  min	  induction	  treatment	  showed	  a	  significant	  (p<0.05)	  increase	  in	  survival	  after	  5.25	  mM	  H2O2	  challenge	  (Figure	  3-­‐4B).	  	  





Fig.	  3-­3	  	  Percent	  survival	  of	  Bifidobacterium	  after	  a	  20	  min	  experimental	  stress	  response	  induction	  at	  1.25	  mM	  H2O2	  challenged	  at	  lethal	  concentrations	  of	  A	  2.55	  mM	  H2O2	  and	  B	  	  5.25	  mM	  H2O2.	  Lanes:	  a	  B.	  infantis	  ATCC	  15697;	  b	  B.	  longum	  NCC2705;	  c	  B.	  longum	  D2957;	  d	  B.	  lactis	  BL-­‐04;	  e	  B.	  lactis	  RH-­‐1;	  f	  B.	  lactis	  DSM10140.	  	  Open	  square,	  Control;	  filled	  square,	  Induced.	  	  Each	  value	  is	  the	  mean	  of	  four	  replicates.	  	  Error	  bars	  correspond	  to	  the	  standard	  error	  of	  the	  mean	  (SEM).	  	  





Fig.	  3-­4	  	  Percent	  survival	  of	  Bifidobacterium	  after	  60	  min	  experimental	  stress	  response	  induction	  at	  1.25	  mM	  H2O2	  challenged	  at	  lethal	  concentrations	  of	  A	  2.55	  mM	  H2O2	  and	  B	  5.25	  mM	  H2O2.	  	  Lanes:	  a	  B.	  infantis	  ATCC	  15697;	  b	  B.	  longum	  NCC2705;	  c	  B.	  longum	  D2957;	  d	  B.	  lactis	  BL-­‐04;	  e	  B.	  lactis	  RH-­‐1;	  f	  B.	  lactis	  DSM10140.	  	  Open	  square,	  Control;	  filled	  square,	  Induced.	  	  Each	  value	  is	  the	  mean	  of	  four	  replicates.	  	  Error	  bars	  correspond	  to	  the	  standard	  error	  of	  the	  mean	  (SEM).	  	  








Although	  certain	  strains	  showed	  higher	  H2O2	  resistance	  than	  others,	  the	  lethal	  H2O2	  concentration	  for	  all	  strains	  was	  relatively	  low	  (2.55-­‐5.25	  mM).	  	  These	  values	  are	  within	  the	  concentration	  range	  of	  H2O2	  produced	  by	  lactic	  starter	  cultures	  during	  manufacture	  of	  yogurt	  and	  other	  bioactive	  foods	  (40),	  which	  underscores	  the	  need	  for	  technologies	  to	  enhance	  H2O2	  resistance	  in	  bifidobacteria.	  	  	  Our	  results	  suggest	  that	  a	  sublethal	  H2O2	  exposure	  could	  be	  used	  to	  enhance	  H2O2	  resistance	  of	  some	  strains	  (e.g.	  B.	  longum	  NCC2705	  and	  B.	  lactis	  BL-­‐04),	  and	  increase	  their	  survival	  in	  functional	  foods.	  	  Additionally,	  more	  detailed	  studies	  of	  inducible	  H2O2	  stress	  resistance	  in	  these	  strains	  may	  reveal	  strategies	  to	  enhance	  H2O2	  resistance	  in	  a	  broader	  range	  of	  strains.	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IDENTIFICATION	  OF	  PLASMALOGENS	  IN	  THE	  CYTOPLASMIC	  MEMBRANE	  OF	  
BIFIDOBACTERIUM	  ANIMALIS	  SUBSP.	  LACTIS	  
	  
ABSTRACT	  
	  Plasmalogens	  are	  ether-­‐linked	  lipids	  that	  may	  influence	  oxidative	  stress	  resistance	  of	  eukaryotic	  cell	  membranes.	  	  Since	  bacterial	  membrane	  composition	  can	  influence	  environmental	  stress	  resistance,	  we	  explored	  the	  prevalence	  of	  plasmalogens	  in	  the	  cytoplasmic	  membrane	  of	  Bifidobacterium	  animalis	  subsp.	  
lactis.	  	  Results	  showed	  plasmalogens	  are	  a	  major	  component	  of	  the	  B.	  animalis	  subsp.	  lactis	  membrane.	  
	  
INTRODUCTION	  
	  Evidence	  suggests	  several	  species	  of	  bifidobacteria	  have	  probiotic	  properties	  (20),	  and	  two	  commercially	  important	  species	  are	  Bifidobacterium	  longum	  and	  
Bifidobacterium	  animalis	  ssp.	  lactis.	  One	  of	  the	  challenges	  associated	  with	  use	  of	  bifidobacteria	  probiotics	  involves	  the	  loss	  of	  viability	  due	  to	  the	  unfavorable	  environmental	  conditions	  that	  are	  encountered	  during	  the	  manufacture	  and	  storage	  of	  most	  food-­‐based	  delivery	  systems	  (21).	  	  One	  potential	  mechanism	  to	  enhance	  cell	  survival	  involves	  manipulation	  of	  bacterial	  cell	  membrane	  fatty	  acid	  (CMFA)	  
                                                
1 Reprinted	  from	  Oberg	  TS,	  Ward	  RE,	  Steele	  JL,	  Broadbent	  JR.	  	  2012.	  	  Identification	  of	  plasmalogens	  in	  the	  cytoplasmic	  membrane	  of	  Bifidobacterium	  animalis	  subsp.	  lactis.	  Appl.	  Environ.	  Microbio.	  78:880–884	  with	  permission	  (Appendix	  B).	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  composition	  (14,	  22).	  	  Several	  studies	  have	  shown	  that	  CMFA	  composition	  influences	  membrane	  fluidity,	  proton	  permeability	  and	  the	  activity	  of	  a	  variety	  of	  transport	  proteins	  (8,	  12,	  23,	  28).	  	  Cell	  exposure	  to	  acidic	  pH,	  for	  example,	  can	  trigger	  an	  increase	  in	  the	  level	  of	  saturated,	  branched,	  or	  cyclopropane	  fatty	  acids	  in	  the	  cell	  membrane	  (2,	  4,	  6,	  9,	  11,	  13).	  	  These	  changes	  render	  the	  cell	  membrane	  more	  rigid	  and	  result	  in	  greater	  cell	  membrane	  stability	  in	  acidic	  environments.	  	  Among	  bifidobacteria,	  a	  bile	  salt	  resistant	  B.	  animalis	  subsp.	  lactis	  mutant	  has	  been	  shown	  to	  increase	  the	  unsaturated/saturated	  fatty	  acid	  ratio	  of	  its	  CMFA	  during	  bile	  salt	  exposure	  whereas	  wild-­‐type	  cells	  showed	  a	  decrease	  in	  the	  unsaturated/saturated	  fatty	  acid	  ratio	  (22).	  	  This	  study	  also	  showed	  that	  in	  both	  strains	  there	  was	  a	  large	  decrease	  in	  the	  amount	  of	  C19:0	  cyclopropyl	  fatty	  acid	  in	  response	  to	  bile	  salt	  exposure.	  Plasmalogens	  are	  phospholipids	  that	  contain	  a	  vinyl	  ether	  bond	  at	  the	  SN1	  position	  as	  opposed	  to	  an	  ester	  bond,	  and	  display	  distinct	  physical	  properties	  compared	  to	  diacyl	  analogs.	  	  Plasmalogens	  are	  widespread	  among	  eukaryotes,	  accounting	  for	  up	  to	  one-­‐fifth	  of	  the	  total	  phospholipid	  pool	  of	  humans	  (26).	  	  In	  eukaryotes,	  cells	  with	  high	  CMFA	  plasmalogen	  content	  are	  associated	  with	  oxidative	  environments,	  and	  display	  lower	  membrane	  ion	  permeability	  and	  surface	  potential,	  and	  an	  increase	  in	  cell	  membrane	  fluidity	  (26).	  	  Additionally,	  the	  vinyl	  ether	  bond	  is	  more	  easily	  oxidized	  than	  the	  carbon-­‐carbon	  double	  bond	  of	  unsaturated	  fatty	  acids,	  and	  in	  contrast	  to	  oxidized	  unsaturated	  fatty	  acids	  plasmalogens	  do	  not	  propagate	  free	  radicals	  in	  response	  to	  peroxides	  (5,	  17).	  	  Because	  of	  these	  characteristics,	  
  
54	  plasmalogens	  have	  been	  proposed	  to	  act	  as	  anti-­‐oxidants	  in	  membrane	  physiology	  via	  protection	  of	  unsaturated	  fatty	  acids	  and	  membrane	  proteins	  from	  harmful	  oxidation	  (7,	  29).	  	  Several	  Clostridium,	  Mycobacterium	  and	  methanogenic	  archea	  species	  have	  also	  been	  found	  to	  possess	  vinyl	  ether-­‐linked	  lipids	  in	  their	  membrane,	  but	  little	  is	  known	  about	  their	  role	  (10,	  13,	  27).	  	  Very	  few	  studies	  on	  the	  membrane	  composition	  of	  bifidobacteria	  have	  noted	  vinyl	  ether	  linked	  lipids	  (1),	  or	  more	  commonly	  group	  them	  with	  their	  esterified	  analogs	  (22).	  Because	  of	  their	  unique	  properties,	  plasmalogen	  content	  should	  be	  considered	  in	  research	  to	  explore	  the	  role	  of	  CMFA	  composition	  in	  environmental	  stress	  resistance	  among	  bifidobacteria.	  	  Here,	  we	  use	  a	  previously	  described	  and	  simple	  methodology	  for	  derivitization	  of	  plasmalogens	  to	  isolate	  these	  lipids,	  and	  provide	  mass	  spectra	  lacking	  in	  the	  literature	  but	  necessary	  for	  their	  identification.	  	  Results	  reveal	  plasmalogens	  are	  a	  significant	  component	  of	  the	  cytoplasmic	  membrane	  of	  B.	  animalis	  subsp.	  lactis.	  	  
MATERIALS	  AND	  METHODS	  	  Two	  industrially	  important	  B.	  animalis	  subsp.	  lactis	  strains,	  DSM10140	  and	  BL-­‐04	  (3),	  were	  maintained	  as	  glycerol	  freezer	  stocks	  at	  -­‐80oC,	  and	  working	  cultures	  were	  prepared	  by	  two	  successive	  transfers	  (1%	  innoculum,	  vol/vol)	  into	  peptonized	  milk	  medium	  (MP5)	  (19)	  and	  incubated	  at	  37oC	  for	  18	  h	  in	  anaerobic	  chambers	  (Becton	  Dickinson	  Microbiology	  Systems,	  Cockeysville,	  MD.).	  	  Batch	  cultures	  of	  each	  strain	  were	  prepared	  by	  dilution	  of	  the	  working	  culture	  to	  an	  absorbance	  at	  600	  nm	  (A600)	  of	  1.0	  in	  MP5	  medium,	  then	  inoculated	  at	  1%	  (vol/vol)	  into	  1	  L	  of	  MP5	  in	  a	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  New	  Brunswick	  BioFlo	  III	  fermenter	  (New	  Brunswik	  Scientific,	  Edison,	  NJ),	  and	  finally	  incubated	  at	  37oC	  with	  an	  agitation	  rate	  of	  100	  rpm	  to	  prevent	  sedimentation.	  	  A	  gas	  mixture	  of	  5%	  CO2	  and	  95%	  N2	  was	  continuously	  passed	  over	  the	  headspace	  of	  the	  fermenter	  to	  achieve	  anaerobic	  conditions,	  and	  the	  pH	  was	  maintained	  at	  6.5	  by	  automatic	  addition	  of	  15%	  (vol/vol)	  NH4OH.	  	  The	  cultures	  were	  incubated	  until	  the	  cells	  reached	  early	  stationary-­‐phase	  (approximately	  12	  h)	  (19).	   Twenty	  mL	  of	  cells	  were	  centrifuged	  and	  washed	  twice	  with	  phosphate	  buffered	  saline	  (PBS).	  	  Total	  fatty	  acids	  were	  extracted	  from	  cell	  pellets	  by	  acid	  hydrolysis	  and	  methylation	  according	  to	  the	  MIDI	  laboratory	  protocol	  described	  by	  Sasser	  (25).	  	  To	  inhibit	  oxidation,	  butylated	  hydroxytoluene	  was	  added	  to	  each	  sample,	  and	  the	  GC	  vial	  headspace	  was	  flushed	  with	  nitrogen	  gas.	  	  The	  samples	  were	  then	  analyzed	  on	  a	  GCMS-­‐QP2010S	  (Shimadzu	  Scientific	  Instruments,	  Columbia,	  MD)	  equipped	  with	  a	  flame	  ionization	  detector	  and	  fitted	  with	  a	  10-­‐m	  guard	  column	  and	  a	  30-­‐m	  DB5	  capillary	  column.	  	  The	  injector	  temperature	  was	  held	  at	  250oC	  and	  1µL	  of	  the	  sample	  was	  injected	  splitless.	  	  The	  temperature	  of	  the	  oven	  was	  held	  at	  50oC	  for	  1	  min	  then	  increased	  to	  150oC	  at	  20oC/min,	  and	  then	  increased	  to	  250oC	  at	  4oC/min,	  with	  the	  final	  temperature	  of	  250oC	  held	  for	  1	  min.	  	  Helium	  was	  used	  as	  the	  carrier	  gas	  at	  a	  column	  flow	  rate	  of	  1.79	  mL/min.	  	  Electron	  impact	  ionization	  at	  70	  eV	  was	  used	  for	  fragmentation.	  	  A	  bacterial	  acid	  methyl	  esters	  standards	  mix	  (SUPELCO,	  Bellefonte,	  PA)	  was	  used	  to	  identify	  derivatized	  methyl	  esters	  in	  the	  samples.	  	  The	  data	  were	  normalized	  and	  the	  percent	  of	  total	  for	  each	  fatty	  acid	  was	  
  
56	  determined.	  	  Because	  ion	  fingerprints	  for	  plasmalogens	  are	  not	  available	  in	  the	  standard	  or	  the	  literature,	  samples	  containing	  suspected	  plasmalogens	  were	  collected	  as	  described,	  and	  sent	  to	  the	  University	  of	  California	  Riverside	  Analytical	  Chemistry	  Instrumentation	  Facility	  for	  GC-­‐accurate	  mass	  of	  ionized	  lipid	  fragments.	  	  Samples	  were	  also	  sent	  to	  the	  University	  of	  Utah	  Mass	  Spectrometry	  and	  Proteomics	  Core	  Facility	  for	  precise	  mass	  measurements	  of	  the	  intact	  parent	  species	  using	  GC-­‐electrospray	  ionization	  accurate	  mass	  on	  a	  Waters	  GCT	  Premiere	  Lockmass.	  	  
RESULTS	  AND	  DISCUSSION	  
	  The	  vinyl	  ether	  bond	  of	  plasmalogens	  is	  easily	  hydrolyzed	  under	  acidic	  conditions	  to	  form	  an	  aldehyde,	  which	  in	  the	  presence	  of	  methanol	  rapidly	  reacts	  to	  form	  dimethyl-­‐acetals	  (DMA)	  (Figure	  4-­‐1)	  (16).	  	  The	  isolated	  DMA	  elute	  at	  a	  slower	  rate	  on	  the	  GC	  column	  than	  their	  methyl	  ester	  analogs,	  allowing	  separation.	  	  Figure	  4-­‐2	  shows	  a	  chromatogram	  of	  the	  membrane	  fatty	  acids	  of	  B.	  animalis	  subsp.	  lactis	  DSM10140.	  	  After	  analysis	  and	  comparison	  to	  the	  standard,	  peaks	  of	  interest	  were	  identified	  based	  on	  their	  elution	  time	  and	  the	  presence	  of	  a	  strong	  ion	  peak	  of	  75.	  Under	  electron	  impact	  ionization,	  DMA	  fragments	  extensively,	  with	  the	  most	  abundant	  ion	  (m/z	  =	  75)	  resulting	  from	  the	  loss	  of	  the	  DMA	  head-­‐group.	  	  This	  ion	  peak	  is	  the	  principal	  identifier	  of	  DMA	  and	  is	  unique	  to	  these	  molecules	  (27).	  The	  extracted	  mass	  spectrum	  of	  each	  peak	  (Figure	  4-­‐3)	  was	  analyzed	  to	  determine	  its	  empirical	  formula.	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FIG	  4-­2	  	  Gas	  chromatogram	  of	  cytoplasmic	  membrane	  lipid	  extract	  from	  





FIG	  4-­3	  	  Mass	  spectra	  of	  dimethyl-­‐acetal	  derived	  plasmalogens.	  	  Spectra	  are	  shown	  for	  C14:1	  (A),	  C14:0	  (B),	  C16:1	  (C),	  C16:0	  (D),	  C17:0	  cyclopropyl	  (E),	  C18:1	  (F)	  and	  C19:0	  cyclopropyl	  (G).	  	  y	  axis,	  relative	  abundance;	  x	  axis,	  mass-­‐to-­‐charge	  ration	  m/z.	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  Another	  important	  fragmentation	  product	  is	  the	  parent	  ion	  molecular	  mass	  minus	  31	  (M-­‐31)	  that	  results	  from	  loss	  of	  a	  methoxy	  group	  (Figure	  4-­‐1).	  	  These	  peaks	  reveal	  the	  number	  of	  carbons	  and	  level	  of	  saturation	  in	  the	  alkenyl	  moieties	  of	  the	  DMA.	  	  Table	  4-­‐1	  shows	  the	  measured	  accurate	  mass	  mass	  to	  charge	  ratio	  (m/z)	  of	  M-­‐31	  for	  each	  peak	  and	  compares	  them	  to	  the	  calculated	  m/z.	  	  A	  parts-­‐per-­‐million	  (ppm)	  error	  was	  calculated	  for	  each	  m/z,	  with	  each	  error	  under	  the	  threshold	  value	  for	  significance	  (5	  ppm).	  	  Under	  electron	  impact	  ionization,	  these	  molecules	  fragment	  easily	  and	  do	  not	  produce	  a	  detectable	  parent	  ion.	  	  Electrospray	  ionization	  was	  used	  to	  measure	  the	  m/z	  of	  the	  parent	  ion	  peak.	  	  This	  is	  a	  soft	  ionization	  method	  which	  allows	  for	  the	  addition	  of	  an	  electron	  without	  fragmenting	  the	  molecule.	  	  The	  measured	  accurate	  m/z	  of	  the	  parent	  ion	  peaks	  were	  also	  compared	  to	  the	  calculated	  m/z,	  with	  all	  having	  a	  ppm	  error	  less	  than	  5	  (Table	  4-­‐1).	  	  Together,	  these	  mass	  spectrometry	  (MS)	  data	  provide	  positive	  identification	  of	  the	  DMA	  in	  B.	  
animalis	  subsp.	  lactis	  membrane	  samples.	  	  	  Previous	  research	  in	  our	  laboratory	  (19)	  showed	  B.	  animalis	  subsp.	  lactis	  BL-­‐04	  has	  significantly	  greater	  intrinsic	  resistance	  to	  H2O2	  than	  strain	  DSM10140.	  	  Data	  collected	  in	  this	  study	  show	  plasmalogens	  make	  up	  a	  significant	  proportion	  of	  the	  total	  membrane	  composition	  of	  B.	  animalis	  subsp.	  lactis	  DSM10140	  and	  BL-­‐04	  (26.34%	  ±	  4.73%	  and	  30.35%	  ±	  5.21%,	  respectively).	  	  Although	  the	  amount	  of	  plasmalogens	  in	  DSM10140	  and	  BL-­‐04	  as	  a	  percent	  of	  total	  CMFA	  are	  not	  significantly	  different	  (P	  =	  0.05),	  levels	  of	  C19:0	  cyclopropyl	  vinyl	  ether	  lipids	  are	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  significantly	  higher	  (P	  <	  0.05)	  in	  strain	  BL-­‐04	  (15.48%	  ±	  7.01%)	  versus	  DSM10140	  (6.71%	  ±	  1.74%).	  	  	  
	  
TABLE	  4-­1	  	  Measured	  masses	  of	  DMA-­‐derived	  plasmalogens.	  
	   	   M	  -­‐31	  Peaks  Parent	  ion	  peaks 
Fatty	  acid	   Empirical	  formula	   Calculated	  m/z	   Measured	  m/z	    Calculated	  m/z	   Measured	  m/z	  C14:1	   C16H32O2	   225.2062	   225.2216a	    256.2402	   256.2396a	  C14:0	   C16H34O2	   227.2219	   227.2373a	    258.2559	   258.2481a	  C16:1	   C18H36O2	   253.2375	   253.2547a	    284.2715	   284.2697a	  C16:0	   C18H38O2	   255.2532	   255.2679a	    286.2872	   286.3019a	  C17:0	  cyclopropyl	   C19H38O2	   267.4760	   267.2675a	    298.5100	   298.3925a	  C18:1	   C20H40O2	   281.2688	   281.2837a	    312.3028	   312.3028a	  C19:0	  cyclopropyl	   C21H42O2	   295.2845	   295.2551a	    326.3185	   326.3138a	  aMeasured	  mass	  with	  error	  less	  than	  5	  ppm.	  	   A	  previous	  study	  (1)	  reported	  that	  oxygen-­‐tolerant	  fecal	  isolates	  of	  
Bifidobacterium	  had	  a	  high	  content	  of	  plasmalogens	  in	  the	  CMFA,	  and	  data	  from	  that	  work	  also	  support	  a	  direct	  correlation	  between	  oxygen	  tolerance	  and	  higher	  CMFA	  concentrations	  of	  C19:0	  cyclopropyl	  plasmalogens.	  	  Because	  plasmalogens	  have	  been	  shown	  to	  have	  physical	  attributes	  that	  affect	  membrane	  physiology	  differently	  compared	  to	  the	  ester-­‐linked	  analogs,	  it	  is	  important	  to	  consider	  these	  lipids	  when	  characterizing	  the	  membrane	  composition	  of	  bifidobacteria.	  	  The	  high	  concentrations	  of	  plasmalogens	  in	  B.	  animalis	  subsp.	  lactis	  membranes,	  together	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  with	  strain-­‐specific	  differences	  in	  lipid	  species	  correlated	  with	  H2O2	  sensitivity,	  suggest	  these	  lipids	  may	  play	  an	  important	  role	  in	  environmental	  stress	  resistance.	  	  Further	  study	  is	  required	  to	  determine	  and	  understand	  the	  role	  of	  plasmalogens	  in	  membrane	  physiology	  and	  environmental	  stress	  adaptation	  of	  bifidobacteria.	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GENETIC	  AND	  PHYSIOLOGICAL	  RESPONSES	  OF	  	  
BIFIDOBACTERIUM	  ANIMALIS	  SUBSP.	  LACTIS	  TO	  HYDROGEN	  PEROXIDE	  STRESS	  
	  
ABSTRACT	  
	  	   Consumer	  interest	  in	  probiotic	  bifidobacteria	  is	  increasing,	  but	  industry	  efforts	  to	  secure	  high	  cell	  viability	  in	  foods	  is	  undermined	  by	  the	  sensitivity	  of	  these	  anaerobes	  to	  oxidative	  stress.	  	  To	  address	  this	  limitation,	  we	  investigated	  genetic	  and	  physiological	  responses	  of	  two	  fully	  sequenced	  Bifidobacterium	  animalis	  subsp.	  
lactis	  strains,	  BL-­‐04	  and	  DSM	  10140,	  to	  hydrogen	  peroxide	  (H2O2)	  stress.	  	  Although	  the	  genome	  sequences	  for	  these	  strains	  are	  highly	  clonal,	  prior	  work	  showed	  they	  differ	  in	  both	  intrinsic	  and	  inducible	  H2O2	  resistance.	  	  Transcriptome	  analysis	  of	  early	  stationary	  phase	  cells	  exposed	  to	  a	  sub-­‐lethal	  H2O2	  concentration	  detected	  significant	  (P<0.05)	  changes	  in	  expression	  of	  138	  genes	  in	  strain	  BL-­‐04	  after	  5	  min,	  and	  27	  genes	  after	  20	  min.	  	  Surprisingly,	  no	  significant	  changes	  in	  gene	  expression	  were	  detected	  in	  strain	  DSM	  10140	  at	  either	  time.	  	  Genomic	  data	  suggested	  differences	  in	  H2O2	  stress	  resistance	  might	  be	  due	  to	  a	  mutation	  in	  a	  BL-­‐04	  gene	  encoding	  long	  chain	  fatty	  acid-­‐coenzyme	  A	  (CoA)	  ligase.	  	  To	  explore	  this	  possibility,	  membrane	  fatty	  acids	  were	  isolated	  and	  analyzed	  by	  gas	  chromatography-­‐mass	  spectrometry	  (GC-­‐MS).	  	  Results	  confirmed	  the	  strains	  had	  significantly	  different	  
                                                1	  Reprintted	  from	  Oberg	  TS,	  Ward	  RE,	  Steele	  JL,	  Broadbent	  JR.	  2013.	  Genetic	  and	  physiological	  responses	  of	  Bifidobacterium	  animalis	  subsp.	  lactis	  to	  hydrogen	  peroxide	  stress.	  J.	  Bacteriol.	  195:3743–3751	  with	  permission	  (Appendix	  B).	  
  
66	  lipid	  profiles;	  the	  BL-­‐04	  membrane	  contained	  higher	  percentages	  of	  C14:0	  and	  C16:0,	  and	  lower	  percentages	  of	  C16:1n7	  and	  C18:1n9.	  	  Alteration	  of	  the	  DSM	  10140	  membrane	  lipid	  composition	  using	  modified	  growth	  medium	  to	  more	  closely	  mimic	  that	  of	  BL-­‐04	  yielded	  cells	  that	  showed	  increased	  intrinsic	  resistance	  to	  lethal	  H2O2	  challenge,	  but	  still	  did	  not	  display	  an	  inducible	  H2O2	  stress	  response.	  	  Results	  show	  deliberate	  stress	  induction	  or	  membrane	  lipid	  modification	  can	  be	  employed	  to	  significantly	  improve	  H2O2	  resistance	  in	  B.	  animalis	  subsp.	  lactis	  strains.	  	  
INTRODUCTION	  
	  Bifidobacteria	  are	  Gram-­‐positive	  rods	  of	  irregular	  shape	  with	  a	  G+C	  content	  of	  55-­‐67%,	  and	  are	  part	  of	  the	  normal	  gastrointestinal	  flora	  in	  human	  infants	  and	  adults	  (1,	  2).	  Bifidobacteria	  have	  been	  associated	  with	  several	  health	  related	  benefits,	  including	  a	  decrease	  in	  severity	  of	  the	  side	  effects	  associated	  with	  use	  of	  antibiotics,	  reduced	  incidence	  of	  infection	  in	  patients	  receiving	  irradiation	  therapy,	  decrease	  in	  the	  duration	  of	  diarrhea	  due	  to	  various	  etiologies,	  reduced	  frequency	  of	  allergic	  reactions,	  and	  alleviation	  of	  constipation	  (3-­‐8).	  Although	  no	  conclusive	  data	  is	  available	  on	  a	  minimal	  effective	  dose	  of	  probiotics	  in	  humans,	  results	  from	  clinical	  trials	  suggest	  a	  direct	  dose-­‐effect	  correlation	  with	  probiotic	  efficacy	  (9,	  10).	  This	  means	  bifidobacteria	  likely	  need	  to	  be	  consumed	  at	  very	  high	  levels	  (>107	  cfu)	  in	  bioactive	  foods	  to	  effect	  a	  probiotic	  outcome.	  	  At	  present,	  yogurt	  or	  fermented	  milks	  are	  the	  most	  common	  foods	  for	  delivery	  of	  probiotic	  bifidobacteria,	  but	  their	  incorporation	  into	  other	  foods	  is	  increasing.	  	  A	  major	  hurdle	  to	  production	  and	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  storage	  of	  bioactive	  foods	  containing	  bifidobacteria	  involves	  the	  susceptibility	  of	  these	  cells	  to	  oxidative	  stress.	  	  Bifidobacteria	  are	  anaerobic,	  and	  therefore	  lack	  common	  enzymes	  for	  detoxification	  of	  oxidative	  free	  radicals	  produced	  in	  the	  cell,	  such	  as	  catalase	  and	  superoxide	  dismutase	  (11,	  12,	  13).	  However,	  previous	  research	  in	  our	  laboratory	  has	  demonstrated	  variability	  in	  the	  intrinsic	  and	  inducible	  resistance	  of	  bifidobacteria	  strains	  to	  hydrogen	  peroxide	  (H2O2)	  (14).	  	  The	  purpose	  of	  this	  study	  was	  to	  investigate	  the	  transcriptional	  and	  physiological	  responses	  of	  2	  closely	  related	  strains	  of	  Bifidobacterium	  animalis	  subsp.	  lactis	  (B.	  animalis	  subsp.	  
lactis),	  BL-­‐04,	  a	  human	  fecal	  isolate,	  and	  DSM	  10140,	  a	  strain	  originally	  isolated	  from	  French	  yogurt	  (12),	  to	  sublethal	  H2O2	  exposure	  in	  an	  industrial	  growth	  medium.	  	  These	  strains	  were	  chosen	  based	  on	  their	  current	  use	  in	  industry	  as	  probiotics	  in	  bioactive	  foods,	  the	  availability	  of	  complete	  genome	  sequence	  information	  for	  both,	  and	  marked	  differences	  in	  their	  inducible	  and	  intrinsic	  H2O2	  resistance	  (12,	  14).	  	  Specifically,	  20	  min	  exposure	  to	  sublethal	  concentration	  (1.25	  mM)	  of	  H2O2	  was	  shown	  to	  significantly	  improve	  survival	  (P	  <	  0.05)	  of	  B.	  animalis	  subsp.	  lactis	  BL-­‐04,	  while	  survival	  of	  strain	  DSM	  10140	  was	  significantly	  decreased	  by	  this	  treatment	  (14).	  	  Additionally,	  B.	  animalis	  subsp.	  lactis	  BL-­‐04	  showed	  two-­‐fold	  higher	  intrinsic	  H2O2	  resistance	  than	  DSM	  10140	  (14).	  	  
MATERIALS	  AND	  METHODS	  
	  
Culture	  conditions.	  	  Bacterial	  strains	  were	  maintained	  as	  glycerol	  freezer	  stocks	  at	  -­‐80oC,	  and	  working	  cultures	  were	  prepared	  by	  two	  successive	  transfers	  
  
68	  (1%	  innoculum,	  [vol/vol])	  into	  peptonized	  milk	  medium	  (MP5)	  (14)	  with	  anaerobic	  incubation	  at	  37oC	  for	  18	  h.	  	  Batch	  cultures	  of	  each	  strain	  were	  prepared	  by	  dilution	  of	  the	  working	  culture	  to	  an	  absorbance	  at	  600	  nm	  (A600)	  of	  1.0	  in	  MP5	  medium,	  then	  inoculated	  at	  1%	  (vol/vol)	  into	  1	  L	  of	  MP5	  in	  a	  New	  Brunswick	  BioFlo	  III	  fermenter	  (New	  Brunswik	  Scientific,	  Edison,	  NJ),	  then	  incubated	  at	  37oC	  with	  an	  agitation	  rate	  of	  100	  rpm	  to	  prevent	  sedimentation.	  	  A	  gas	  mixture	  of	  5%	  CO2	  and	  95%	  N2	  was	  continuously	  passed	  over	  the	  headspace	  of	  the	  fermenter	  to	  achieve	  anaerobic	  conditions,	  and	  the	  pH	  was	  maintained	  at	  6.5	  by	  automatic	  addition	  of	  15%	  (vol/vol)	  NH4OH.	  	  The	  cultures	  were	  incubated	  until	  the	  cells	  reached	  early	  stationary-­‐phase	  (approximately	  12	  h;	  ~log	  5.8)	  (14).	  
RNA	  isolation.	  	  Cells	  from	  5	  mL	  samples	  grown	  in	  the	  conditions	  indicated	  just	  above	  were	  harvested	  by	  centrifugation	  at	  7500	  x	  g	  for	  10	  min.	  	  The	  cell	  pellets	  were	  suspended	  in	  50	  mL	  of	  pre-­‐warmed	  MP5	  media	  containing	  a	  sublethal	  H2O2	  concentration	  of	  1.25	  mM	  and	  held	  at	  37oC	  for	  5	  (T1)	  or	  20	  (T2)	  min	  (14).	  	  Immediately	  after	  treatment,	  100mL	  of	  RNAprotect	  bacterial	  reagent	  (Qiagen,	  Inc.,	  Valencia,	  CA)	  was	  added	  to	  the	  cell	  suspensions	  to	  stop	  transcription	  and	  prevent	  mRNA	  degradation.	  	  A	  control	  sample	  was	  also	  prepared,	  which	  was	  not	  exposed	  to	  H2O2.	  	  Cells	  in	  RNAprotect	  were	  held	  at	  room	  temperature	  for	  10	  min,	  then	  collected	  by	  centrifugation	  at	  9500	  x	  g	  for	  10	  min	  and	  stored	  at	  -­‐20oC	  until	  RNA	  isolation.	  	  	  Cell	  pellets	  were	  thawed	  at	  room	  temperature	  and	  suspended	  in	  900	  µL	  of	  lysozyme	  solution	  (20	  mg/mL	  in	  TE	  buffer)	  that	  also	  contained	  20	  U	  of	  mutanolysin	  (Sigma-­‐Aldrich).	  	  	  Samples	  were	  incubated	  for	  30	  min	  at	  37oC	  on	  a	  shaker	  incubator	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  at	  240	  rpm,	  after	  which	  20	  µl	  of	  proteinase	  K	  (Omega	  Bio-­‐Tek	  Inc.,	  Norcross,	  GA)	  (>600	  mAU/ml)	  was	  added	  and	  the	  samples	  were	  returned	  to	  the	  shaker/incubator	  for	  30	  min.	  	  The	  RNA	  was	  then	  isolated	  using	  the	  Aurum	  total	  RNA	  mini	  kit	  (Biorad,	  Hurcules,	  CA)	  following	  the	  vendor’s	  recommended	  procedures.	  	  The	  quantity	  of	  recovered	  RNA	  was	  measured	  with	  a	  NanoDrop	  8000	  spectrophotometer	  (ThermoFisher	  Scientific,	  Waltham,	  MA)	  and	  the	  quality	  of	  the	  RNA	  was	  assayed	  using	  an	  Agilent	  2100	  bioanalyzer	  (Agilent	  Technologies,	  Inc.,	  Waldbronn,	  Germany).	  	  Samples	  that	  had	  sufficient	  quantities	  (>10µg)	  of	  quality	  RNA	  were	  stored	  at	  -­‐80oC	  until	  needed.	  
Synthesis	  and	  labeling	  of	  cDNA.	  	  cDNA	  was	  synthesized	  and	  labeled	  as	  recommended	  by	  the	  Affymetrix	  (Santa	  Clara,	  CA)	  protocol	  for	  prokaryotic	  target	  preparation	  in	  the	  GeneChip	  Expression	  Analysis	  Technical	  Manual.	  	  The	  cDNA	  was	  fragmented	  into	  approximately	  50-­‐100	  bp	  using	  DNAse	  I	  and	  labeled	  with	  GeneChip	  DNA	  labeling	  reagent	  (Affymetrix,	  Santa	  Clara,	  CA)	  and	  terminal	  deoxynucleotidyl	  transferase	  (Promega,	  Madison,	  WI).	  	  Fragmentation	  labeling	  efficiency	  was	  measured	  by	  gel	  shift	  assay.	  
DNA	  microarrays.	  	  Sample	  hybridization	  was	  performed	  at	  the	  Center	  for	  Integrated	  Bio-­‐systems	  at	  Utah	  State	  University	  against	  a	  custom	  Affymetrix	  bifidobacterial	  DNA	  microarray	  designed	  to	  include	  1,761	  shared	  plus	  unique	  chromosomal	  genes	  predicted	  to	  occur	  in	  B.	  animalis	  subsp.	  lactis	  BL-­‐04	  and	  DSM	  10140	  (12).	  	  The	  only	  predicted	  coding	  sequences	  not	  included	  in	  the	  microarray	  design	  were	  redundant	  transposases	  and	  rRNA	  genes.	  	  Hybridization	  was	  
  
70	  performed	  according	  to	  the	  Affymetrix	  protocol	  for	  prokaryotic	  target	  hybridization	  in	  the	  GeneChip	  Expression	  Analysis	  Technical	  Manual	  using	  a	  hybridization	  temperature	  of	  50oC.	  	  The	  DNA	  microarrays	  were	  scanned	  using	  the	  HP	  GeneArray	  scanner	  (Affymetrix,	  Santa	  Clara,	  CA)	  to	  generate	  raw	  intensity	  values	  for	  each	  probe.	  	  Statistical	  analysis	  of	  microarray	  data	  was	  performed	  using	  Bioconductor	  (www.bioconductor.org)	  in	  the	  open	  source	  statistical	  platform	  R	  (www.r-­‐project.org).	  	  The	  raw	  probe	  data	  was	  preprocessed	  using	  the	  RMA-­‐MS	  method	  (15)	  and	  filtered	  to	  only	  include	  genes	  that	  had	  a	  high	  signal	  intensity	  and	  a	  low	  coefficient	  of	  variation.	  	  To	  test	  for	  differential	  expression,	  the	  preprocessed,	  filtered	  data	  was	  analyzed	  using	  the	  limma/eBayes	  method	  (16).	  	  Genes	  were	  determined	  to	  be	  significantly	  differentially	  expressed	  if	  they	  had	  a	  false	  discovery	  rate	  corrected	  P-­‐value	  less	  than	  0.05.	  	  The	  significantly	  differentially	  expressed	  genes	  were	  grouped	  according	  to	  function	  and	  by	  treatment	  times	  and	  strain.	  
Microarray	  validation.	  	  To	  validate	  the	  microarray	  data,	  quantitative	  real-­‐time	  PCR	  (RT-­‐PRC)	  was	  performed	  for	  6	  different	  genes	  (Table	  5-­‐1)	  using	  cDNA	  produced	  after	  each	  treatment	  as	  described	  by	  Smeianov	  et	  al.	  (17).	  	  A	  log-­‐fold	  change	  (LFC)	  was	  calculated	  between	  control	  and	  treatment	  samples,	  and	  graphed	  vs.	  the	  LFC	  calculated	  from	  the	  microarray	  data.	  	  A	  positive	  LFC	  represents	  up-­‐regulation	  of	  a	  particular	  gene	  in	  treated	  cells	  versus	  the	  control,	  while	  a	  negative	  LFC	  reflects	  gene	  down-­‐regulation.	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TABLE 5-1  Target genes oligonucleotide primers for RT-PCR. 
Primer Sequence 







Peroxiredoxin       
(Balac_0865) 
CCGTGTGAAGGCGTCGCAGT GCTCGGCTCGAGCGTTTCGT 91 61.5 
Ribonucleotide   
Reductase (Balac_0326) 
CACCACGCTCGCCGAGATCC TGCTCATCGTGATGCGCCCG 104 61.5 
Long Chain acyl-CoA   
synthetase 
(Balac_1406) 
TCCAGGGCTACGGCCTGACC CGCCGGTGGGTGAGATACGC 123 61.5 
dnaK (Balac_1557) ACGCCGCTGTCCCTCGGTAT ACGGCTGGTTGTCTTCGGCG 121 61.5 
3-oxoacyl-ACP 
Reductase (Balac_0317) 




TGCGTGGAAACCGGCGACTC CCGCCCACTTCGTTCTGCGT 149 61.5 
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Membrane	  fatty	  acid	  analysis.	  To	  determine	  whether	  H2O2	  exposure	  altered	  cytoplasmic	  membrane	  fatty	  acid	  (CMFA)	  composition,	  cells	  were	  grown	  in	  batch	  culture	  as	  described	  before,	  and	  treated	  with	  a	  sublethal	  H2O2	  concentration	  of	  1.25	  mM	  for	  5	  (T1)	  or	  20	  (T2)	  min.	  	  Cells	  in	  20	  mL	  samples	  were	  collected	  by	  centrifugation	  at	  5000	  ×	  g	  for	  5	  min,	  then	  washed	  twice	  with	  phosphate	  buffered	  saline.	  	  Membrane	  fatty	  acids	  were	  then	  isolated	  from	  the	  pelleted	  cells	  according	  to	  the	  protocol	  of	  Sasser	  (18)	  and	  identified	  using	  gas	  chromatography	  as	  described	  previously	  (19).	  	  An	  untreated	  control	  sample	  was	  also	  prepared.	  	  	  To	  determine	  the	  effect	  of	  exogenous	  fatty	  acids	  in	  the	  growth	  medium	  on	  CMFA	  composition,	  cells	  were	  grown	  to	  early	  stationary	  phase	  in	  MP5	  broth	  containing	  1%	  Tween	  80	  (C18:1	  n9),	  1%	  Tween	  20	  (C12:0),	  or	  no	  exogenous	  fatty	  acid	  substrate.	  Bacteria	  in	  20-­‐mL	  samples	  were	  collected	  and	  analyzed	  as	  described	  above.	  
Inducible	  and	  intrinsic	  H2O2	  resistance.	  	  Cells	  were	  grown	  to	  early	  stationary	  phase	  in	  MP5	  media	  with	  1%	  Tween	  80	  (C18:1	  n9)	  or	  no	  added	  exogenous	  fatty	  acids,	  exposed	  to	  a	  sublethal	  H2O2	  concentration	  of	  1.25	  mM	  for	  20	  or	  60	  min,	  then	  challenged	  with	  a	  30-­‐min	  exposure	  to	  a	  lethal	  H2O2	  concentration	  of	  2.55	  or	  5.25	  mM	  (14).	  	  Control	  cells	  were	  also	  prepared	  that	  received	  no	  H2O2	  treatment.	  Samples	  were	  plated	  on	  MRS	  agar	  containing	  0.05%	  filter	  sterilized	  cysteine	  after	  0	  and	  30	  mins,	  and	  then	  incubated	  anaerobically	  at	  37oC	  for	  48	  h	  before	  enumeration.	  	  Results	  are	  expressed	  as	  a	  percent	  survival,	  which	  is	  calculated	  by	  dividing	  the	  log10	  CFU/mL	  of	  surviving	  cells	  after	  30	  mins	  by	  the	  log10	  CFU/mL	  of	  cells	  after	  0	  min	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  (14).	  	  The	  student	  t	  test	  was	  used	  to	  identify	  significant	  differences	  (P	  <0.05)	  between	  treatment	  means	  (20).	  
Microarray	  data	  accession	  number.	  Microarray	  hybridization	  data	  have	  been	  deposited	  in	  Gene	  Expression	  Omnibus	  under	  accession	  number	  GSE44382.	  	  
RESULTS	  AND	  DISCUSSION	  
	  




FIG 5-1  Numbers of B. animalis subsp. lactis BL-04 genes, grouped according to functional category, that were 




 exposure for 5 min (A) or 20 
min (B).	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FIG 5-2  Correlation of fold change values from DNA microarray and real-time 
quantitative PCR results.  Fold change values were obtained for the 6 genes listed in 
Table 1.  Symbols denote expression values from B. animalis subsp. lactis BL-04 cells 










Bifidobacterium	  spp.	  lack	  the	  most	  common	  genes	  associated	  with	  oxidative	  stress	  defense,	  such	  as	  super	  oxide	  dismutase	  and	  catalase.	  	  However	  grouping	  of	  DE	  genes	  into	  predicted	  functional	  categories	  showed	  that	  exposure	  of	  BL-­‐04	  to	  an	  oxidative	  stress	  triggered	  up-­‐regulation	  of	  genes	  involved	  in	  the	  thioredoxin	  reductase	  system	  (Table	  5-­‐2).	  	  Under	  favorable	  conditions,	  this	  system	  functions	  with	  ribonucleoside	  reductase	  to	  use	  NADPH	  to	  reduce	  the	  2’	  OH	  group	  of	  ribose	  for	  deoxynucleotide	  production,	  as	  well	  as	  to	  maintain	  cytoplasmic	  redox	  for	  disulfide	  bond	  production	  in	  proteins	  (21,	  22).	  	  During	  oxidative	  stress,	  however,	  cells	  can	  use	  thioredoxin	  reductase	  and	  peroxiredoxin	  to	  direct	  NADPH	  toward	  the	  removal	  of	  oxidative	  free	  radicals	  via	  the	  reduction	  of	  H2O2	  and	  toxic	  lipid	  hydroperoxides	  (23,	  24,	  25).	  	  Schell	  et	  al.	  (26)	  suggested	  these	  enzymes	  might	  be	  one	  of	  the	  primary	  defense	  mechanisms	  against	  oxidative	  stress	  in	  bifidobacteria,	  and	  other	  research	  has	  shown	  up-­‐regulation	  of	  thioredoxin,	  thioredoxin	  reductase	  and	  peroxiredoxin	  in	  response	  to	  oxygen	  stress	  (27,	  28).	  Interestingly,	  exposure	  to	  bile	  can	  also	  produce	  an	  oxidative	  stress	  response	  via	  generation	  of	  oxygen	  free	  radicals	  (29),	  and	  Sanchez	  et	  al.	  (30)	  found	  bile	  stress	  induced	  a	  thioredoxin-­‐dependent	  thiol	  peroxidase	  in	  B.	  animalis	  subsp.	  lactis.	  	  Collectively,	  our	  results	  and	  these	  prior	  data	  confirm	  that	  thioredoxin	  reductase	  (Balac_0866)	  and	  peroxiredoxin	  (Balac_0865)	  provide	  a	  primary	  defense	  mechanism	  against	  oxidative	  stress	  in	  B.	  animalis	  subsp.	  
lactis.	   Transcriptome	  data	  also	  showed	  ribonucleaside-­‐diphosphate	  reductase	  alpha	  and	  beta	  chains	  (Balac_0326	  and	  Balac_0327)	  were	  differentially	  expressed	  
  
77	  with	  a	  high	  LFC,	  as	  were	  several	  other	  genes	  (Balac_1501,	  Balac_1503,	  Balac_1081,	  and	  Balat_0464	  [which	  corresponds	  to	  BL-­‐04	  gene	  Balac_0464])	  involved	  in	  nucleotide	  turnover	  (Table	  5-­‐2).	  	  These	  genes	  encode	  proteins	  used	  for	  dNTP	  production	  and	  to	  hydrolyze	  nucleic	  acids	  for	  DNA/RNA	  turnover	  and	  scavenging	  (31).	  	  Under	  H2O2	  stress	  conditions,	  where	  peroxiredoxin	  consumes	  NADPH	  for	  detoxification	  (and	  therefore	  makes	  it	  less	  available	  for	  deoxyribonucleotide	  synthesis),	  the	  observed	  high-­‐level	  induction	  of	  genes	  for	  nucleotide	  turnover	  could	  be	  a	  reflection	  of	  the	  need	  to	  maintain	  a	  constant	  pool	  of	  dNTPs	  to	  support	  excision	  and	  repair	  of	  oxidative-­‐damaged	  DNA	  (21,	  32,	  33).	  Additionally,	  there	  is	  an	  apparent	  operon	  in	  BL-­‐04	  (Balac_0440-­‐Balac_0444)	  that	  contains	  genes	  involved	  in	  protein	  degradation,	  which	  showed	  significant	  up	  regulation	  after	  5	  min	  (T1)	  and	  a	  significant	  down	  regulation	  after	  20	  min	  (T2)	  (Table	  5-­‐2).	  	  Previous	  research	  has	  shown	  that	  some	  bacteria	  utilize	  proteolytic	  enzymes	  to	  detoxify	  proteins	  that	  have	  been	  irreparably	  damaged	  by	  oxidative	  stress	  (34,	  35).	  	  Our	  data	  suggests	  this	  operon	  might	  be	  used	  by	  BL-­‐04	  to	  perform	  a	  similar	  function.	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TABLE 5-2  Differentially regulated genes associated with oxidative stress response of 
B. animalis subsp. lactis BL-04.	  
Log-fold 
change vs. 
control Gene ID Predicted function 
T1 T2 
Balac_0326 Ribonucleoside-diphosphate reductase beta chain 5.39 2.77 
Balac_0327 Ribonucleoside-diphosphate reductase alpha chain 4.23   NSa 
Balac_0328 NrdI protein / ribonucleotide reductase stimulatory 
protein  
1.71 NS 
Balac_0865 Peroxiredoxin 1.10 NS 
Balac_0866 Thioredoxin reductase 1.84 1.19 
Balac_0118 Oxidoreductase  1.40 NS 
Balac_0120 Vanillate O-demethylase oxidoreductase / ferric 
reductase  
1.59 NS 
Balac_0121 Flavodoxin 2.14 NS 
Balac_0123 Flavodoxin 1.54 NS 
Balac_1314 Anaerobic ribonucleoside-triphosphate reductase 
activating protein 
1.05 NS 
Balac_1315 Anaerobic ribonucleoside-triphosphate reductase 0.72 NS 
Balac_0573 NTP pyrophosphohydrolases including oxidative 
damage repair enzymes 
NS 1.34 
Balac_0025 Oxidoreductase  0.56 NS 
Balac_1337 MoxR-like ATPase -0.88 NS 
Balac_0086 Penicillin-binding protein -0.74 NS 
Balac_1247 DNA repair protein recO -0.97 NS 
Balac_1114 RecA protein 0.58 NS 
Balac_1212 LexA repressor 0.60 NS 
Balac_1437 Multidrug resistance protein B 0.52 -1.22 
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Balac_1555 DnaJ-class molecular chaperone NS -1.34 




Balac_0441 Aminopeptidase C 0.76 NS 
Balac_0442 Glutamate/gamma-aminobutyrate antiporter 0.74 -1.37 
Balac_0443 Carboxypeptidase S1 1.28 -1.27 
Balac_0444 Amino acid permease 0.77 NS 
Balac_1501 Sugar kinases, ribokinase family 3.03 2.41 
Balac_1502 tetracycline resistance permease/tetracycline efflux 
pump/MFSb transporter/ 
2.98 2.53 
Balac_1503 Inosine-uridine preferring nucleoside hydrolase  2.79 2.54 
Balat_0464 5'-nucleotidase 1.05 NS 
Balac_1081 Ribonuclease D 1.25 NS 
Balac_1597 Raffinose transport system permease protein 3.46 NS 
Balac_1598 Raffinose transport system permease protein 3.20 NS 
Balac_1599 Raffinose-binding protein 3.12 NS 
aNS,	  Not	  Significant	  bMFS,	  Mutli-­‐facilitator	  superfamily
  
80	  Finally,	  28	  genes	  were	  associated	  with	  energy	  production	  or	  sugar	  transport	  in	  strain	  BL-­‐04,	  with	  19	  (68%)	  of	  those	  genes	  being	  upregulated	  in	  response	  to	  H2O2	  stress	  (Fig.	  5-­‐1).	  In	  this	  study,	  the	  DE	  genes	  involved	  in	  sugar	  metabolism	  with	  the	  highest	  LFC	  included	  those	  involved	  in	  raffinose	  (Balac_1597	  to	  Balac_1601)	  and	  maltose	  transport	  and	  metabolism	  (Balac_1567	  to	  Balac_	  1573)	  (see	  Table	  S1	  in	  appendix	  B).	  The	  influence	  of	  these	  sugars	  on	  H2O2	  resistance	  was	  not	  explored	  here,	  but	  other	  studies	  have	  suggested	  that	  complex	  carbohydrates	  can	  enhance	  bile	  salt	  resistance	  in	  bifidobacteria	  (36,	  37).	  




FIG 5-3  Membrane fatty acid composition for B. animalis subsp. lactis BL-04 (A) and 









 in MP5 broth for 5 or 20 min. Error bars 
correspond to the standard error of the mean (SEM). Means with the same letters within 
each strain are not significantly different (P < 0.05).
  
82	  into	  the	  increased	  survival	  of	  BL-­‐04	  under	  oxidative	  stress	  compared	  to	  DSM	  10140	  (14).	   In	  an	  effort	  to	  identify	  the	  basis	  for	  the	  dramatic	  differences	  we	  observed	  in	  the	  gene	  expression	  profiles	  and	  membrane	  lipid	  composition	  of	  BL-­‐04	  versus	  DSM	  10140,	  we	  reviewed	  the	  comparative	  genome	  analysis	  of	  these	  bacteria	  (12).	  	  The	  two	  strains	  are	  highly	  clonal	  with	  only	  39	  coding	  single	  nucleotide	  polymorphisms	  and	  4	  insertion/deletions	  totaling	  443	  base	  pairs.	  	  However,	  we	  found	  one	  of	  these	  lesions	  produced	  a	  45-­‐bp	  deletion	  in	  a	  BL-­‐04	  gene	  (Balac_0771)	  predicted	  to	  encode	  a	  long	  chain	  fatty	  acid-­‐coenzyme	  A	  (CoA)	  ligase.	  	  In	  other	  bacteria,	  this	  gene	  has	  been	  shown	  to	  activate	  exogenous	  long	  chain	  fatty	  acids	  for	  incorporation	  into	  the	  cellular	  membrane	  (46),	  and	  therefore	  might	  result	  in	  a	  different	  membrane	  lipid	  profile	  for	  MP5-­‐grown	  BL-­‐04	  compared	  to	  DSM	  10140.	  	  To	  test	  whether	  this	  lesion	  affected	  the	  ability	  of	  BL-­‐04	  to	  incorporate	  exogenous	  fatty	  acids	  into	  its	  membrane,	  both	  strains	  were	  grown	  in	  MP5	  medium	  modified	  to	  contain	  1%	  Tween	  80	  (C18:1),	  1%	  Tween	  20	  (C12:0),	  or	  no	  fatty	  acids,	  then	  lipids	  were	  extracted	  for	  membrane	  fatty	  acid	  analysis.	  As	  shown	  in	  Fig.	  5-­‐4,	  DSM	  10140	  cells	  grown	  in	  MP5	  with	  Tween	  20	  showed	  dramatic	  and	  significantly	  higher	  (P	  <	  0.05)	  amounts	  of	  C12:0	  and	  significantly	  decreased	  (P	  <	  0.05)	  the	  pooled	  total	  of	  C18:1n9	  and	  its	  derivatives	  (C19:0	  cyclic	  propanol	  [Cyc],	  C19:0	  cyc	  plasmologens	  [Plas]	  and	  C18:1n9	  Plas)	  (19)	  than	  cells	  grown	  in	  MP5	  with	  no	  fatty	  acid	  supplementation	  (21.4%	  versus	  35.7%,	  respectively).	  	  Conversely,	  when	  DSM	  10140	  cells	  were	  grown	  in	  MP5	  containing	  Tween	  80,	  their	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FIG 5-4  Membrane fatty acid composition as a function of growth medium composition 
for B. animalis subsp. lactis BL-04 (A) and DSM 10140 (B) cells. The graphs shows data 
from cells grown in MP5 media with no exogenous fatty acids and cells grown in MP5 
with 1% Tween 20 (C12:0) or 1% Tween 80 (C18:1 n9). Error bars correspond to the 
standard error of the mean (SEM). Means with the same letters within each strain are not 
significantly different (P < 0.05).
  
84	  membrane	  showed	  significantly	  (P	  <	  0.05)	  higher	  percentages	  of	  C18:1n9,	  as	  well	  as	  an	  increase	  in	  C18:1n9	  Plas	  which	  was	  not	  significant,	  versus	  cells	  grown	  in	  MP5	  without	  added	  fatty	  acid	  (Fig.	  5-­‐4).	  	  DSM	  10140	  cells	  grown	  in	  MP5	  supplemented	  with	  Tween	  20	  or	  80	  also	  had	  significantly	  less	  (P	  <	  0.05)	  C16:0	  than	  cells	  grown	  in	  MP5	  without	  fatty	  acids.	  	  These	  results	  confirm	  DSM	  10140	  is	  able	  to	  efficiently	  incorporate	  exogenous	  fatty	  acids	  into	  its	  lipid	  membrane.	  In	  contrast	  to	  DSM	  10140,	  membrane	  lipid	  profiles	  of	  BL-­‐04	  cells	  grown	  under	  the	  same	  conditions	  showed	  far	  less	  change	  in	  response	  to	  the	  exogenous	  fatty	  acid	  type,	  which	  supports	  our	  hypothesis	  that	  the	  45-­‐bp	  lesion	  in	  Balac_0771	  impairs	  the	  function	  of	  its	  cognate	  enzyme.	  	  Supplementation	  with	  Tween	  20,	  for	  example,	  did	  produce	  a	  significant	  increase	  (P	  <	  0.05)	  in	  the	  membrane	  level	  of	  C12:0	  relative	  to	  cells	  grown	  without	  added	  fatty	  acids,	  but	  the	  degree	  of	  change	  was	  substantially	  lower	  than	  seen	  in	  DSM	  10140	  (from	  5.2	  to	  6.8%	  in	  BL-­‐04	  versus	  3.0	  to	  27.3%	  in	  DSM	  10140).	  	  Additionally,	  levels	  of	  C18:1n9	  and	  its	  derivatives	  were	  not	  significantly	  different	  (P	  >	  0.05)	  from	  that	  found	  in	  BL-­‐04	  cells	  grown	  without	  fatty	  acid	  supplementation	  (totals	  of	  26.5%	  versus	  27.5%,	  respectively)	  (Fig.	  5-­‐4).	  	  Growth	  of	  BL-­‐04	  in	  MP5	  with	  Tween	  80	  did	  produce	  a	  significant	  increase	  (P	  <	  0.05)	  in	  the	  concentration	  of	  C18:1n9	  and	  its	  derivative	  fatty	  acids	  relative	  to	  cells	  grown	  in	  MP5	  without	  fatty	  acids	  (totals	  of	  38.1%	  versus	  27.5%,	  respectively).	  	  These	  differences,	  which	  would	  have	  been	  present	  in	  stress-­‐treated	  cells,	  could	  affect	  membrane	  fluidity	  and,	  potentially,	  transduction	  of	  environmental	  stress	  signals,	  either	  of	  which	  could	  explain	  the	  observed	  contrasts	  in	  intrinsic	  and	  inducible	  H2O2	  
  
85	  stress	  resistance	  (14).	  	  As	  a	  whole,	  these	  data	  support	  our	  hypothesis	  that	  the	  mutation	  in	  the	  BL-­‐04	  long	  chain	  fatty	  acid-­‐CoA	  ligase	  limits	  the	  ability	  of	  this	  strain	  to	  incorporate	  certain	  exogenous	  fatty	  acids	  into	  its	  cytoplasmic	  membrane.	  In	  our	  experiments	  with	  different	  exogenous	  fatty	  acids,	  we	  noted	  that	  DSM	  10140	  cells	  grown	  in	  MP5	  containing	  no	  fatty	  acids	  had	  a	  gross	  lipid	  profile	  that	  most	  closely	  matched	  the	  lipid	  profile	  of	  BL-­‐04	  grown	  in	  media	  containing	  Tween	  80	  (Table	  5-­‐3).	  	  Because	  membrane	  fluidity	  could	  influence	  the	  efficiency	  of	  environmental	  stress	  triggers,	  we	  wondered	  if	  an	  inducible	  stress	  response	  in	  DSM	  10140	  might	  be	  restored	  by	  modification	  of	  its	  membrane	  fatty	  acid	  composition	  to	  more	  closely	  match	  the	  profile	  of	  BL-­‐04.	  	  To	  explore	  this	  possibility,	  DSM	  10140	  cells	  were	  grown	  in	  MP5	  media	  that	  contained	  no	  supplemented	  fatty	  acids,	  treated	  with	  a	  sublethal	  H2O2	  concentration	  [1.25	  mM],	  and	  subsequently	  exposed	  to	  a	  lethal	  H2O2	  concentration	  [2.55	  or	  5.25	  mM]	  (14).	  	  Results	  showed	  no	  significant	  change	  in	  survival	  after	  H2O2	  challenge	  of	  induced	  versus	  control	  cells	  grown	  in	  MP5	  with	  Tween	  80,	  and	  a	  significant	  decrease	  in	  survival	  of	  induced	  cells	  compared	  to	  control	  cells	  grown	  in	  media	  with	  no	  exogenous	  fatty	  acids	  (Fig.	  5-­‐5).	  	  As	  is	  also	  shown	  in	  Fig.	  5-­‐5,	  however,	  cells	  grown	  with	  no	  exogenous	  fatty	  acid	  had	  significantly	  greater	  survival	  (P	  <	  0.05)	  after	  lethal	  challenge	  at	  5.25	  mM	  H2O2	  as	  compared	  to	  cells	  grown	  in	  MP5	  with	  Tween	  80	  (Fig.	  5-­‐5).	  	  The	  increase	  in	  intrinsic	  H2O2	  resistance	  could	  be	  associated	  with	  the	  higher	  percentage	  of	  cyclic	  fatty	  acids	  in	  the	  membrane	  (47,	  48).
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TABLE 5-3  Membrane fatty acid (FA) composition of B. animalis subsp. lactis strains grown with different exogenous FA. 	   	   Mean	  %	  of	  each	  FA	  species	  in	  total	  cytoplasmic	  membrane	  lipid	  pool	   	  Strain	  and	  treatment	   Cyclic	   Plasmalogenc	   Saturatedd	   Unsaturatede	   Saturated/unsaturated	  Bl-­‐04	   	   	   	   	   	  	   No	  Tween	   18.81	   22.03	   62.35	   37.65	   1.66	  	   Tween	  20a	   11.71	   16.04	   70.07	   29.93	   2.34	  	   Tween	  80b	   16.61	   30.52	   49.87	   50.13	   0.99	  	   	   	   	   	   	   	  DSM	  10140	   	   	   	   	   	  	   No	  Tween	   13.87	   25.08	   54.94	   45.06	   1.22	  	   Tween	  20a	   10.51	   15.47	   74.41	   25.59	   2.91	  	   Tween	  80b	   7.96	   26.60	   43.39	   56.61	   0.77	  
	  	  aPolyoxyethylene	  (20)	  sorbitan	  monolaurate	  (C12:0)	  
bPolyoxyethylene	  (20)	  sorbitan	  monooleate	  (C18:1)	  
cPlasmologens	  (ether-­‐linked	  lipids)	  
dPercentage	  of	  saturated	  FA	  in	  membrane	  including	  cyclic	  FA	  and	  plasmologens	  
ePercentage	  of	  unsaturated	  FA	  in	  the	  membrane	  including	  plasmologens	  
  
	  	  	  	  	  	  
FIG 5-5  Experimental stress induction in B. animalis subsp. lactis DSM 10140. Graph 
shows percent survival of DSM 10140 cells after 20 min (A) or 60 min (B) exposure to a 
sublethal (1.25 mM) H2O2 followed by 30 min challenge at lethal concentrations of 2.55 
mM H2O2 or 5.25 mM H2O2.  White bar, cells grown in MP5 with no exogenous FA 
source and no induction (control); hashed bar, cells grown with no exogenous FA source 
and given induction treatment; filled bar, cells grown in MP5 with Tween 80 as FA 
source and no induction (control); cross-hatched bar, cells grown in MP5 with Tween 80 
and given induction treatment.  Each value is the mean of four replicates.  Error bars 
correspond to the standard error of the mean (SEM). Means with the same letters within 




88	  Previous	  studies	  have	  shown	  that	  in	  response	  to	  low	  pH	  and	  osmotic	  stress,	  cells	  modify	  their	  membrane	  through	  chain	  length,	  saturation	  and	  cyclopropanation	  of	  fatty	  acids,	  which	  alters	  the	  transition	  temperature	  of	  the	  membrane	  and	  makes	  it	  less	  permeable	  to	  organic	  acids	  and	  salts	  (44,	  45,	  49).	  	  More	  importantly,	  cyclopropanation	  decreases	  the	  susceptibility	  of	  the	  cell	  membrane	  to	  lipid	  peroxidation	  by	  stabilizing	  the	  unsaturated	  bond	  by	  addition	  of	  a	  methyl	  group	  (50).	  	  These	  properties	  would	  make	  the	  membrane	  less	  permeable	  to	  oxidative	  free	  radicals	  and	  more	  resistant	  to	  lipid	  peroxidation.	  In	  summary,	  B.	  animalis	  subsp.	  lactis	  BL-­‐04	  and	  DSM	  10140	  are	  highly	  clonal	  yet	  display	  significant	  differences	  in	  their	  intrinsic	  and	  inducible	  resistance	  to	  H2O2	  (14).	  Transcriptome	  data	  demonstrate	  H2O2	  exposure	  triggers	  induction	  of	  an	  oxidative	  stress	  response	  in	  BL-­‐04,	  but	  this	  mechanism	  is	  somehow	  impaired	  in	  DSM	  10140.	  	  Genetic	  and	  membrane	  lipid	  data	  suggest	  some	  of	  the	  differences	  in	  H2O2	  resistance	  between	  these	  cells	  may	  be	  associated	  with	  membrane	  lipid	  composition,	  which	  in	  turn	  is	  affected	  by	  the	  activity	  of	  a	  long	  chain	  fatty	  acyl-­‐CoA	  ligase	  which	  is	  functional	  in	  DSM	  10140	  but	  impaired	  in	  BL-­‐04.	  	  However,	  confirmation	  of	  this	  relationship	  will	  require	  functional	  studies	  involving	  genetic	  manipulation	  of	  B.	  animalis	  subsp.	  lactis,	  where	  genetic	  tools	  are	  only	  poorly	  developed.	  	  While	  efforts	  to	  restore	  an	  inducible	  H2O2	  stress	  response	  in	  DSM	  10140	  via	  modification	  of	  its	  CMFA	  composition	  were	  unsuccessful,	  modification	  did	  significantly	  increase	  intrinsic	  H2O2	  resistance.	  	  These	  data	  show	  deliberate	  H2O2	  
  
89	  stress	  induction	  or	  membrane	  lipid	  modification	  can	  be	  used	  to	  significantly	  improve	  H2O2	  resistance	  in	  B.	  animalis	  subsp.	  lactis.	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TRANSCRIPTOME	  ANALYSIS	  OF	  BIFIDOBACTERIUM	  LONGUM	  	  
STRAINS	  THAT	  SHOW	  A	  DIFFERENTIAL	  RESPONSE	  	  
TO	  HYDROGEN	  PEROXIDE	  STRESS	  
	  
ABSTRACT	  
	  Consumer	  and	  commercial	  interest	  in	  foods	  containing	  probiotic	  bifidobacteria	  is	  increasing	  worldwide.	  	  However,	  because	  bifidobacteria	  are	  anaerobic,	  oxidative	  stress	  can	  diminish	  cell	  viability	  during	  production	  and	  storage	  of	  bioactive	  foods.	  	  We	  previously	  found	  Bifidobacterium	  longum	  strain	  NCC2705	  had	  significantly	  greater	  intrinsic	  and	  inducible	  resistance	  to	  hydrogen	  peroxide	  (H2O2)	  than	  strain	  D2957.	  	  Here,	  we	  explored	  the	  basis	  for	  these	  differences	  by	  examining	  the	  transcriptional	  responses	  of	  both	  strains	  to	  sub-­‐lethal	  H2O2	  exposure	  for	  5	  or	  60	  min	  showed	  NCC2705	  had	  288	  genes	  that	  were	  differentially	  expressed	  after	  the	  5-­‐min	  treatment	  and	  114	  differentially	  expressed	  genes	  after	  the	  60-­‐min	  treatment.	  	  In	  contrast,	  strain	  D2957	  had	  only	  21	  and	  90	  differentially	  expressed	  genes	  after	  the	  5-­‐and	  60-­‐min	  treatments,	  respectively.	  	  Both	  strains	  showed	  up-­‐regulation	  of	  genes	  coding	  enzymes	  implicated	  in	  oxidative	  stress	  resistance,	  such	  as	  thioredoxin,	  thioredoxin	  reductase,	  peroxiredoxin,	  ferredoxin,	  glutaredoxin,	  and	  anaerobic	  ribonucleotide	  reductase,	  but	  induction	  levels	  were	  typically	  highest	  in	  NCC2705.	  	  Compared	  to	  D2957,	  NCC2705	  also	  had	  more	  up-­‐regulated	  genes	  involved	  in	  transcriptional	  regulation	  and	  more	  down-­‐regulated	  genes	  involved	  in	  sugar	  
  
95 transport	  and	  metabolism.	  	  These	  results	  provide	  a	  greater	  understanding	  of	  the	  molecular	  basis	  for	  strain	  variability	  in	  oxidative	  stress	  resistance	  of	  B.	  longum	  and	  reveal	  possible	  methods	  to	  promote	  their	  survival	  in	  bioactive	  food	  products.	  
	  
INTRODUCTION	  
	  Consumption	  of	  food	  or	  food	  ingredients	  with	  bioactive	  properties	  has	  increased	  in	  recent	  years	  and	  probiotic	  bacteria	  represent	  one	  of	  the	  most	  promising	  categories	  of	  bioactive	  food	  ingredients.	  	  The	  term	  probiotic	  refers	  to	  living	  microorganisms	  which,	  when	  ingested	  at	  sufficient	  numbers,	  exert	  a	  beneficial	  effect	  on	  the	  host	  organism	  beyond	  inherent	  general	  nutrition	  (1).	  	  Currently,	  bacteria	  from	  the	  genera	  Lactobacillus	  and	  Bifidobacterium	  are	  the	  most	  widely	  used	  probiotic	  bacteria	  added	  functional	  foods.	  	  Bifidobacteria	  are	  Gram-­‐positive,	  non-­‐acid-­‐fast,	  non-­‐spore	  forming,	  non-­‐motile,	  anaerobic,	  catalase	  negative	  rods	  of	  irregular	  shape,	  with	  a	  G+C	  content	  of	  55-­‐67%,	  and	  are	  part	  of	  the	  normal	  gastrointestinal	  flora	  in	  human	  adults	  (2,	  3).	  	  Bifidobacteria	  are	  thought	  to	  promote	  or	  provide	  several	  health	  related	  functions,	  including	  a	  decrease	  in	  severity	  of	  the	  side	  effects	  associated	  with	  antibiotics	  use,	  a	  reduced	  incidence	  of	  infection	  in	  patients	  receiving	  irradiation	  therapy,	  a	  decrease	  in	  the	  duration	  of	  diarrhea	  due	  to	  various	  etiologies,	  improved	  lactose	  digestion,	  a	  reduced	  frequency	  of	  allergic	  reactions,	  normalization	  of	  blood	  lipid	  composition,	  and	  a	  decrease	  in	  gut	  transit	  time	  (4-­‐8).	  Although	  no	  conclusive	  data	  is	  available	  on	  a	  minimal	  effective	  dose	  of	  probiotics	  in	  humans,	  results	  from	  several	  clinical	  trials	  suggest	  a	  direct	  dose-­‐effect	  
  
96 correlation	  (9,	  10,	  11).	  	  In	  practice	  this	  means	  that	  bifidobacteria	  need	  to	  be	  delivered	  at	  very	  high	  concentrations	  in	  bioactive	  foods	  to	  function	  as	  a	  probiotic.	  	  At	  present,	  yogurt	  or	  fermented	  milks	  are	  the	  most	  common	  vehicle	  foods	  for	  delivery	  of	  probiotic	  bifidobacteria,	  but	  cheese,	  ice	  cream,	  infant	  formula,	  fruit	  juice,	  and	  other	  foods	  are	  also	  used	  to	  a	  lesser	  extent	  (12).	  	  One	  of	  the	  major	  hurdles	  to	  production	  and	  storage	  of	  bioactive	  foods	  containing	  bifidobacteria	  as	  a	  probiotic	  is	  oxidative	  stress.	  	  This	  is	  because	  bifidobacteria	  are	  anaerobic	  and	  lack	  common	  enzymes	  such	  as	  superoxide	  dismutase	  that	  detoxify	  oxidative	  free	  radicals	  in	  the	  presence	  of	  oxygen	  (13,	  14,	  15).	  	  We	  previously	  found	  Bifidobacterium	  longum	  strain	  NCC2705	  had	  greater	  intrinsic	  and	  inducible	  resistance	  to	  H2O2	  than	  strain	  D2957.	  	  Specifically,	  60	  min	  exposure	  to	  sublethal	  concentration	  (1.25	  mM)	  of	  H2O2	  was	  shown	  to	  significantly	  improve	  survival	  (P	  <	  0.05)	  of	  B.	  longum	  NCC2705	  at	  lethal	  (5.25mM)	  H2O2	  concentrations,	  but	  a	  similar	  response	  was	  not	  detected	  with	  strain	  D2957	  (16).	  	  Additionally,	  B.	  longum	  NCC2705	  showed	  a	  1.5-­‐fold	  higher	  intrinsic	  H2O2	  resistance	  than	  D2957	  (16).	  	  The	  purpose	  of	  this	  study	  was	  to	  explore	  the	  physiological	  basis	  for	  these	  differences	  by	  determining	  the	  transcriptional	  responses	  of	  B.	  longum	  NCC2705	  and	  D2957	  to	  sublethal	  H2O2	  exposure.	  	  
MATERIALS	  AND	  METHODS	  
	  
Culture	  conditions.	  	  Bacterial	  strains	  were	  maintained	  as	  glycerol	  freezer	  stocks	  at	  -­‐80oC,	  and	  working	  cultures	  were	  prepared	  by	  two	  successive	  transfers	  (1%	  innoculum	  [vol/vol])	  into	  peptonized	  milk	  medium	  (MP5)	  (16)	  with	  anaerobic	  
  
97 incubation	  at	  37oC	  for	  18	  h.	  	  Batch	  cultures	  of	  each	  strain	  were	  prepared	  by	  dilution	  of	  the	  working	  culture	  to	  an	  absorbance	  at	  600	  nm	  (A600)	  of	  1.0	  in	  MP5	  medium,	  then	  inoculated	  at	  1%	  (vol/vol)	  into	  1	  L	  of	  MP5	  in	  a	  New	  Brunswick	  BioFlo	  III	  fermenter	  (New	  Brunswik	  Scientific,	  Edison,	  New	  Jersey).	  	  Cells	  were	  incubated	  at	  37oC	  with	  an	  agitation	  rate	  of	  100	  rpm	  to	  prevent	  sedimentation.	  	  A	  gas	  mixture	  of	  5%	  CO2	  and	  95%	  N2	  was	  continuously	  passed	  over	  the	  headspace	  of	  the	  fermenter	  to	  achieve	  anaerobic	  conditions,	  and	  the	  pH	  was	  maintained	  at	  6.5	  by	  automatic	  addition	  of	  15%	  (vol/vol)	  NH4OH.	  	  Bifidobacteria	  were	  incubated	  until	  the	  cells	  reached	  early	  stationary-­‐phase	  (approximately	  12	  h)	  (16).	  
RNA	  isolation.	  	  RNA	  isolation	  was	  performed	  as	  previously	  described	  (17).	  	  Cells	  were	  grown	  in	  batch	  culture	  under	  pH	  control	  to	  early	  stationary	  phase	  and	  then	  samples	  (5	  mL)	  were	  harvested	  by	  centrifugation	  at	  7500	  x	  g	  for	  10	  min.	  	  The	  cell	  pellets	  were	  suspended	  in	  50	  mL	  of	  pre-­‐warmed	  MP5	  media	  containing	  a	  sublethal	  H2O2	  concentration	  of	  1.25mM	  (16)	  for	  5	  (T1)	  or	  60	  (T2)	  min.	  	  Immediately	  after	  treatment,	  100mL	  of	  RNAprotect	  bacterial	  reagent	  (Qiagen,	  Inc.,	  Valencia,	  CA)	  was	  added	  to	  the	  cell	  suspensions	  to	  stop	  transcription	  and	  prevent	  mRNA	  degradation.	  	  A	  control	  sample	  was	  also	  prepared	  which	  was	  not	  exposed	  to	  H2O2.	  	  Cells	  in	  RNAprotect	  were	  held	  at	  room	  temperature	  for	  10	  min,	  then	  collected	  by	  centrifugation	  at	  9500	  x	  g	  for	  10	  min	  and	  stored	  at	  -­‐20oC	  until	  RNA	  isolation.	  	  	  Cell	  pellets	  were	  thawed	  at	  room	  temperature	  and	  suspended	  in	  900	  µL	  of	  a	  lysis	  solution	  containing	  20	  mg	  lysozyme	  (Sigma-­‐Aldrich)	  and	  20	  U	  of	  mutanolysin	  (Sigma-­‐Aldrich)	  per	  mL	  in	  1mM	  TE	  buffer	  adjusted	  to	  pH	  7.6.	  	  Samples	  were	  
  
98 incubated	  for	  30	  min	  at	  37oC	  on	  a	  shaker	  incubator	  at	  240	  rpm,	  after	  which	  20	  µl	  of	  proteinase	  K	  (Omega	  Bio-­‐Tek	  Inc.,	  Norcross,	  GA)	  (>600	  mAU/ml)	  was	  added	  and	  the	  samples	  were	  returned	  to	  the	  shaker/incubator	  for	  30	  min.	  	  The	  RNA	  was	  then	  isolated	  using	  the	  Aurum	  total	  RNA	  mini	  kit	  (Biorad,	  Hurcules,	  CA)	  following	  the	  vendor’s	  recommended	  procedures.	  	  The	  quantity	  of	  recovered	  RNA	  was	  measured	  with	  a	  NanoDrop	  8000	  spectrophotometer	  (ThermoFisher	  Scientific,	  Waltham,	  MA)	  and	  the	  quality	  of	  the	  RNA	  was	  assayed	  using	  an	  Agilent	  2100	  bioanalyzer	  (Agilent	  Technologies,	  Inc.,	  Waldbronn,	  Germany).	  	  Samples	  that	  had	  sufficient	  quantities	  (>10µg)	  of	  quality	  RNA	  were	  stored	  at	  -­‐80oC	  until	  needed.	  
Synthesis	  and	  labeling	  of	  cDNA.	  	  cDNA	  synthesis	  and	  labeling	  was	  performed	  as	  described	  previously	  (17).	  	  cDNA	  was	  synthesized	  and	  labeled	  as	  recommended	  by	  the	  Affymetrix	  (Santa	  Clara,	  CA)	  protocol	  for	  prokaryotic	  target	  preparation	  in	  the	  GeneChip	  Expression	  Analysis	  Technical	  Manual	  (media.affymetrix.com).	  	  The	  cDNA	  was	  fragmented	  into	  approximately	  50-­‐100	  bp	  using	  DNAse	  I	  and	  labeled	  with	  GeneChip	  DNA	  labeling	  reagent	  (Affymetrix,	  Santa	  Clara,	  CA)	  and	  terminal	  deoxynucleotidyl	  transferase	  (Promega,	  Madison,	  WI).	  	  Fragmentation	  labeling	  efficiency	  was	  measured	  by	  gel	  shift	  assay.	  	  	  
DNA	  microarrays.	  	  DNA	  microarray	  hybridization	  and	  statistical	  analysis	  was	  performed	  as	  described	  previously	  (17).	  	  Sample	  hybridization	  was	  performed	  at	  the	  Center	  for	  Integrated	  Bio-­‐systems	  at	  Utah	  State	  University	  against	  a	  custom	  Affymetrix	  bifidobacterial	  DNA	  microarray	  designed	  to	  include	  3113	  shared	  plus	  unique	  chromosomal	  genes	  predicted	  to	  occur	  in	  B.	  longum	  NCC2705	  and	  D2957.	  	  
  
99 The	  only	  predicted	  coding	  sequences	  not	  included	  in	  the	  microarray	  design	  were	  redundant	  transposases	  and	  rRNA	  genes.	  	  Hybridization	  was	  performed	  according	  to	  the	  Affymetrix	  protocol	  for	  prokaryotic	  target	  hybridization	  in	  the	  GeneChip	  Expression	  Analysis	  Technical	  Manual	  using	  a	  hybridization	  temperature	  of	  50oC.	  	  The	  DNA	  microarrays	  were	  scanned	  using	  the	  HP	  GeneArray	  scanner	  (Affymetrix,	  Santa	  Clara,	  CA)	  to	  generate	  raw	  intensity	  values	  for	  each	  probe.	  Statistical	  analysis	  of	  microarray	  data	  was	  performed	  using	  Biocunductor	  (www.bioconductor.org)	  in	  the	  open	  source	  statistical	  platform	  R	  (www.r-­‐project.org).	  	  The	  raw	  probe	  data	  was	  preprocessed	  using	  the	  RMA-­‐MS	  method	  (18)	  and	  filtered	  to	  only	  include	  genes	  that	  had	  a	  high	  signal	  intensity	  and	  a	  low	  coefficient	  of	  variation.	  	  To	  test	  for	  differential	  expression,	  the	  preprocessed,	  filtered	  data	  was	  analyzed	  using	  the	  limma/eBayes	  method	  (19).	  	  Genes	  were	  determined	  to	  be	  significantly	  differentially	  expressed	  if	  they	  had	  a	  false	  discovery	  rate	  corrected	  P-­‐value	  <	  0.05.	  	  The	  significantly	  differentially	  expressed	  genes	  were	  grouped	  according	  to	  function	  and	  by	  treatment	  times	  and	  strain.	  
Microarray	  validation.	  	  To	  validate	  the	  microarray	  data,	  quantitative	  real-­‐time	  PCR	  (RT-­‐PRC)	  was	  performed	  as	  described	  by	  Smeianov	  et	  al.	  (20)	  for	  6	  different	  genes	  (Table	  6-­‐1)	  using	  cDNA	  produced	  after	  each	  treatment.	  	  A	  log-­‐fold	  change	  (LFC)	  was	  calculated	  between	  control	  and	  treatment	  samples,	  and	  graphed	  vs.	  the	  LFC	  calculated	  from	  the	  microarray	  data.	  
Whole	  genome	  sequencing	  of	  B.	  longum	  D2957.	  	  Total	  genomic	  DNA	  was	  isolated	  from	  strain	  D2957	  using	  the	  Masterpure	  Gram	  Positive	  DNA	  purification	  kit	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Table	  6-­1	  	  Target	  genes	  oligonucleotide	  primers	  for	  RT-­‐PCR.	  Primer	  Sequence	  Protein	  function	  (Gene	  ID)	   Forward	   Reverse	   Amplicon	  size	  (bp)	   Annealing	  temp	  (oC)	  Peroxiredoxin	  	  	  	  	  	  	  (BL0615)	   GTGGCTGAGCGTGGCGACTT	   ACCTGGTCGCCGTGCTCGTA	   146	   61.5	  Glutaredoxin	  (BL0668)	   CACCAAGCGCCAGCTCACCA	   GCGTGATGACCACCGGAGCC	   122	   61.5	  Thioredoxin	  (RBLN00690)	  (BLD_0988	  )	   GCGCGTTCGGCCCGATTTTC	   GGGCCAGATCCTGGTTGGCG	   99	   61.5	  Ferredoxin	  (BL01563)	   TACGAGGGTTCCCGCTCGCT	   AAGATGGCCTCGGTGGGGCA	   89	   61.5	  Ferridoxin	  (BL1725)	   GGCTACGCGGGTGCATTGGT	   CCGGGGTGAAACGTGGGTCG	   105	   61.5	  Anaerobic	  Ribonucleotide	  Reductase	  (BL1752)	  	  
TCAAGGGGCGTTACACCGGC	   GGCGCGAGCCACATCGTACA	   97	   61.5	  
dnaK	  (BL0520)	   CCCAGCGTCAGGCCACCAAG	   GCTGCGGTCGGCTCGTTGAT	   79	   61.5	  
  
101 (Epicenter	  Biotechnologies,	  Madison	  WI)	  then	  high-­‐throughput	  whole-­‐genome	  shotgun	  DNA	  sequencing	  and	  assembly	  was	  performed	  at	  the	  Utah	  State	  University	  Center	  for	  Integrated	  Biosystems	  using	  the	  Roche	  454	  GS	  Titanium	  pyrosequencer	  platform.	  	  The	  sequence	  data	  was	  assembled	  into	  a	  2.33	  Mbp	  draft	  genome	  consisting	  of	  13	  contigs,	  and	  automated	  genome	  annotation	  was	  performed	  using	  the	  RAST	  algorithm	  (rast.nmpdr.org).	  
Membrane	  fatty	  acid	  analysis.	  To	  determine	  whether	  H2O2	  exposure	  altered	  cytoplasmic	  membrane	  fatty	  acid	  (CMFA)	  composition,	  cells	  were	  grown	  in	  batch	  culture	  as	  described,	  and	  treated	  with	  a	  sublethal	  H2O2	  concentration	  of	  1.25mM	  for	  5	  (T1)	  or	  60	  (T2)	  min.	  	  Twenty	  mL	  samples	  were	  collected	  by	  centrifugation	  at	  5000	  ×	  g	  for	  5	  min	  and	  then	  washed	  twice	  with	  phosphate	  buffered	  saline.	  	  Membrane	  fatty	  acids	  were	  isolated	  from	  the	  pelleted	  cells	  according	  to	  the	  protocol	  of	  Sasser	  (21)	  and	  identified	  using	  gas	  chromatography	  as	  described	  previously	  (22).	  	  An	  untreated	  control	  sample	  was	  also	  prepared.	  	  Amounts	  of	  individual	  fatty	  acids	  were	  calculated	  as	  a	  percent	  of	  total	  and	  a	  two-­‐tailed	  student	  t	  test	  was	  used	  to	  determine	  differences	  in	  means	  between	  samples.	  
Microarray	  data	  accession	  number.	  	  Microarray	  hybridization	  data	  have	  been	  deposited	  in	  the	  Gene	  Expression	  Omnibus	  under	  accession	  number	  GSE44709.	  
WGS	  sequence	  accession	  number.	  	  The	  Whole	  Genome	  Shotgun	  sequence	  for	  B.	  longum	  D2957	  has	  been	  deposited	  at	  DDBJ/EMBL/GenBank	  under	  the	  
  
102 accession	  AQGL00000000.	  The	  version	  described	  in	  this	  paper	  is	  the	  first	  version,	  AQGL01000000.	  	  
RESULTS	  AND	  DISCUSSION	  
	  
Influence	  of	  H2O2	  stress	  on	  global	  gene	  expression.	  	  To	  explore	  possible	  causes	  for	  differences	  in	  H2O2	  resistance	  between	  B.	  longum	  NCC2705	  and	  D2957,	  we	  analyzed	  their	  transcriptional	  changes	  after	  5	  or	  60	  min	  sublethal	  H2O2	  exposure.	  	  Because	  our	  original	  DNA	  microarray	  design	  was	  based	  on	  the	  two	  B.	  




FIG	  6-­1	  	  Numbers	  of	  B.	  longum	  D2957	  genes,	  grouped	  according	  to	  functional	  category,	  that	  were	  significantly	  upregulated	  (black	  bars)	  or	  downregulated	  (white	  bars)	  after	  1.25	  mM	  H2O2	  exposure	  for	  5	  min	  (A)	  or	  60	  min	  (B)
  




FIG	  6-­2	  	  Numbers	  of	  B.	  longum	  NCC2705	  genes,	  grouped	  according	  to	  functional	  category,	  that	  were	  significantly	  upregulated	  (black	  bars)	  or	  downregulated	  (white	  bars)	  after	  1.25	  mM	  H2O2	  exposure	  for	  5	  min	  (A)	  or	  60	  min	  (B).
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Table	  6-­2	  	  Examples	  of	  differentially	  regulated	  genes	  associated	  with	  oxidative	  stress	  response	  of	  B.	  longum	  strains.	  
Fold	  Change	  vs.	  Control	  







T1	   T2	   T1	   T2	  
BL0555	   Trypsin-­‐like	  serine	  proteases,	  typically	  periplasmic,	  	   1.68	   NSa	   NS	   NS	  
BL0781	   Putative	  intracellular	  protease/amidase	   0.94	   0.96	   NS	   NS	  
BL0944	   ATP-­‐dependent	  endopeptidase	  clp	  proteolytic	  subunit	  clpP	   NS	   NS	   NS	   0.96	  
BL0945	   Protease	  subunit	  of	  ATP-­‐dependent	  Clp	  proteases	   0.79	   NS	   NS	   1.48	  
BL1682	   ATP-­‐dependent	  Zn	  proteases	   0.99	   NS	   NS	   NS	  
BL0139	   NAD(P)H-­‐dependent	  FMN	  reductase	  	   NS	   NS	   NS	   1.92	  
BL0399	   Protoporphyrinogen	  oxidase	   1.06	   NS	   NS	   NS	  
BL0552	   NADPH-­‐dependent	  glutamate	  synthase	  beta	  chain	  and	  related	  oxidoreductases	   NS	   1.03	   NS	   NS	  BL0614	   Thioredoxin	  reductase	   1.92	   1.56	   NS	   0.88	  
BL0615	   Peroxiredoxin	   1.36	   1.29	   NS	   1.16	  
BL0668	   Glutaredoxin	  and	  related	  proteins	   1.79	   1.59	   1.57	   1.49	  
BL0669	   NrdI	  protein/	  ribonucleotide	  reductase	  stimulatory	  protein	   1.42	   NS	   NS	   NS	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BL0670	   Ribonucleotide	  reductase,	  alpha	  subunit	   0.92	   NS	   NS	   NS	  
BL0671	   Ribonucleoside-­‐diphosphate	  reductase	  beta	  chain	   1.40	   NS	   NS	   0.73	  
BL1563	   Ferredoxin	   0.86	   NS	   NS	   NS	  
BL1750	   Exodeoxyribonuclease	  VII	  small	  subunit	   0.75	   1.10	   NS	   NS	  
BL1752	   Oxygen-­‐sensitive	  ribonucleoside-­‐triphosphate	  reductase	   1.88	   1.59	   NS	   NS	  
BL1753	   Anaerobic	  ribonucleoside-­‐triphosphate	  reductase	  activating	  protein	   0.95	   0.89	   NS	   NS	  BLD_0988	   Thioredoxin	   NS	   NS	   NS	   1.52	  
BL0001	   Cold	  shock	  proteins	   0.75	   NS	   NS	   0.85	  
BL0002	   60	  kDa	  chaperonin	  GROEL	   NS	   NS	   NS	   1.09	  
BL0010	   ATPases	  with	  chaperone	  activity,	  ATP-­‐binding	  subunit	   0.89	   NS	   NS	   NS	  
BL0355	   Predicted	  nuclease	  of	  the	  RecB	  family	   -­‐0.82	   NS	   NS	   NS	  
BL0517	   Molecular	  chaperone	  (small	  heat	  shock	  protein)	   NS	   0.92	   NS	   NS	  
BL0519	   ATPases	  with	  chaperone	  activity,	  ATP-­‐binding	  subunit	   NS	   -­‐1.08	   NS	   NS	  
BL0520	   DnaJ-­‐class	  molecular	  chaperone	   NS	   -­‐1.28	   NS	   NS	  
BL1250	   Molecular	  chaperone	   NS	   -­‐1.72	   NS	   NS	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BL1558	   10	  kDa	  chaperonin	  GROES	   NS	   NS	   NS	   0.98	  
BLD_0001	   Cold	  shock	  protein	   NS	   NS	   1.51	   1.06	  
BL1664	   Universal	  stress	  protein	  UspA	  and	  related	  nucleotide-­‐binding	  proteins	   -­‐1.15	   -­‐1.74	   NS	   NS	  
BLD_1771	   Stress-­‐responsive	  transcriptional	  regulator	  PspC	   0.84	   NS	   NS	   NS	  aNS,	  Not	  Significant	  	  (Table	  6-­‐2).	  	  Examples	  include	  several	  genes	  involved	  in	  the	  thioredoxin	  reductase	  system	  which,	  under	  favorable	  growth	  conditions,	  functions	  with	  ribonucleoside	  reductase	  to	  use	  NADPH	  to	  reduce	  the	  2’	  OH	  group	  of	  ribose	  for	  deoxynucleotide	  production,	  as	  well	  as	  to	  maintain	  cytoplasmic	  redox	  for	  disulfide	  bond	  production	  in	  proteins	  (25,	  26).	  	  During	  oxidative	  stress,	  however,	  cells	  may	  use	  thioredoxin	  reductase	  and	  peroxiredoxin	  to	  direct	  NADPH	  toward	  the	  removal	  of	  oxidative	  free	  radicals	  via	  the	  reduction	  of	  H2O2	  and	  toxic	  lipid	  hydroperoxides	  (27,	  28,	  29).	  	  Schell	  et	  al.	  (30)	  suggested	  these	  enzymes	  might	  be	  one	  of	  the	  primary	  defense	  mechanisms	  against	  oxidative	  stress	  in	  bifidobacteria,	  and	  other	  research	  has	  shown	  up-­‐regulation	  of	  thioredoxin,	  thioredoxin	  reductase	  and	  peroxiredoxin	  in	  response	  to	  oxygen	  stress	  (31,	  32).	  	  B.	  longum	  NCC2705	  showed	  	  significant	  up	  regulation	  of	  thioredoxin	  reductase	  (BL0614)	  and	  peroxiredoxin	  (BL0615)	  along	  with	  ribonucleotide	  reductase	  alpha	  and	  beta	  subunits	  (BL0670,	  BL0671)	  after	  only	  5	  min	  sublethal	  H2O2	  treatment	  (Table	  6-­‐2).	  	  In	  contrast,	  D2957	  did	  not	  display	  significant	  upregulation	  of	  these	  genes	  until	  60	  min	  exposure	  to	  H2O2.	  	  These	  results	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  confirm	  that	  thioredoxin	  reductase	  and	  peroxiredoxin	  provide	  a	  primary	  defense	  mechanism	  against	  oxidative	  stress	  in	  B.	  longum	  and	  suggest	  that	  the	  greater	  H2O2	  resistance	  of	  strain	  NCC2705	  versus	  D2957	  may	  be	  tied	  to	  earlier	  induction	  of	  these	  mechanisms.	  Oxidative	  stress	  causes	  protein	  damage	  and	  denaturation,	  and	  protection	  of	  proteins	  and	  processing	  of	  damaged	  proteins	  is	  an	  important	  component	  of	  the	  oxidative	  stress	  response	  in	  bacteria	  (33,	  34,	  35).	  	  Although	  bifidobacteria	  possess	  well	  studied	  chaparones	  and	  chaparonins	  (eg.	  DnaJ/DnaK	  and	  GroEL/GroES),	  their	  role	  in	  H2O2	  resistance	  is	  unclear.	  	  B.	  longum	  NCC2705	  for	  example,	  showed	  significant	  down	  regulation	  of	  several	  general	  stress	  response	  genes,	  including	  DnaJ,	  UspA	  and	  several	  chaperone	  proteins	  (BL0519,	  BL1250	  and	  BL1664)	  in	  response	  to	  H2O2	  exposure	  (Table	  6-­‐2).	  	  This	  observation	  is	  consistent	  with	  prior	  studies,	  which	  reported	  no	  change	  in	  expression	  or	  down	  regulation	  of	  the	  general	  stress	  response	  genes	  in	  response	  to	  acid	  stress	  (36,	  37).	  	  However,	  NCC2705	  did	  show	  an	  up	  regulation	  of	  several	  proteases	  (BL0555,	  BL0781,	  BL0945)	  after	  5	  min	  H2O2	  exposure,	  including	  an	  ATP-­‐dependent	  metallo-­‐protease	  (BL1682).	  	  Jin	  et	  al.	  (36)	  also	  reported	  upregulation	  of	  a	  similar	  metallo-­‐protease	  during	  acid	  stress,	  which	  was	  hypothesized	  to	  function	  in	  response	  to	  damage	  of	  membrane	  proteins	  which	  result	  in	  perturbation	  of	  membrane	  function	  (38).	  	  In	  contrast,	  strain	  D2957	  only	  showed	  upregulation	  of	  two	  proteases	  (BL0944,	  BL0945)	  after	  60	  min	  exposure.	  
Membrane	  fatty	  acid	  analysis.	  	  Bacterial	  cell	  envelopes	  provide	  an	  initial	  line	  of	  defense	  against	  environmental	  stress	  and	  their	  lipid	  composition	  plays	  a	  
  




FIG	  6-­3	  	  Membrane	  fatty	  acid	  composition	  for	  B.	  longum	  NCC2705	  (A)	  and	  B.	  longum	  D2957	  (B).	  The	  graphs	  shows	  data	  from	  cells	  grown	  in	  MP5	  media	  with	  no	  H2O2	  (control)	  and	  cells	  exposed	  to	  1.25	  mM	  H2O2	  in	  MP5	  broth	  for	  5	  or	  20	  min.	  Error	  bars	  correspond	  to	  the	  standard	  error	  of	  the	  mean	  (SEM).	  Means	  with	  the	  same	  letters	  within	  each	  strain	  are	  not	  significantly	  different	  (P	  <	  0.05).	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  In	  summary,	  transcriptome	  data	  suggest	  that	  the	  significant	  differences	  in	  the	  intrinsic	  and	  inducible	  resistance	  to	  H2O2	  noted	  previously	  between	  B.	  longum	  NCC2705	  and	  D2957	  (16),	  may	  be	  largely	  due	  to	  the	  timing	  and	  degree	  of	  induction	  of	  genes	  involved	  in	  an	  oxidative	  stress	  response.	  	  These	  data	  demonstrate	  that	  NCC2705	  has	  a	  rapid	  and	  highly	  inducible	  H2O2	  stress	  response,	  whereas	  strain	  D2957	  showed	  a	  more	  delayed	  and	  less	  pronounced	  transcriptional	  response	  to	  H2O2	  stress.	  	  Because	  of	  the	  highly	  reactive	  nature	  of	  oxidative	  free	  radicals,	  an	  immediate	  and	  robust	  inducible	  stress	  response	  may	  be	  more	  effective	  in	  neutralizing	  the	  damaging	  effects	  of	  H2O2.	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SUMMARY	  AND	  CONCLUSIONS	  
	  This	  study	  focused	  on	  defining	  the	  physiological	  and	  transcriptional	  stress	  responses	  of	  Bifidobacterium	  species	  to	  H2O2	  stress.	  	  The	  fist	  phase	  of	  the	  study	  determined	  the	  intrinsic	  and	  inducible	  H2O2	  stress	  responses	  of	  3	  strains	  of	  B.	  
longum	  and	  3	  strains	  of	  B.	  animalis	  subsp.	  lactis.	  	  Results	  from	  this	  phase	  indicate	  that	  intrinsic	  and	  inducible	  H2O2	  resistance	  is	  both	  species	  and	  strain	  specific.	  	  Our	  study	  design	  sought	  to	  explore	  H2O2	  resistance	  of	  each	  strain	  in	  a	  milk	  peptone-­‐based	  growth	  medium	  similar	  to	  those	  used	  for	  commercial	  production	  of	  probiotic	  cultures	  to	  study	  cells	  in	  active	  metabolism	  during	  exposure.	  	  Because	  H2O2	  is	  a	  strong	  oxidizing	  agent,	  we	  anticipated	  there	  would	  be	  a	  loss	  in	  concentration	  upon	  addition	  to	  broth	  medium	  and	  preliminary	  tests	  confirmed	  the	  concentration	  of	  H2O2	  decreased	  from	  20-­‐60%.	  	  Because	  of	  this	  variability,	  our	  data	  analysis	  for	  intrinsic	  resistance	  was	  calculated	  similar	  to	  a	  Z-­‐value	  determination	  in	  thermal	  destruction	  of	  an	  organism.	  	  The	  measured	  concentrations	  of	  H2O2	  were	  plotted	  against	  the	  log10CFUof	  surviving	  cells	  and	  a	  line	  was	  fitted	  to	  the	  data.	  	  A	  steeper	  slope	  of	  the	  line	  indicates	  faster	  cell	  death	  at	  higher	  concentrations	  of	  H2O2.	  Although	  certain	  strains	  showed	  higher	  H2O2	  resistance	  than	  others,	  the	  lethal	  H2O2	  concentration	  for	  all	  strains	  was	  relatively	  low	  (2.55-­‐5.25	  mM),	  which	  are	  within	  the	  concentration	  range	  of	  H2O2	  produced	  by	  LAB	  starter	  cultures	  during	  manufacture	  of	  yogurt	  and	  other	  bioactive	  foods.	  	  Our	  results	  suggest	  that	  a	  sublethal	  H2O2	  exposure	  could	  be	  used	  to	  enhance	  H2O2	  resistance	  of	  some	  strains	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  (e.g.	  B.	  longum	  NCC2705	  and	  B.	  animalis	  subsp.	  lactis	  BL-­‐04),	  but	  that	  H2O2	  inducible	  stress	  responses	  are	  not	  only	  species	  and	  strain	  dependent,	  but	  also	  dependent	  on	  the	  exposure	  time	  and	  concentration.	  	  This	  can	  be	  seen	  by	  the	  fact	  that	  B.	  animalis	  subsp.	  lactis	  BL-­‐04	  showed	  an	  increase	  in	  survival	  after	  a	  20	  min	  induction	  but	  not	  after	  a	  60	  min	  induction.	  	  It	  was	  also	  interesting	  to	  note	  that	  sublethal	  H2O2	  exposure	  increased	  some	  strains	  sensitivity	  to	  lethal	  H2O2	  concentrations	  in	  some	  strains,	  as	  was	  the	  case	  for	  B.	  animalis	  subsp.	  lactis	  DSM10140.	  	   Initial	  analysis	  of	  membrane	  fatty	  acid	  compositions	  for	  Bifidobacterium	  strains	  revealed	  the	  possibility	  that	  a	  significant	  percentage	  of	  the	  membrane	  phospholipids	  contained	  ether	  bound	  lipids,	  more	  commonly	  referred	  to	  as	  plasmalogens.	  	  Previous	  research	  on	  membrane	  composition	  during	  stress	  exposure	  in	  bifidobacteria	  has	  not	  typically	  taken	  these	  ether-­‐bonded	  lipids	  into	  account.	  	  Our	  collected	  data	  show	  that	  plasmalogens	  make	  up	  a	  significant	  proportion	  of	  the	  total	  membrane	  composition	  of	  B.	  animalis	  subsp.	  lactis	  DSM10140	  and	  BL-­‐04	  strains.	  	  Isolated	  membrane	  fatty	  acids	  were	  analysed	  using	  GC-­‐MS	  accurate	  mass	  for	  positive	  identification	  of	  ether-­‐bonded	  lipids.	  	  This	  data	  represent	  the	  first	  published	  gas	  chromatograms	  and	  mass	  spectrometry	  tables	  for	  plasmalogens	  isolated	  from	  bifidobacteria.	  	  Because	  plasmalogens	  have	  been	  shown	  to	  have	  physical	  attributes	  that	  affect	  membrane	  physiology	  differently	  compared	  to	  the	  ester	  linked	  analogs,	  it	  is	  important	  to	  consider	  these	  lipids	  when	  characterizing	  the	  membrane	  composition	  of	  bifidobacteria.	  	  The	  high	  concentrations	  of	  plasmalogens	  in	  B.	  animalis	  subsp.	  lactis	  membranes,	  together	  with	  strain-­‐specific	  differences	  in	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  lipid	  species	  correlated	  with	  H2O2	  sensitivity,	  suggest	  these	  lipids	  may	  play	  an	  important	  role	  in	  environmental	  stress	  resistance.	  	  	  The	  second	  phase	  of	  this	  study	  explored	  the	  transcriptional	  stress	  responses	  of	  bifidobacteria	  to	  H2O2	  using	  DNA	  microarrays.	  	  Transcriptome	  data	  show	  a	  sublethal	  H2O2	  exposure	  triggers	  induction	  of	  an	  oxidative	  stress	  response	  in	  B.	  
animalis	  subsp.	  lactis	  BL-­‐04,	  but	  that	  this	  mechanism	  is	  somehow	  impaired	  in	  strain	  DSM	  10140.	  	  Comparison	  of	  the	  whole	  genome	  sequences	  B.	  animalis	  subsp.	  lactis	  BL-­‐04	  and	  DSM	  10140	  reveal	  that	  they	  are	  highly	  clonal,	  yet	  display	  significant	  differences	  in	  their	  intrinsic	  and	  inducible	  resistance	  to	  H2O2.	  	  Genetic	  and	  membrane	  lipid	  data	  suggest	  some	  of	  the	  differences	  in	  H2O2	  resistance	  between	  these	  cells	  may	  be	  associated	  with	  activity	  of	  a	  long	  chain	  fatty	  acyl-­‐CoA	  ligase	  gene	  which	  activates	  long	  chain	  fatty	  acids	  for	  integration	  into	  the	  membrane.	  	  While	  efforts	  to	  restore	  an	  inducible	  H2O2	  stress	  response	  in	  DSM	  10140	  via	  modification	  of	  its	  CMFA	  composition	  were	  unsuccessful,	  modification	  did	  significantly	  increase	  intrinsic	  H2O2	  resistance.	  	  These	  data	  show	  deliberate	  H2O2	  stress	  induction	  or	  membrane	  lipid	  modification	  can	  be	  used	  to	  significantly	  improve	  H2O2	  resistance	  in	  
B.	  animalis	  subsp.	  lactis.	  Transcriptome	  data	  for	  B.	  longum	  suggest	  that	  the	  significant	  differences	  in	  the	  intrinsic	  and	  inducible	  resistance	  to	  H2O2	  between	  strains	  NCC2705	  and	  D2957,	  may	  be	  largely	  due	  to	  the	  timing	  and	  degree	  of	  induction	  of	  genes	  involved	  in	  an	  oxidative	  stress	  response.	  	  These	  data	  demonstrate	  that	  NCC2705	  has	  a	  rapid	  and	  highly	  inducible	  H2O2	  stress	  response,	  whereas	  strain	  D2957	  showed	  a	  more	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  delayed	  and	  less	  pronounced	  transcriptional	  response	  to	  H2O2	  stress.	  	  Because	  of	  the	  highly	  reactive	  nature	  of	  oxidative	  free	  radicals,	  an	  immediate	  and	  robust	  inducible	  stress	  response	  may	  be	  more	  effective	  in	  neutralizing	  the	  damaging	  effects	  of	  H2O2.	  	   Because	  genetic	  tools	  are	  only	  poorly	  developed	  in	  B.	  animalis	  subsp.	  lactis	  and	  B.	  longum	  strains,	  confirmation	  of	  the	  functional	  roles	  of	  stress	  response	  systems	  identified	  in	  this	  study	  was	  not	  feasible.	  	  To	  truly	  understand	  these	  mechanisms	  will	  require	  functional	  studies	  involving	  genetic	  manipulation	  of	  B.	  
































category	  and	  gene	  
ID	  
Predicted	  function	   T1	   T2	  
Metabolism	   	   	  Energy	  production,	  conversion	   	   	  Balac_1082	   Pyruvate	  formate-­‐lyase	  activating	  enzyme	   1.46	   NSa	  Balac_0124	   Predicted	  nucleoside-­‐diphosphate-­‐sugar	  epimerase	  /	  NAD-­‐dependent	  epimerase/dehydratase	  	   1.13	   NS	  Balac_1561	   [phosphocarrier	  protein	  HPr]-­‐phosphatase	  /	  halo	  acid	  dehalogenase-­‐like	  hydrolase	  	   0.65	   NS	  Balac_0538	   Citrate	  synthase	   0.50	   NS	  Balac_0768	   Isocitrate	  dehydrogenase	  [NADP]	   -­‐0.46	   NS	  Balac_0345	   Phosphate	  transport	  system	  permease	  protein	  pstA	   -­‐0.80	   NS	  Balac_0459	   Protein	  tyrosine	  phosphatase	   -­‐1.28	   NS	  Balac_0378	   Alcohol	  dehydrogenase	  /	  Acetaldehyde	  dehydrogenase	  [acetylating]	   -­‐2.67	   NS	  Carbohydrate	  transport,	  	  metabolism	   	   	  Balac_1597	   Raffinose	  transport	  system	  permease	  protein	   3.46	   NS	  Balac_1598	   Raffinose	  transport	  system	  permease	  protein	   3.20	   NS	  Balac_1599	   Raffinose-­‐binding	  protein	   3.12	   NS	  Balac_1601	   Alpha-­‐galactosidase	   2.10	   NS	  Balac_1567	   4-­‐alpha-­‐glucanotransferase	   3.13	   NS	  Balac_1568	   Alpha-­‐glucosidase	   1.43	   NS	  Balac_1569	   Multiple	  sugar	  transport	  system	  permease	  protein	  msmG	   2.58	   NS	  Balac_1570	   Sugar	  transport	  system	  permease	  protein	   2.55	   NS	  Balac_1572	   Maltose/maltodextrin-­‐binding	  protein	   1.90	   NS	  Balac_1573	   Trehalose-­‐6-­‐phosphate	  hydrolase	   0.99	   NS	  Balac_1593	   Oligo-­‐1,6-­‐glucosidase	   2.34	   NS	  Balac_1562	   Pullulanase	   0.96	   NS	  Balac_1563	   Maltose	  transport	  system	  permease	  protein	  malG	  	   0.67	   NS	  Balac_1564	   Maltodextrin	  transport	  system	  permease	  protein	  malC	   0.59	   NS	  Balac_0483	   MalE-­‐type	  ABC	  sugar	  transport	  system	   -­‐0.68	   NS	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  periplasmic	  component	  	  Balac_0977	   Isoamylase	  /	  glycogen	  operon	  protein	  GlgX	  	   -­‐0.68	   NS	  Balac_0065	   Alpha-­‐L-­‐arabinofuranosidase	   -­‐0.79	   NS	  Amino	  acid	  transport,	  	  metabolism	   	   	  Balac_0217	   2-­‐isopropylmalate	  synthase	   0.88	   NS	  Balac_0241	   3-­‐isopropylmalate	  dehydratase	  large	  subunit	   0.86	   NS	  Balac_0444	   Amino	  acid	  permease	   0.77	   NS	  Balac_1332	   N-­‐acetylglutamate	  synthase	  	   0.76	   NS	  Balac_0442	   Glutamate/gamma-­‐aminobutyrate	  antiporter	   0.74	   -­‐1.37	  Balac_1592	   Threonine	  dehydratase	   0.68	   NS	  Balac_1362	   3-­‐isopropylmalate	  dehydrogenase	   0.59	   NS	  Balac_0505	   O-­‐acetyl-­‐L-­‐homoserine	  sulfhydrolase	  /	  O-­‐acetyl-­‐L-­‐serine	  sulfhydrolase	   0.49	   NS	  Balac_0880	   Aspartate	  carbamoyltransferase	   -­‐0.48	   NS	  Balac_0672	   Glutamate	  transport	  system	  permease	  protein	  gluC/	  ABC-­‐type	  amino	  acid	  transport	  system	  permease	  component	  	   -­‐0.65	   NS	  Balac_0559	   ABC-­‐type	  dipeptide/oligopeptide/nickel	  transport	  systems,	  permease	  components	   -­‐0.84	   NS	  Balac_0560	   ABC-­‐type	  dipeptide/oligopeptide/nickel	  transport	  systems,	  permease	  components	   -­‐0.79	   NS	  Balac_0561	   ABC-­‐type	  dipeptide/oligopeptide/nickel	  transport	  system,	  ATPase	  component	   -­‐0.74	   NS	  Balac_1201	   Phospho-­‐N-­‐acetylmuramoyl-­‐pentapeptide-­‐transferase	   -­‐1.01	   NS	  Balac_1242	   ABC-­‐type	  nitrate/sulfonate/bicarbonate	  transport	  system,	  permease	  component	   -­‐1.59	   -­‐1.79	  Balac_1243	   ABC-­‐type	  nitrate/sulfonate/bicarbonate	  transport	  systems,	  periplasmic	  components	   -­‐1.81	   -­‐2.20	  Nucleotide	  transport,	  	  metabolism	   	   	  Balac_1501	   Sugar	  kinases,	  ribokinase	  family	   3.03	   2.41	  Balac_1503	   Inosine-­‐uridine	  preferring	  nucleoside	  hydrolase	   2.79	   2.54	  Balac_1081	   Ribonuclease	  D	   1.25	   NS	  Balac_0946	   Xanthine	  phosphoribosyltransferase	  	   1.14	   NS	  Balat_0464	   5'-­‐nucleotidase	   1.05	   NS	  Balac_0785	   Uracil	  DNA	  glycosylase	  superfamily	  protein	   0.83	   NS	  Balac_0112	   O6-­‐methylguanine-­‐DNA	  methyltransferase	   0.82	   NS	  Balac_0529	   Oligoribonuclease	  	   0.57	   NS	  Balac_0595	   Phosphoribosylformylglycinamidine	  cyclo-­‐ -­‐0.90	   NS	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  ligase	  Balac_0814	   Phosphoribosylaminoimidazolecarboxamide	  formyltransferase	  /	  IMP	  cyclohydrolase	   -­‐0.90	   NS	  Balac_0874	   Orotate	  phosphoribosyltransferase	   -­‐1.05	   NS	  Balac_0875	   Dihydroorotate	  dehydrogenase	  	   -­‐1.06	   NS	  Balac_0876	   Dihydroorotate	  dehydrogenase	  electron	  transfer	  subunit	   -­‐0.94	   NS	  Balac_0877	   Orotidine	  5'-­‐phosphate	  decarboxylase	   -­‐0.96	   NS	  Balac_0878	   Dihydroorotase	   -­‐0.83	   NS	  Balac_0922	   CTP	  synthase	   -­‐1.03	   NS	  Balac_0627	   Orotidine	  5'-­‐phosphate	  decarboxylase	   -­‐1.20	   NS	  Balac_0628	   Guanylate	  kinase	   -­‐1.26	   NS	  Balac_1438	   Inosine-­‐uridine	  nucleoside	  N-­‐ribohydrolase	   NS	   -­‐1.25	  Balac_1244	   Inosine-­‐uridine	  preferring	  nucleoside	  hydrolase	   -­‐1.78	   -­‐2.26	  
Coenzyme	  metabolism	   	   	  Balac_1405	   ABC-­‐type	  transport	  system	  involved	  in	  cytochrome	  b	  biosynthesis,	  ATPase	  and	  permease	  components	   NS	   1.29	  Balac_1397	   pyridoxine	  biosynthesis	  protein	   0.76	   NS	  
Information	  Storage	  and	  Processing	  Translation,	  	  ribosomal	  structure,	  	  biogenesis	  Balac_0618	   SSU	  ribosomal	  protein	  S7P	   -­‐0.64	   NS	  Balac_0350	   LSU	  ribosomal	  protein	  L12P	  (L7/L12)	   -­‐0.92	   NS	  Balac_0760	   Ribosomal-­‐protein-­‐S18-­‐alanine	  acetyltransferase	   -­‐0.94	   NS	  Transcription	   	   	   	  Balac_1571	   Transcriptional	  regulator,	  LacI	  family	   2.29	   NS	  Balac_1275	   Histone	  acetyltransferase	  HPA2	  and	  related	  acetyltransferases	   NS	   1.73	  
Balac_0477	   LacI-­‐type	  transcriptional	  regulator	  	   0.63	   NS	  Balac_0064	   Hypothetical	  protein	  /	  RbsR-­‐type	  transcription	  regulator/	  ribose	  operon	  repressor	  	   -­‐0.86	   NS	  DNA	  Replication,	  	  recombination,	  repair	   	   	  Balac_1304	   ATP-­‐dependent	  helicase	  /	  CRISPR-­‐associated	  helicase	  Cas3	  family	  protein	  	   0.58	   NS	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  Balac_0006	   Type	  IIA	  topoisomerase	  (DNA	  gyrase/topo	  II,	  topoisomerase	  IV),	  A	  subunit	   NS	   -­‐1.03	  
Cellular	  Processes	   	   	  Protein	  turnover,	  	  stress	  response	   	   	  Balac_0326	   Ribonucleoside-­‐diphosphate	  reductase	  beta	  chain	   5.39	   2.77	  Balac_0327	   Ribonucleoside-­‐diphosphate	  reductase	  alpha	  chain	   4.23	   NS	  Balac_0328	   NrdI	  protein	  /	  ribonucleotide	  reductase	  stimulatory	  protein	  	   1.71	   NS	  Balac_1502	   tetracycline	  resistance	  permease/tetracycline	  efflux	  pump/MFSb	  transporter/	   2.98	   2.53	  Balac_0865	   Peroxiredoxin	  AhpC	   1.10	   NS	  Balac_0866	   Thioredoxin	  reductase	  /	  Thioredoxin/Glutaredoxin	  family	  protein	   1.84	   1.19	  Balac_0118	   Oxidoreductase	  	   1.40	   NS	  Balac_0120	   Vanillate	  O-­‐demethylase	  oxidoreductase	  /	  ferric	  reductase	  	   1.59	   NS	  Balac_0121	   Flavodoxin	   2.14	   NS	  Balac_0123	   Flavodoxin	   1.54	   NS	  Balac_0331	   Peptidase	  family	  U32	   1.35	   NS	  Balac_0443	   Carboxypeptidase	  S1	   1.28	   -­‐1.27	  Balac_0573	   NTP	  pyrophosphohydrolases	  including	  oxidative	  damage	  repair	  enzymes	   NS	   1.34	  Balac_1314	   Anaerobic	  ribonucleoside-­‐triphosphate	  reductase	  activating	  protein	   1.05	   NS	  Balat_0226	   Dipeptidase	  A	   0.81	   1.54	  Balac_0440	   Acyl-­‐coenzyme	  A:6-­‐aminopenicillanic-­‐acid-­‐acyltransferase	  precursor	   NS	   -­‐1.63	  Balac_0441	   Aminopeptidase	  C	   0.76	   NS	  Balac_1315	   Anaerobic	  ribonucleoside-­‐triphosphate	  reductase	   0.72	   NS	  Balac_1212	   LexA	  repressor	   0.60	   NS	  Balac_1114	   RecA	  protein	   0.58	   NS	  Balac_0025	   Oxidoreductase	  	   0.56	   NS	  Balac_0856	   Excinuclease	  ABC	  subunit	  A	   0.55	   NS	  Balac_1437	   Multidrug	  resistance	  protein	  B	   0.52	   -­‐1.22	  Balac_1556	   GrpE	  protein	   0.47	   NS	  Balac_1247	   DNA	  repair	  protein	  recO	   -­‐0.97	   NS	  Balac_1555	   DnaJ-­‐class	  molecular	  chaperone	   NS	   -­‐1.34	  Cell	  secretion	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  Balac_0308	   Protein	  translocase	  subunit	  secE	   0.60	   NS	  Balac_1110	   Protein	  translocase	  subunit	  secA	   -­‐1.07	   NS	  Ion	  transport	   	   	   	  Balac_0182	   High-­‐affinity	  zinc	  uptake	  system	  protein	  znuA	  precursor	  /	  Hypothetical	  exported	  protein	   2.22	   NS	  Balac_1036	   Fe2+	  transport	  system	  protein	  B	   NS	   1.88	  Balac_0014	   Large-­‐conductance	  mechanosensitive	  channel	   0.99	   NS	  Balac_0348	   Manganese-­‐binding	  protein	   0.84	   NS	  Balac_0991	   Manganese	  transport	  system	  ATP-­‐binding	  protein	   0.79	   NS	  Balac_0917	   ATP-­‐dependent	  transporter	  sufC	   0.55	   NS	  Balac_0919	   ABC-­‐type	  transport	  system	  for	  Fe-­‐S	  cluster	  assembly	  permease	  component	  sufB	   0.67	   NS	  Cell	  envelope	  	  biogenesis	   	   	  Balac_0261	   Fibronectin-­‐binding	  protein	   NS	   1.18	  Balac_1132	   O-­‐acetyltransferase	  (cell	  wall	  biosynthesis)	   1.15	   NS	  Balac_0316	   Propionyl-­‐CoA	  carboxylase	  beta	  chain	   -­‐0.84	   NS	  Balac_0317	   Fatty	  acid	  synthase	   -­‐0.77	   NS	  Balac_1406	   Long-­‐chain-­‐fatty-­‐acid-­‐-­‐CoA	  ligase	   -­‐0.82	   NS	  Balac_1380	   Flippase	  Wzx	  	   -­‐0.97	   NS	  Balac_1387	   Capsular	  polysaccharide	  synthesis	  protein	   -­‐0.99	   NS	  Cell	  division,	  	  chromosome	  partitioning	   	   	  Balac_0696	   ATPases	  involved	  in	  chromosome	  partitioning	   NS	   1.64	  Balac_0084	   Serine/threonine	  protein	  kinase	   -­‐0.81	   NS	  Balac_0085	   Serine/threonine	  protein	  kinase	   -­‐0.81	   NS	  Balac_0086	   Penicillin-­‐binding	  protein/FtsI	   -­‐0.74	   NS	  Balac_0087	   Cell	  division	  protein	  ftsW	   -­‐0.68	   NS	  Balac_0088	   Protein	  phosphatase	  2C	   -­‐0.82	   NS	  Balac_1196	   Cell	  division	  protein	  ftsQ	   -­‐0.74	   NS	  
Poorly	  characterized,	  	  
general	  function	  only	  
	   	  Balac_0019	   none	  assigned	  /	  membrane-­‐anchored	  glycerophosphoryl	  diesterphosphodiesterase-­‐like	  protein	  	   NS	   1.79	  Balac_1052	   Hypothetical	  cytosolic	  protein	   1.05	   NS	  Balac_0868	   Predicted	  hydrolase	  (HAD	  superfamily)	   NS	   1.03	  Balac_0325	   Hypothetical	  membrane	  spanning	  protein	   0.81	   NS	  Balac_0147	   Transporter,	  MFS	  superfamily	   0.68	   NS	  Balac_0636	   DedA	  family	  protein	   0.53	   NS	  Balac_1248	   Transporter	  /	  Hydrolases	  of	  the	  alpha/beta	   -­‐0.84	   NS	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  superfamily	  Balac_0580	   Hypothetical	  membrane	  spanning	  protein	   -­‐0.86	   -­‐1.66	  Balac_0815	   Hypothetical	  membrane	  spanning	  protein	   -­‐0.90	   NS	  Balac_1381	   Hypothetical	  protein	  /	  glycosyl	  transferase	  family	  protein	  	   -­‐0.96	   NS	  Balac_0515	   Hypothetical	  protein	  /	  putative	  binding	  protein-­‐dependent	  transporter	  	   -­‐1.17	   NS	  Balac_0516	   Transporter	  /	  putative	  binding	  protein-­‐dependent	  transporter	  	   -­‐0.98	   NS	  Balac_0139	   Hypothetical	  protein	  /	  membrane	  protein	  with	  transport	  function	  	   -­‐1.23	   NS	  Balac_0097	   Integral	  membrane	  protein	   -­‐1.46	   -­‐3.11	  
Uncharacterized,	  	  
hypothetical	  proteins	  
	   	  Balac_0119	   Hypothetical	  protein	   1.68	   NS	  Balac_1037	   Hypothetical	  protein	  	   NS	   1.66	  Balac_1133	   Hypothetical	  protein	   1.15	   NS	  Balac_1558	   Hypothetical	  protein	   1.12	   NS	  Balac_1275	   Hypothetical	  protein	   1.00	   NS	  Balac_0355	   Hypothetical	  protein	   0.68	   NS	  Balac_0074	   Hypothetical	  cytosolic	  protein	   0.67	   NS	  Balac_1340	   Hypothetical	  protein	   0.67	   NS	  Balac_0094	   Hypothetical	  protein	   0.62	   NS	  Balac_1323	   Hypothetical	  protein	   0.50	   NS	  Balac_0648	   Hypothetical	  protein	   -­‐0.73	   NS	  Balac_1468	   Hypothetical	  protein	   -­‐0.76	   NS	  Balac_1409	   Hypothetical	  protein	   -­‐0.79	   NS	  Balac_0650	   Hypothetical	  protein	   -­‐0.83	   NS	  aNS,	  Not	  Significant	  bMFS,	  Mutli-­‐facilitator	  superfamily
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Table	  A-­2	  	  Sequenced	  genes	  from	  B.	  longum	  D2957	  predicted	  to	  not	  hybridize	  on	  DNA	  microarray.	  
General	  functional	  
category	  and	  gene	  ID	  
Predicted	  Function	  
Metabolism	  Energy	  production	  and	  conversion	  I118_0104	   Phosphoenolpyruvate	  carboxylase	  I118_0928	   Alcohol	  dehydrogenase	  I118_1667	   Ribokinase	  I118_1714	   Radical	  SAM,	  Pyruvate-­‐formate	  lyase-­‐activating	  enzyme	  like	  Carbohydrate	  transport,	  metabolism	  I118_0011	   Alpha-­‐glucosidase	  I118_0012	   ABC-­‐type	  sugar	  transport	  system,	  permease	  component	  I118_0013	   Multiple	  sugar	  ABC	  transporter,	  membrane-­‐spanning	  permease	  protein	  MsmF	  I118_0015	   Multiple	  sugar	  ABC	  transporter,	  substrate-­‐binding	  protein	  I118_0017	   Multiple	  sugar	  ABC	  transporter,	  substrate-­‐binding	  protein	  I118_0018	   MSM	  (multiple	  sugar	  metabolism)	  operon	  regulatory	  protein	  I118_0019	   MSM	  (multiple	  sugar	  metabolism)	  operon	  regulatory	  protein	  I118_0052	   Beta-­‐glucosidase	  I118_0081	   Putative	  pectinesterase	  I118_0291	   Maltose/maltodextrin	  ABC	  transporter,	  substrate	  binding	  periplasmic	  protein	  MalE	  I118_0293	   ABC-­‐type	  sugar	  transport	  system,	  permease	  component	  I118_0448	   Arabinose	  permease	  I118_0450	   Arabinose-­‐proton	  symporter	  I118_0454	   Lactose	  and	  galactose	  permease,	  GPH	  translocator	  family	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I118_0627	   Beta-­‐glucuronidase	  I118_1225	   Cytidylate	  kinase	  /	  GTP-­‐binding	  protein	  EngA	  I118_1428	   Predicted	  glucose	  transporter	  in	  maltodextrin	  utilization	  gene	  cluster	  I118_1563	   Alpha-­‐xylosidase	  I118_1663	   Lactose	  and	  galactose	  permease,	  GPH	  translocator	  family	  I118_1664	   Beta-­‐galactosidase	  	  I118_1926	   Sucrose	  phosphorylase	  	  I118_1999	   Rhamnose-­‐containing	  polysacharide	  translocation	  permease	  I118_2058	   Endo-­‐1,4-­‐beta-­‐xylanase	  Amino	  acid	  transport,	  metabolism	  I118_0702	   L-­‐serine	  dehydratase	  I118_1182	   N-­‐formylglutamate	  deformylase	  I118_1536	   Methionine	  ABC	  transporter	  ATP-­‐binding	  protein	  I118_1896	   Methionine	  gamma-­‐lyase	  	  I118_1945	   Aspartate	  aminotransferase	  	  Nucleotide	  transport,	  metabolism	  I118_0718	   Competence	  protein	  F	  homolog	  protein	  YhgH	  required	  for	  utilization	  of	  DNA	  as	  sole	  source	  of	  carbon	  and	  energy	  I118_1142	   3',	  5'	  oligoribonuclease	  (orn)	  I118_1483	   ATP-­‐dependent	  nuclease,	  subunit	  A	  I118_1484	   ATP-­‐dependent	  nuclease,	  subunit	  B	  I118_1599	   3',	  5'-­‐cyclic-­‐nucleotide	  3',	  5'-­‐phosphodiesterase	  /	  3',	  5'-­‐nucleotidase	  	  I118_1600	   3',	  5'-­‐cyclic-­‐nucleotide	  3',	  5'-­‐phosphodiesterase	  /	  3',	  5'-­‐nucleotidase	  	  I118_1669	   Inosine-­‐uridine	  preferring	  nucleoside	  hydrolase	  Coenzyme	  metabolism	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I118_0292	   Inositol	  transport	  system	  permease	  protein	  I118_1996	   Rhamnosyltransferase	  Secondary	  metabolites,	  biosynthesis,	  transport,	  catabolism	  I118_1917	   ABC-­‐type	  bacteriocin/lantibiotic	  exporters,	  contain	  an	  N-­‐terminal	  double-­‐glycine	  peptidase	  domain	  
Information	  Storage	  and	  Processing	  Translation,	  ribosomal	  structure,	  biogenesis	  I118_1398	   Translation	  initiation	  factor	  3	  I118_1637	   DNA-­‐directed	  RNA	  polymerase	  specialized	  sigma	  subunit	  I118_1952	   Cytoplasmic	  axial	  filament	  protein	  CafA	  and	  Ribonuclease	  G	  	  Transcription	  I118_0156	   LacI-­‐type	  transcriptional	  regulator	  I118_0254	   Transcriptional	  regulator,	  LysR	  family	  I118_0290	   LacI-­‐type	  transcriptional	  regulator	  I118_0461	   Transcriptional	  regulator	  I118_0617	   MarR-­‐type	  transcriptional	  regulator	  I118_0619	   Transcription	  regulator	  I118_1558	   TetR-­‐type	  transcriptional	  regulator	  I118_1568	   Transcriptional	  regulators	  I118_1671	   Transcriptional	  regulator	  I118_1928	   LacI-­‐type	  transcriptional	  regulator	  DNA	  Replication,	  recombination,	  repair	  I118_0105	   ATPase	  involved	  in	  DNA	  repair	  I118_0146	   DNA/RNA	  helicase	  of	  DEAD/DEAH	  box	  family	  I118_0147	   Mutator	  mutT	  protein	  (7,8-­‐dihydro-­‐8-­‐oxoguanine-­‐triphosphatase)	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0I118_0639	   Replication	  protein	  I118_0999	   Adenine-­‐specific	  methyltransferase	  I118_1123	   DNA	  polymerase	  III	  beta	  subunit	  I118_1137	   putative	  helicase	  I118_1138	   putative	  helicase	  I118_1187	   Adenine-­‐specific	  methyltransferase	  EcoRI	  I118_1196	   Replicative	  DNA	  helicase	  I118_1485	   DNA	  polymerase	  III	  alpha	  subunit	  	  I118_1670	   GCN5-­‐related	  N-­‐acetyltransferase	  I118_1694	   Histone	  acetyltransferase	  HPA2	  and	  related	  acetyltransferases	  I118_2047	   DNA-­‐damage-­‐inducible	  protein	  D	  I118_2050	   ATP-­‐dependent	  DNA	  helicase	  RecG	  I118_0631	   Type	  I	  restriction-­‐modification	  system,	  specificity	  subunit	  S	  I118_0951	   Putative	  DNA-­‐binding	  protein	  in	  cluster	  with	  Type	  I	  restriction-­‐modification	  system	  I118_1011	   Putative	  DNA	  methyltransferase	  I118_1012	   Type	  II	  restriction	  enzyme,	  methylase	  subunit	  YeeA	  I118_1013	   Putative	  DNA	  methyltransferase	  I118_1189	   EcoRI	  methylase/methyltransferase	  I118_1656	   Type	  I	  restriction-­‐modification	  system,	  specificity	  subunit	  S	  I118_1657	   Type	  I	  restriction-­‐modification	  system,	  specificity	  subunit	  S	  I118_1658	   Type	  I	  restriction-­‐modification	  system,	  DNA-­‐methyltransferase	  subunit	  M	  I118_1659	   Type	  I	  restriction-­‐modification	  system,	  restriction	  subunit	  R	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I118_2057	   ATP-­‐dependent	  DNA	  helicase	  Mobile	  DNA	  Elements	  and	  Plasmids	  I118_0628	   Phage-­‐related	  integrase	  I118_0629	   Mobile	  element	  protein	  I118_0758	   Transposase	  IS66	  I118_0759	   Transposase	  IS66	  I118_0915	   Mobile	  element	  protein	  I118_0919	   Mobile	  element	  protein	  I118_0996	   Phage-­‐related	  integrase	  I118_0997	   Phage-­‐related	  integrase	  I118_1038	   Mobile	  element	  protein	  I118_1341	   Transposase	  and	  inactivated	  derivatives	  I118_1342	   Transposase	  and	  inactivated	  derivatives	  I118_1738	   Transposase	  I118_2002	   Mobile	  element	  protein	  I118_2003	   Mobile	  element	  protein	  I118_2004	   Mobile	  element	  protein	  
Cellular	  Processes	  Protein	  turnover,	  stress	  response	  I118_0255	   Flavodoxin	  I118_0754	   ATP-­‐dependent	  Zn	  protease	  I118_0761	   Arsenate	  reductase	  I118_0762	   Arsenical-­‐resistance	  protein	  ACR3	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I118_0930	   Oxidoreductase	  I118_1427	   Lactoylglutathione	  lyase	  and	  related	  lyases	  I118_1744	   Oxidoreductase	  of	  aldo/keto	  reductase	  family,	  subgroup	  1	  Signal	  transduction	  I118_0921	   ADP-­‐ribosylglycohydrolase	  I118_1320	   GTP	  pyrophosphokinase	  ,	  (p)ppGpp	  synthetase	  I	  Cell	  secretion	  I118_0158	   Twin-­‐arginine	  translocation	  protein	  TatC	  I118_0159	   Twin-­‐arginine	  translocation	  protein	  TatA	  I118_1077	   Preprotein	  translocase	  subunit	  SecG	  I118_1079	   Preprotein	  translocase	  subunit	  SecE	  Ion	  transport	  I118_0449	   Transport	  ATP-­‐binding	  protein	  CydCD	  I118_0682	   Na+-­‐dependent	  transporters	  of	  the	  Snf	  family	  Cell	  envelope	  biogenesis	  I118_0080	   Flagellar	  hook-­‐length	  control	  protein	  FliK	  I118_0931	   Phospholipase/carboxylesterase	  I118_1111	   Sortase	  A,	  LPXTG	  specific	  I118_1556	   Protein	  similar	  to	  YcbI	  of	  B.	  subtilis	  I118_1773	   N-­‐Acetyl-­‐D-­‐glucosamine	  permease	  2,	  possible	  I118_1994	   Glycosyltransferase	  I118_1997	   Glycosyltransferase	  I118_2000	   Teichoic	  acid	  export	  ATP-­‐binding	  protein	  TagH	  I118_2001	   putative	  LicD-­‐family	  phosphotransferase	  I118_2010	   1,4-­‐beta-­‐N-­‐acetylmuramidase	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I118_2014	   Glycosyltransferase	  Cell	  division,	  chromosome	  partitioning	  I118_1482	   Cell	  division	  protein	  FtsZ	  
Poorly	  characterized,	  general	  function	  only	  I118_0039	   Cell	  wall	  surface	  anchor	  family	  protein	  I118_0090	   ATPase	  I118_0160	   Secreted	  protein	  I118_0294	   Putative	  glycosyl	  hydrolase	  of	  unknown	  function	  (DUF1680)	  I118_0455	   Possible	  arabinogalactan	  endo-­‐beta-­‐galactosidase	  or	  galactanase	  I118_0757	   Permeases	  of	  the	  major	  facilitator	  superfamily	  I118_0971	   DUF1526	  domain-­‐containing	  protein	  I118_0974	   Uncharacterized	  protein	  conserved	  in	  bacteria	  I118_1010	   HipA	  protein	  I118_1028	   Bifidobacterial	  FemAB-­‐like	  protein	  type	  4	  I118_1039	   Putative	  virulence	  protein	  I118_1049	   Beta-­‐propeller	  domains	  of	  methanol	  dehydrogenase	  type	  I118_1050	   LemA	  family	  protein	  I118_1071	   Putative	  virulence	  protein	  I118_1172	   NLP/P60	  family	  protein	  I118_1296	   Membrane	  proteins	  related	  to	  metalloendopeptidases	  I118_1431	   Macro	  domain,	  possibly	  ADP-­‐ribose	  binding	  module	  I118_1486	   Predicted	  transcriptional	  regulator	  I118_1564	   Extracellular	  solute-­‐binding	  protein,	  family	  1	  I118_1681	   O-­‐Glycosyl	  hydrolase	  family	  30	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I118_1995	   Integral	  membrane	  protein	  I118_1998	   Probable	  glucosyltransferase	  
Uncharacterized,	  hypothetical	  proteins	  I118_0010	   hypothetical	  protein	  I118_0014	   hypothetical	  protein	  I118_0016	   hypothetical	  protein	  I118_0027	   hypothetical	  protein	  I118_0037	   hypothetical	  protein	  I118_0050	   hypothetical	  protein	  I118_0061	   hypothetical	  protein	  I118_0089	   hypothetical	  protein	  I118_0100	   hypothetical	  protein	  I118_0101	   hypothetical	  protein	  I118_0106	   hypothetical	  protein	  I118_0107	   hypothetical	  protein	  I118_0108	   hypothetical	  protein	  I118_0112	   hypothetical	  protein	  I118_0120	   hypothetical	  protein	  I118_0136	   hypothetical	  protein	  I118_0141	   hypothetical	  protein	  I118_0151	   hypothetical	  protein	  I118_0157	   hypothetical	  protein	  I118_0161	   hypothetical	  protein	  I118_0171	   hypothetical	  protein	  I118_0179	   hypothetical	  protein	  I118_0185	   hypothetical	  protein	  I118_0195	   hypothetical	  protein	  I118_0196	   hypothetical	  protein	  I118_0217	   hypothetical	  protein	  I118_0223	   hypothetical	  protein	  I118_0248	   hypothetical	  protein	  I118_0249	   hypothetical	  protein	  I118_0250	   hypothetical	  protein	  I118_0258	   hypothetical	  protein	  I118_0295	   hypothetical	  protein	  I118_0296	   hypothetical	  protein	  I118_0297	   hypothetical	  protein	  I118_0317	   hypothetical	  protein	  I118_0323	   hypothetical	  protein	  I118_0334	   hypothetical	  protein	  I118_0336	   hypothetical	  protein	  I118_0355	   hypothetical	  protein	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  I118_0370	   hypothetical	  protein	  I118_0387	   hypothetical	  protein	  I118_0422	   hypothetical	  protein	  I118_0462	   hypothetical	  protein	  I118_0463	   hypothetical	  protein	  I118_0464	   hypothetical	  protein	  I118_0475	   hypothetical	  protein	  I118_0479	   hypothetical	  protein	  I118_0507	   hypothetical	  protein	  I118_0508	   hypothetical	  protein	  I118_0512	   hypothetical	  protein	  I118_0546	   hypothetical	  protein	  I118_0555	   hypothetical	  protein	  I118_0556	   hypothetical	  protein	  I118_0595	   hypothetical	  protein	  I118_0597	   hypothetical	  protein	  I118_0605	   hypothetical	  protein	  I118_0614	   hypothetical	  protein	  I118_0615	   hypothetical	  protein	  I118_0616	   hypothetical	  protein	  I118_0618	   hypothetical	  protein	  I118_0623	   hypothetical	  protein	  I118_0630	   hypothetical	  protein	  I118_0632	   hypothetical	  protein	  I118_0633	   hypothetical	  protein	  I118_0634	   hypothetical	  protein	  I118_0635	   hypothetical	  protein	  I118_0636	   hypothetical	  protein	  I118_0637	   hypothetical	  protein	  I118_0638	   hypothetical	  protein	  I118_0659	   hypothetical	  protein	  I118_0670	   hypothetical	  protein	  I118_0673	   hypothetical	  protein	  I118_0711	   hypothetical	  protein	  I118_0717	   hypothetical	  protein	  I118_0741	   hypothetical	  protein	  I118_0755	   hypothetical	  protein	  I118_0756	   hypothetical	  protein	  I118_0760	   hypothetical	  protein	  I118_0764	   hypothetical	  protein	  I118_0804	   hypothetical	  protein	  I118_0809	   hypothetical	  protein	  I118_0811	   hypothetical	  protein	  I118_0826	   hypothetical	  protein	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  I118_0827	   hypothetical	  protein	  I118_0832	   hypothetical	  protein	  I118_0836	   hypothetical	  protein	  I118_0860	   hypothetical	  protein	  I118_0892	   hypothetical	  protein	  I118_0895	   hypothetical	  protein	  I118_0902	   hypothetical	  protein	  I118_0914	   hypothetical	  protein	  I118_0920	   hypothetical	  protein	  I118_0922	   hypothetical	  protein	  I118_0923	   hypothetical	  protein	  I118_0924	   hypothetical	  protein	  I118_0925	   hypothetical	  protein	  I118_0926	   hypothetical	  protein	  I118_0927	   hypothetical	  protein	  I118_0945	   hypothetical	  protein	  I118_0952	   hypothetical	  protein	  I118_0953	   hypothetical	  protein	  I118_0954	   hypothetical	  protein	  I118_0956	   hypothetical	  protein	  I118_0966	   hypothetical	  protein	  I118_0967	   hypothetical	  protein	  I118_0969	   hypothetical	  protein	  I118_0972	   hypothetical	  protein	  I118_0982	   hypothetical	  protein	  I118_0998	   hypothetical	  protein	  I118_1000	   hypothetical	  protein	  I118_1001	   hypothetical	  protein	  I118_1002	   hypothetical	  protein	  I118_1003	   hypothetical	  protein	  I118_1004	   hypothetical	  protein	  I118_1005	   hypothetical	  protein	  I118_1006	   hypothetical	  protein	  I118_1007	   hypothetical	  protein	  I118_1008	   hypothetical	  protein	  I118_1009	   hypothetical	  protein	  I118_1014	   hypothetical	  protein	  I118_1015	   hypothetical	  protein	  I118_1016	   hypothetical	  protein	  I118_1017	   hypothetical	  protein	  I118_1018	   hypothetical	  protein	  I118_1019	   hypothetical	  protein	  I118_1020	   hypothetical	  protein	  I118_1021	   hypothetical	  protein	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  I118_1022	   hypothetical	  protein	  I118_1023	   hypothetical	  protein	  I118_1024	   hypothetical	  protein	  I118_1025	   hypothetical	  protein	  I118_1026	   hypothetical	  protein	  I118_1027	   hypothetical	  protein	  I118_1029	   hypothetical	  protein	  I118_1030	   hypothetical	  protein	  I118_1031	   hypothetical	  protein	  I118_1032	   hypothetical	  protein	  I118_1033	   hypothetical	  protein	  I118_1034	   hypothetical	  protein	  I118_1035	   hypothetical	  protein	  I118_1036	   hypothetical	  protein	  I118_1037	   hypothetical	  protein	  I118_1040	   hypothetical	  protein	  I118_1041	   hypothetical	  protein	  I118_1042	   hypothetical	  protein	  I118_1043	   hypothetical	  protein	  I118_1044	   hypothetical	  protein	  I118_1045	   hypothetical	  protein	  I118_1046	   hypothetical	  protein	  I118_1047	   hypothetical	  protein	  I118_1048	   hypothetical	  protein	  I118_1051	   hypothetical	  protein	  I118_1052	   hypothetical	  protein	  I118_1053	   hypothetical	  protein	  I118_1054	   hypothetical	  protein	  I118_1055	   hypothetical	  protein	  I118_1056	   hypothetical	  protein	  I118_1057	   hypothetical	  protein	  I118_1058	   hypothetical	  protein	  I118_1059	   hypothetical	  protein	  I118_1060	   hypothetical	  protein	  I118_1061	   hypothetical	  protein	  I118_1062	   hypothetical	  protein	  I118_1063	   hypothetical	  protein	  I118_1064	   hypothetical	  protein	  I118_1065	   hypothetical	  protein	  I118_1066	   hypothetical	  protein	  I118_1067	   hypothetical	  protein	  I118_1068	   hypothetical	  protein	  I118_1069	   hypothetical	  protein	  I118_1070	   hypothetical	  protein	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  I118_1072	   hypothetical	  protein	  I118_1073	   hypothetical	  protein	  I118_1074	   hypothetical	  protein	  I118_1075	   hypothetical	  protein	  I118_1076	   hypothetical	  protein	  I118_1078	   hypothetical	  protein	  I118_1095	   hypothetical	  protein	  I118_1102	   hypothetical	  protein	  I118_1104	   hypothetical	  protein	  I118_1105	   hypothetical	  protein	  I118_1106	   hypothetical	  protein	  I118_1107	   hypothetical	  protein	  I118_1108	   hypothetical	  protein	  I118_1109	   hypothetical	  protein	  I118_1110	   hypothetical	  protein	  I118_1112	   hypothetical	  protein	  I118_1113	   hypothetical	  protein	  I118_1114	   hypothetical	  protein	  I118_1115	   hypothetical	  protein	  I118_1116	   hypothetical	  protein	  I118_1117	   hypothetical	  protein	  I118_1118	   hypothetical	  protein	  I118_1119	   hypothetical	  protein	  I118_1120	   hypothetical	  protein	  I118_1121	   hypothetical	  protein	  I118_1122	   hypothetical	  protein	  I118_1124	   hypothetical	  protein	  I118_1126	   hypothetical	  protein	  I118_1127	   hypothetical	  protein	  I118_1128	   hypothetical	  protein	  I118_1129	   hypothetical	  protein	  I118_1130	   hypothetical	  protein	  I118_1131	   hypothetical	  protein	  I118_1132	   hypothetical	  protein	  I118_1133	   hypothetical	  protein	  I118_1134	   hypothetical	  protein	  I118_1135	   hypothetical	  protein	  I118_1136	   hypothetical	  protein	  I118_1139	   hypothetical	  protein	  I118_1140	   hypothetical	  protein	  I118_1141	   hypothetical	  protein	  I118_1143	   hypothetical	  protein	  I118_1144	   hypothetical	  protein	  I118_1145	   hypothetical	  protein	  
  
141	  I118_1146	   hypothetical	  protein	  I118_1147	   hypothetical	  protein	  I118_1148	   hypothetical	  protein	  I118_1149	   hypothetical	  protein	  I118_1150	   hypothetical	  protein	  I118_1151	   hypothetical	  protein	  I118_1152	   hypothetical	  protein	  I118_1153	   hypothetical	  protein	  I118_1154	   hypothetical	  protein	  I118_1155	   hypothetical	  protein	  I118_1156	   hypothetical	  protein	  I118_1157	   hypothetical	  protein	  I118_1158	   hypothetical	  protein	  I118_1159	   hypothetical	  protein	  I118_1160	   hypothetical	  protein	  I118_1161	   hypothetical	  protein	  I118_1162	   hypothetical	  protein	  I118_1163	   hypothetical	  protein	  I118_1164	   hypothetical	  protein	  I118_1165	   hypothetical	  protein	  I118_1166	   hypothetical	  protein	  I118_1167	   hypothetical	  protein	  I118_1168	   hypothetical	  protein	  I118_1169	   hypothetical	  protein	  I118_1170	   hypothetical	  protein	  I118_1171	   hypothetical	  protein	  I118_1173	   hypothetical	  protein	  I118_1174	   hypothetical	  protein	  I118_1175	   hypothetical	  protein	  I118_1176	   hypothetical	  protein	  I118_1177	   hypothetical	  protein	  I118_1178	   hypothetical	  protein	  I118_1179	   hypothetical	  protein	  I118_1180	   hypothetical	  protein	  I118_1181	   hypothetical	  protein	  I118_1183	   hypothetical	  protein	  I118_1184	   hypothetical	  protein	  I118_1185	   hypothetical	  protein	  I118_1186	   hypothetical	  protein	  I118_1188	   hypothetical	  protein	  I118_1190	   hypothetical	  protein	  I118_1191	   hypothetical	  protein	  I118_1192	   hypothetical	  protein	  I118_1193	   hypothetical	  protein	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  I118_1194	   hypothetical	  protein	  I118_1195	   hypothetical	  protein	  I118_1197	   hypothetical	  protein	  I118_1198	   hypothetical	  protein	  I118_1199	   hypothetical	  protein	  I118_1200	   hypothetical	  protein	  I118_1201	   hypothetical	  protein	  I118_1202	   hypothetical	  protein	  I118_1203	   hypothetical	  protein	  I118_1204	   hypothetical	  protein	  I118_1205	   hypothetical	  protein	  I118_1206	   hypothetical	  protein	  I118_1207	   hypothetical	  protein	  I118_1208	   hypothetical	  protein	  I118_1209	   hypothetical	  protein	  I118_1210	   hypothetical	  protein	  I118_1211	   hypothetical	  protein	  I118_1212	   hypothetical	  protein	  I118_1213	   hypothetical	  protein	  I118_1214	   hypothetical	  protein	  I118_1215	   hypothetical	  protein	  I118_1216	   hypothetical	  protein	  I118_1217	   hypothetical	  protein	  I118_1266	   hypothetical	  protein	  I118_1318	   hypothetical	  protein	  I118_1338	   hypothetical	  protein	  I118_1340	   hypothetical	  protein	  I118_1363	   hypothetical	  protein	  I118_1393	   hypothetical	  protein	  I118_1399	   hypothetical	  protein	  I118_1402	   hypothetical	  protein	  I118_1430	   hypothetical	  protein	  I118_1432	   hypothetical	  protein	  I118_1453	   hypothetical	  protein	  I118_1476	   hypothetical	  protein	  I118_1478	   hypothetical	  protein	  I118_1479	   hypothetical	  protein	  I118_1480	   hypothetical	  protein	  I118_1481	   hypothetical	  protein	  I118_1497	   hypothetical	  protein	  I118_1504	   hypothetical	  protein	  I118_1505	   hypothetical	  protein	  I118_1512	   hypothetical	  protein	  I118_1537	   hypothetical	  protein	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  I118_1557	   hypothetical	  protein	  I118_1561	   hypothetical	  protein	  I118_1567	   hypothetical	  protein	  I118_1574	   hypothetical	  protein	  I118_1606	   hypothetical	  protein	  I118_1614	   hypothetical	  protein	  I118_1661	   hypothetical	  protein	  I118_1666	   hypothetical	  protein	  I118_1668	   hypothetical	  protein	  I118_1679	   hypothetical	  protein	  I118_1683	   hypothetical	  protein	  I118_1684	   hypothetical	  protein	  I118_1708	   hypothetical	  protein	  I118_1713	   hypothetical	  protein	  I118_1715	   hypothetical	  protein	  I118_1718	   hypothetical	  protein	  I118_1728	   hypothetical	  protein	  I118_1735	   hypothetical	  protein	  I118_1771	   hypothetical	  protein	  I118_1813	   hypothetical	  protein	  I118_1816	   hypothetical	  protein	  I118_1825	   hypothetical	  protein	  I118_1841	   hypothetical	  protein	  I118_1885	   hypothetical	  protein	  I118_1922	   hypothetical	  protein	  I118_1939	   hypothetical	  protein	  I118_1958	   hypothetical	  protein	  I118_1970	   hypothetical	  protein	  I118_1973	   hypothetical	  protein	  I118_1976	   hypothetical	  protein	  I118_1991	   hypothetical	  protein	  I118_1993	   hypothetical	  protein	  I118_2007	   hypothetical	  protein	  I118_2009	   hypothetical	  protein	  I118_2011	   hypothetical	  protein	  I118_2012	   hypothetical	  protein	  I118_2013	   hypothetical	  protein	  I118_2016	   hypothetical	  protein	  I118_2028	   hypothetical	  protein	  I118_2033	   hypothetical	  protein	  I118_2038	   hypothetical	  protein	  I118_2056	   hypothetical	  protein	  I118_2059	   hypothetical	  protein	  I118_2060	   hypothetical	  protein	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  I118_2061	   hypothetical	  protein	  I118_2062	   hypothetical	  protein	  I118_2070	   hypothetical	  protein	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Table	  A-­3	  	  Differentially	  regulated	  genes	  associated	  with	  the	  oxidative	  stress	  response	  of	  B.	  longum	  strains.	  
Fold	  Change	  vs	  Control	  






T1	   T2	   T1	   T2	  
Metabolism	   	   	   	   	  Energy	  production,	  conversion	   	   	   	   	  BL0279	   Glucose-­‐6-­‐phosphate	  isomerase	   0.85	   NSa	   NS	   1.07	  BL0358	   ATP	  synthase	  gamma	  chain	   NS	   NS	   NS	   0.87	  BL0361	   F0F1-­‐type	  ATP	  synthase,	  subunit	  b	   1.06	   NS	   NS	   NS	  BL0362	   F0F1-­‐type	  ATP	  synthase,	  subunit	  c	   1.03	   NS	   NS	   NS	  BL0363	   F0F1-­‐type	  ATP	  synthase,	  subunit	  a	   0.95	   NS	   0.95	   1.09	  BL0604	   Phosphoenolpyruvate	  carboxylase	   1.06	   NS	   NS	   0.97	  BL0620	   Gluconate	  kinase	   -­‐0.78	   NS	   NS	   NS	  BL0707	   3-­‐phosphoglycerate	  kinase	   1.55	   1.48	   NS	   1.13	  BL0715	   Transaldolase	   -­‐0.95	   NS	   NS	   NS	  BL0732	   Succinyl-­‐CoA	  synthetase,	  beta	  subunit	   0.72	   NS	   NS	   NS	  BL0753	   Pentose-­‐5-­‐phosphate-­‐3-­‐epimerase	   0.91	   NS	   NS	   NS	  BL0884	   Fructose-­‐2,6-­‐bisphosphatase	   0.85	   NS	   NS	   NS	  BL0963	   Ribose-­‐phosphate	  pyrophosphokinase	   NS	   NS	   NS	   1.05	  BL0969	   Acetate	  kinase	   1.04	   NS	   NS	   NS	  BL0988	   Pyruvate	  kinase	   1.55	   1.30	   NS	   1.35	  BL1022	   Enolase	   1.29	   NS	   NS	   NS	  BL1259	   Polyphosphate	  kinase	   0.78	   NS	   NS	   NS	  BL1308	   Malate/lactate	  dehydrogenases	   1.56	   1.82	   NS	   2.23	  BL1360	   Galactose	  mutarotase	  and	  related	  enzymes	   0.72	   NS	   NS	   NS	  BL1575	   Alcohol	  dehydrogenase	  /	  Acetaldehyde	  dehydrogenase	  (acetylating)	   NS	   NS	   NS	   1.35	  BL1656	   Phosphoglycerate	  mutase	  1	   0.74	   1.01	   NS	   1.32	  BL1673	   Lactaldehyde	  reductase	   NS	   -­‐2.30	   NS	   NS	  BL1726	   Pyruvate-­‐formate	  lyase-­‐activating	  enzyme	   -­‐1.57	   -­‐1.58	   NS	   NS	  Carbohydrate	  transport,	  metabolism	   	   	   	   	  BL0143	   ABC-­‐type	  sugar	  transport	  systems,	  permease	  components	   1.51	   NS	   NS	   NS	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  BL0208	   ABC-­‐type	  polysaccharide/polyol	  phosphate	  export	  systems,	  permease	  component	   0.84	   NS	   NS	   NS	  BL0273	   Ribulose-­‐5-­‐phosphate	  4-­‐epimerase	  and	  related	  epimerases	  and	  aldolases	   NS	   -­‐1.05	   NS	   NS	  BL0420	   Beta-­‐xylosidase	   -­‐0.73	   NS	   NS	   NS	  BL0423	   ABC-­‐type	  sugar	  transport	  system,	  permease	  component	   -­‐0.71	   NS	   NS	   NS	  BL0425	   ABC-­‐type	  sugar	  transport	  system,	  periplasmic	  component	   NS	   -­‐1.73	   NS	   -­‐1.66	  BL0476	   Monosaccharide	  translocase	  (flippase	  type)	   0.92	   NS	   NS	   NS	  BL0527	   4-­‐alpha-­‐glucanotransferase	  (Maltose	  Degredation)	   1.25	   NS	   NS	   NS	  BL0536	   Glycosidases	   NS	   -­‐0.95	   NS	   NS	  BL0597	   Glucan	  phosphorylase	   1.86	   1.10	   1.12	   1.25	  BL0774	   ADP-­‐ribose	  pyrophosphatase	   1.15	   0.78	   NS	   NS	  BL0999	   1,4-­‐alpha-­‐glucan	  branching	  enzyme	   1.54	   0.92	   NS	   NS	  BL1164	   ABC-­‐type	  sugar	  transport	  system,	  periplasmic	  component	   NS	   -­‐2.14	   NS	   -­‐1.75	  BL1168	   Beta-­‐galactosidase	   -­‐1.24	   -­‐2.23	   NS	   -­‐1.57	  BL1169	   ABC-­‐type	  sugar	  transport	  system,	  permease	  component	   -­‐1.49	   -­‐2.89	   NS	   -­‐1.63	  BL1170	   ABC-­‐type	  sugar	  transport	  systems,	  permease	  components	   -­‐1.65	   -­‐2.82	   NS	   -­‐1.80	  BL1187	   Phosphomannomutase	   0.87	   NS	   NS	   NS	  BL1292	   2,5-­‐diketo-­‐D-­‐gluconic	  acid	  reductase	  	   NS	   NS	   NS	   0.99	  BL1339	   Sugar	  kinases,	  ribokinase	   NS	   -­‐1.55	   NS	   NS	  BL1431	   Sugar	  kinases,	  ribokinase	   NS	   1.01	   NS	   NS	  BL1443	   Cellobiohydrolase	  A	  (1,4-­‐beta-­‐cellobiosidase	  A)	   1.00	   NS	   NS	   NS	  BL1639	   ABC-­‐type	  sugar	  transport	  systems,	  permease	  components	   1.23	   NS	   NS	   NS	  BL1694	   ABC-­‐type	  xylose	  transport	  system,	  periplasmic	  component	   -­‐1.45	   -­‐2.68	   NS	   -­‐2.50	  BL1695	   ABC-­‐type	  sugar	  transport	  system,	  ATPase	  component	   -­‐1.64	   -­‐2.54	   NS	   -­‐1.71	  BL1696	   ABC-­‐type	  xylose	  transport	  system,	  permease	  component	   -­‐1.18	   -­‐2.14	   NS	   NS	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  BL1796	   Archaeal	  fructose-­‐1,6-­‐bisphosphatase	  and	  related	  enzymes	  of	  inositol	  monophosphatase	  family	  
1.12	   NS	   NS	   NS	  
BLD_1756	   Permeases	  of	  the	  major	  facilitator	  superfamily	  (Arabinose	  efflux	  permease)	   NS	   0.85	   NS	   NS	  BLD_1390	   Glucan	  phosphorylase	   1.13	   NS	   NS	   NS	  BLD_1323	   Trehalose-­‐6-­‐phosphate	  hydrolase	   NS	   NS	   NS	   0.98	  BLD_1497	   Oligo-­‐1,6-­‐glucosidase	   NS	   NS	   NS	   1.51	  BLD_1557	   ABC-­‐type	  sugar	  transport	  system,	  ATPase	  component	   1.69	   NS	   NS	   NS	  Amino	  acid	  transport,	  metabolism	   	   	   	   	  BL0074	   ABC-­‐type	  amino	  acid	  transport	  system,	  permease	  component	   1.03	   1.18	   NS	   1.33	  BL0488	   2-­‐isopropylmalate	  synthase	   NS	   0.95	   NS	   NS	  BL0555	   Trypsin-­‐like	  serine	  proteases,	  typically	  periplasmic	   NS	   1.37	   NS	   NS	  BL0552	   NADPH-­‐dependent	  glutamate	  synthase	  beta	  chain	  and	  related	  oxidoreductases	   0.88	   NS	   NS	   NS	  BL0628	   Aspartate/tyrosine/aromatic	  aminotransferase	   1.00	   1.36	   NS	   NS	  BL0704	   Shikimate	  5-­‐dehydrogenase	   1.06	   NS	   NS	   NS	  BL0829	   Oligopeptide-­‐binding	  protein	  oppA	   NS	   NS	   NS	   0.92	  BL0869	   Cysteine	  desulfurase	  /	  Selenocysteine	  lyase	  	   NS	   NS	   NS	   0.78	  BL1016	   FKBP-­‐type	  peptidyl-­‐prolyl	  cis-­‐trans	  isomerases	  1	   NS	   1.35	   NS	   NS	  BL1076	   Glutamine	  synthetase	   1.67	   NS	   1.15	   0.89	  BL1118	   ABC-­‐type	  amino	  acid	  transport/signal	  transduction	  systems,	  periplasmic	  component/domain	  
0.90	   NS	   NS	   0.73	  
BL1119	   ABC-­‐type	  amino	  acid	  transport	  system,	  permease	  component	   0.86	   NS	   NS	   NS	  BL1142	   Asparaginase	   1.04	   0.93	   NS	   NS	  BL1193	   Dihydrodipicolinate	  synthase	   NS	   NS	   NS	   0.96	  BL1274	   Homoserine	  dehydrogenase	   NS	   NS	   NS	   1.16	  BL1302	   Glutamine	  synthetase	   0.85	   NS	   NS	   NS	  BL1350	   Xaa-­‐Pro	  aminopeptidase	   0.83	   NS	   NS	   NS	  BL1386	   ABC-­‐type	  oligopeptide	  transport	   1.36	   NS	   NS	   1.53	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  system,	  periplasmic	  component	  BL1387	   ABC-­‐type	  dipeptide/oligopeptide/nickel	  transport	  systems,	  permease	  components	  
1.25	   NS	   NS	   NS	  
BL1389	   ABC-­‐type	  dipeptide/oligopeptide/nickel	  transport	  systems,	  permease	  components	  
1.14	   NS	   NS	   NS	  
BL1442	   Peptidyl-­‐prolyl	  cis-­‐trans	  isomerase	  (rotamase)	   1.30	   NS	   NS	   1.03	  BLD_0784	   Gamma-­‐glutamyl	  phosphate	  reductase	   0.94	   NS	   NS	   NS	  Nucleotide	  transport,	  metabolism	   	   	   	   	  BL0229	   dTDP-­‐D-­‐glucose	  4,6-­‐dehydratase	   -­‐0.77	   NS	   NS	   NS	  BL0444	   6-­‐phosphogluconate	  dehydrogenase	   0.80	   1.06	   NS	   NS	  BL0731	   Adenine/guanine	  phosphoribosyltransferases	  	   1.00	   NS	   NS	   NS	  BL0739	   UDP-­‐glucose	  pyrophosphorylase	   1.42	   0.97	   NS	   NS	  BL0788	   Orotate	  phosphoribosyltransferase	   0.78	   1.49	   NS	   1.18	  BL0874	   CTP	  synthase	  (UTP-­‐ammonia	  lyase)	   1.20	   NS	   NS	   NS	  BL0963	   Phosphoribosylpyrophosphate	  synthetase	   0.77	   NS	   NS	   NS	  BL1107	   Phosphoribosylaminoimidazolesuccinocarboxamide	  (SAICAR)	  synthase	   0.87	   NS	   NS	   1.08	  BL1245	   UDP-­‐galactopyranose	  mutase	   0.97	   NS	   NS	   NS	  BL1392	   dUTPase	   1.19	   NS	   NS	   NS	  BL1437	   dUTPase	   1.31	   1.07	   NS	   NS	  BL1439	   Guanosine	  polyphosphate	  pyrophosphohydrolases/synthetases	   1.09	   NS	   NS	   NS	  BL1500	   IMP	  dehydrogenase/GMP	  reductase	   0.90	   NS	   NS	   0.84	  BL1505	   Uridylate	  kinase	   1.02	   1.05	   1.00	   0.80	  BL1681	   Hypoxanthine-­‐guanine	  phosphoribosyltransferase	   1.30	   1.17	   1.09	   NS	  BL1722	   Inosine-­‐5'-­‐monophosphate	  dehydrogenase	   NS	   NS	   NS	   1.39	  BL1770	   Inosine-­‐uridine	  nucleoside	  N-­‐ NS	   -­‐2.69	   NS	   -­‐1.88	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  ribohydrolase	  BL1800	   Adenylosuccinate	  lyase	   0.96	   NS	   NS	   1.02	  BLD_0406	   Uridylate	  kinase	   1.06	   NS	   0.92	   0.70	  BLD_0702	   GMP	  synthase,	  PP-­‐ATPase	  domain/subunit	   0.87	   NS	   NS	   0.79	  BLD_1589	   Uracil	  phosphoribosyltransferase	   1.41	   NS	   NS	   NS	  BLD_0976	   Dihydroorotate	  dehydrogenase	   NS	   NS	   NS	   0.69	  Coenzyme	  metabolism	   	   	   	   	  BL0287	   Nicotinic	  acid	  phosphoribosyltransferase	   0.89	   1.20	   NS	   NS	  BL0735	   AICAR	  transformylase	  /	  IMP	  cyclohydrolase	  PurH	  	   1.29	   NS	   NS	   NS	  BL1361	   4-­‐hydroxy-­‐3-­‐methylbut-­‐2-­‐enyl	  diphosphate	  reductase	  	   0.80	   NS	   NS	   NS	  BLD_0218	   Folylpolyglutamate	  synthase	  /	  Dihydrofolate	  synthase	  	   NS	   NS	   NS	   0.79	  BL1145	   Predicted	  glutamine	  amidotransferase	  involved	  in	  pyridoxine	  biosynthesis	   0.93	   NS	   NS	   NS	  BL1146	   Pyridoxine	  biosynthesis	  enzyme	   1.34	   NS	   NS	   NS	  BL1292	   Aldo/keto	  reductases,	  related	  to	  diketogulonate	  reductase	   0.81	   NS	   NS	   NS	  Secondary	  metabolites,	  biosynthesis,	  transport,	  catabolism	   	   	   	   	  BL0103	   ABC-­‐type	  nitrate/sulfonate/bicarbonate	  transport	  systems,	  periplasmic	  components	  
0.77	   NS	   NS	   1.15	  
BL0155	   ABC-­‐type	  antimicrobial	  peptide	  transport	  system,	  permease	  component	   -­‐0.86	   NS	   NS	   NS	  BL0198	   ABC-­‐type	  antimicrobial	  peptide	  transport	  system,	  permease	  component	   1.22	   NS	   NS	   NS	  BL0251	   Permeases	  of	  the	  major	  facilitator	  superfamily	   -­‐0.78	   NS	   NS	   NS	  BL0342	   ABC-­‐type	  spermidine/putrescine	  transport	  system,	  permease	  component	  II	   -­‐0.81	   NS	   NS	   NS	  BL0844	   Na+-­‐driven	  multidrug	  efflux	  pump	   -­‐0.83	   NS	   NS	   NS	  BL0931	   ABC-­‐type	  antimicrobial	  peptide	  transport	  system,	  permease	  component	   NS	   2.11	   NS	   NS	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  BL0932	   ABC-­‐type	  antimicrobial	  peptide	  transport	  system,	  ATPase	  component	   2.00	   2.45	   NS	   NS	  BL1041	   ABC-­‐type	  multidrug	  transport	  system,	  ATPase	  component	   -­‐0.92	   NS	   NS	   NS	  BL1192	   Predicted	  hydrolase	  of	  the	  metallo-­‐beta-­‐lactamase	  superfamily	   1.15	   NS	   NS	   NS	  BL1277	   ABC-­‐type	  antimicrobial	  peptide	  transport	  system,	  ATPase	  component	   1.38	   1.25	   NS	   NS	  BL1631	   Permeases	  of	  the	  major	  facilitator	  superfamily	   1.76	   NS	   NS	   NS	  BL1699	   Permeases	  of	  the	  major	  facilitator	  superfamily	   -­‐0.95	   NS	   NS	   NS	  BL1771	   C4-­‐dicarboxylate	  transporter	   NS	   -­‐2.23	   NS	   NS	  BLD_0673	   ABC-­‐type	  antimicrobial	  peptide	  transport	  system,	  ATPase	  component	   1.65	   NS	   NS	   NS	  BLD_1756	   Permeases	  of	  the	  major	  facilitator	  superfamily	   1.66	   NS	   NS	   NS	  BLD_1557	   ABC-­‐type	  antimicrobial	  peptide	  transport	  system,	  ATPase	  component	   NS	   0.89	   NS	   NS	  
Information	  Storage	  and	  Processing	   	   	   	   	  Translation,	  ribosomal	  structure,	  biogenesis	   	   	   	   	  BL0294	   LSU	  ribosomal	  protein	  L32P	   0.96	   1.04	   NS	   NS	  BL0305	   Ribosomal	  protein	  S16	   0.85	   NS	   NS	   NS	  BL0330	   Ribosomal	  protein	  L28	   0.99	   NS	   NS	   NS	  BL0414	   Ribosomal	  protein	  S18	   0.70	   NS	   NS	   NS	  BL0416	   Ribosomal	  protein	  S6	   1.31	   0.88	   NS	   NS	  BL0849	   Ribosomal	  protein	  S20	   1.06	   NS	   NS	   NS	  BL0853	   Ribosomal	  protein	  L25	   1.27	   0.91	   NS	   NS	  BL0886	   Ribosomal	  protein	  S4	  and	  related	  proteins	   0.82	   NS	   NS	   NS	  BL1282	   Ribosomal	  protein	  L21	   1.53	   1.16	   1.32	   0.86	  BL1283	   Ribosomal	  protein	  L27	   1.00	   NS	   NS	   NS	  BL1366a	   LSU	  ribosomal	  protein	  L35P	   1.42	   NS	   NS	   NS	  BL1367	   Ribosomal	  protein	  L20	   1.02	   NS	   NS	   NS	  BL1418	   Ribosome-­‐associated	  protein	  Y	  (PSrp-­‐1)	   -­‐0.82	   -­‐1.34	   NS	   NS	  BL1503	   Ribosomal	  protein	  S2	   1.16	   NS	   NS	   NS	  BL1506	   Ribosome	  recycling	  factor	   0.94	   NS	   NS	   0.92	  BL1550	   LSU	  ribosomal	  protein	  L12P	   NS	   NS	   NS	   -­‐1.00	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  (L7/L12)	  BL1560	   Ribosomal	  protein	  L33	   1.05	   NS	   NS	   NS	  BL1577	   Ribosomal	  protein	  S10	   0.77	   NS	   NS	   NS	  BL1586	   Ribosomal	  protein	  L16/L10E	   -­‐0.79	   -­‐1.02	   NS	   NS	  BL1588	   Ribosomal	  protein	  L29	   -­‐1.04	   -­‐1.31	   NS	   NS	  BL1589	   Ribosomal	  protein	  S17	   -­‐1.00	   -­‐1.36	   NS	   NS	  BL1603	   Ribosomal	  protein	  L36	   0.64	   NS	   NS	   NS	  BL1605	   SSU	  ribosomal	  protein	  S11P	   0.89	   NS	   NS	   NS	  BL1604	   Ribosomal	  protein	  S13	   0.89	   NS	   NS	   NS	  BL0016	   tRNA	  delta(2)-­‐isopentenylpyrophosphate	  transferase	   1.11	   1.07	   NS	   NS	  BL0065	   Translation	  elongation	  factor	  P	  (EF-­‐P)/translation	  initiation	  factor	  5A	  (eIF-­‐5A)	   1.57	   1.38	   1.17	   1.17	  BL0286	   RNase	  PH	  (tRNA	  processing)	   0.80	   NS	   NS	   NS	  BL0404	   Asp-­‐tRNAAsn/Glu-­‐tRNAGln	  amidotransferase	  C	  subunit	   0.72	   NS	   NS	   NS	  BL0724	   Threonyl-­‐tRNA	  synthetase	   0.82	   NS	   NS	   NS	  BL0882	   Alanyl-­‐tRNA	  synthetase	   1.04	   NS	   NS	   NS	  BL1098	   Protein	  Translation	  Elongation	  Factor	  G	  (EF-­‐G)	   NS	   NS	   NS	   0.98	  BL1067	   Phenylalanyl-­‐tRNA	  synthetase	  alpha	  chain	   NS	   NS	   NS	   0.91	  BL1186	   N-­‐formylmethionyl-­‐tRNA	  deformylase	   1.08	   NS	   NS	   NS	  BL1366	   Translation	  initiation	  factor	  3	  (IF-­‐3)	   1.36	   NS	   NS	   NS	  BL1602	   Translation	  initiation	  factor	  1	  (IF-­‐1)	   0.94	   NS	   NS	   NS	  BL1635	   Seryl-­‐tRNA	  synthetase	   0.76	   0.90	   NS	   NS	  Transcription	   	   	   	   	  BL0010	   Negative	  regulator	  of	  genetic	  competence	  clpC/	  Hemolysin	  TlyB	   NS	   NS	   NS	   0.89	  BL0047	   Transcriptional	  regulator/sugar	  kinase	   0.79	   NS	   NS	   NS	  BL0066	   Transcription	  termination	  factor	   0.89	   NS	   NS	   NS	  BL0516	   Predicted	  transcriptional	  regulators	   NS	   -­‐1.04	   NS	   NS	  BL0543	   Transcriptional	  regulators	   -­‐0.68	   NS	   NS	   NS	  BL0746	   Predicted	  transcriptional	  regulators	   1.18	   1.05	   NS	   NS	  BL0986	   Transcriptional	  regulator	   NS	   NS	   1.04	   NS	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  BL1011	   DNA-­‐directed	  RNA	  polymerase	  specialized	  sigma	  subunit,	  sigma24	  homolog	   2.16	   2.36	   NS	   NS	  BL1015	   Transcription	  elongation	  factor	   1.38	   1.27	   NS	   NS	  BL1041a	   Predicted	  transcriptional	  regulators	   -­‐0.88	   NS	   NS	   NS	  BL1171	   Transcriptional	  regulator,	  LacI	  family	   -­‐1.63	   -­‐2.38	   NS	   -­‐1.83	  BL1204	   DNA-­‐directed	  RNA	  polymerase	  beta'	  chain	   NS	   NS	   NS	   0.69	  BL1205	   DNA-­‐directed	  RNA	  polymerase	  beta	  chain	   NS	   NS	   NS	   0.80	  BL1312	   Predicted	  transcriptional	  regulator,	  consists	  of	  a	  Zn-­‐ribbon	  and	  ATP-­‐cone	  domains	   0.99	   1.03	   NS	   NS	  BL1325	   Predicted	  transcriptional	  regulator	   -­‐1.47	   -­‐1.71	   NS	   NS	  BL1357	   DNA-­‐directed	  RNA	  polymerase	  specialized	  sigma	  subunit,	  sigma24	  homolog	   1.67	   1.30	   NS	   NS	  BL1358	   ECF-­‐type	  sigma	  factor	  negative	  effector	   -­‐0.95	   -­‐1.00	   NS	   NS	  BL1414	   Predicted	  transcriptional	  regulators	   0.86	   NS	   NS	   NS	  BL1428	   DNA-­‐directed	  RNA	  polymerase,	  sigma	  subunit	  (sigma70/sigma32)	   0.84	   NS	   NS	   NS	  BL1504	   Translation	  elongation	  factor	  Ts	   0.86	   NS	   NS	   NS	  BL1574	   Transcriptional	  regulator/sugar	  kinase	   -­‐0.83	   NS	   NS	   NS	  BL1769	   Histone	  acetyltransferase	  HPA2	  and	  related	  acetyltransferases	   NS	   -­‐2.58	   NS	   -­‐2.04	  BL1787	   DNA-­‐directed	  RNA	  polymerase,	  subunit	  K/omega	   0.98	   0.91	   NS	   NS	  BLD_0762	   Transcriptional	  regulator	  LytR	  family	   1.19	   NS	   NS	   NS	  BLD_0925	   Transcriptional	  regulators	  LacI	  family	   1.15	   NS	   NS	   NS	  BLD_1459	   Putative	  transcriptional	  regulator	  	   -­‐0.83	   NS	   NS	   NS	  DNA	  Replication,	  recombination,	  repair	   	   	   	   	  BL0415	   Single-­‐stranded	  DNA-­‐binding	  protein	   0.70	   NS	   NS	   NS	  BL1415	   RecA/RadA	  recombinase	   NS	   0.88	   NS	   NS	  Mobile	  DNA	  Elements	  and	  Plasmids	   	   	   	   	  BL0240	   DNA	  integration/recombination	   -­‐0.93	   NS	   NS	   NS	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  protein	  BL0241	   Integrase/Phage	  associated	   -­‐0.96	   NS	   NS	   NS	  BL0246	   Integrase/Phage	  associated	   -­‐0.93	   NS	   NS	   NS	  BL1779	   Integrase/Phage	  associated	   -­‐0.81	   NS	   NS	   NS	  BLD_0309	   Transposase	   -­‐0.77	   NS	   NS	   NS	  BLD_0313	   Transposase	   -­‐0.74	   NS	   NS	   NS	  BLD_0995	   Transposase	  and	  inactivated	  derivatives	   -­‐0.93	   NS	   NS	   NS	  BLD_1412	   Transposase	   -­‐0.85	   NS	   NS	   NS	  BLD_0996	   DNA	  replication	  protein	  (transposase)	   -­‐0.82	   NS	   NS	   NS	  BLD_1655	   DNA	  replication	  protein	  (transposase)	   -­‐0.77	   NS	   NS	   NS	  pBLO1_01	   Replication	  protein	  (on	  plasmid)	   -­‐0.80	   NS	   NS	   NS	  BLD_1562	   Transposase	  and	  inactivated	  derivatives	   -­‐0.79	   NS	   NS	   NS	  BLD_1562	   Transposase	  and	  inactivated	  derivatives	   -­‐0.81	   NS	   NS	   NS	  
Cellular	  Processes	   	   	   	   	  Protein	  turnover,	  stress	  response	   	   	   	   	  BL0555	   Trypsin-­‐like	  serine	  proteases,	  typically	  periplasmic	   1.68	   NS	   NS	   NS	  BL0781	   Putative	  intracellular	  protease/amidase	   0.94	   0.96	   NS	   NS	  BL0944	   ATP-­‐dependent	  endopeptidase	  clp	  proteolytic	  subunit	  clpP	   NS	   NS	   NS	   0.96	  BL0945	   Protease	  subunit	  of	  ATP-­‐dependent	  Clp	  proteases	   0.79	   NS	   NS	   1.48	  BL1682	   ATP-­‐dependent	  Zn	  proteases	   0.99	   NS	   NS	   NS	  BL0139	   NAD(P)H-­‐dependent	  FMN	  reductase	   NS	   NS	   NS	   1.92	  BL0399	   Protoporphyrinogen	  oxidase	   1.06	   NS	   NS	   NS	  BL0552	   NADPH-­‐dependent	  glutamate	  synthase	  beta	  chain	  and	  related	  oxidoreductases	   NS	   1.03	   NS	   NS	  BL0614	   Thioredoxin	  reductase	   1.92	   1.56	   NS	   0.88	  BL0615	   Peroxiredoxin	   1.36	   1.29	   NS	   1.16	  BL0668	   Glutaredoxin	  and	  related	  proteins	   1.79	   1.59	   1.57	   1.49	  BL0669	   NrdI	  protein/	  ribonucleotide	  reductase	  stimulatory	  protein	   1.42	   NS	   NS	   NS	  BL0670	   Ribonucleotide	  reductase,	  alpha	  subunit	   0.92	   NS	   NS	   NS	  BL0671	   Ribonucleoside-­‐diphosphate	   1.40	   NS	   NS	   0.73	  
  
154	  reductase	  beta	  chain	  	  BL1563	   Ferredoxin	   0.86	   NS	   NS	   NS	  BL1750	   Exodeoxyribonuclease	  VII	  small	  subunit	  	   0.75	   1.10	   NS	   NS	  BL1752	   Oxygen-­‐sensitive	  ribonucleoside-­‐triphosphate	  reductase	   1.88	   1.59	   NS	   NS	  BL1753	   Anaerobic	  ribonucleoside-­‐triphosphate	  reductase	  activating	  protein	   0.95	   0.89	   NS	   NS	  BLD_0988	   Thioredoxin	   NS	   NS	   NS	   1.52	  BL0001	   Cold	  shock	  proteins	   0.75	   NS	   NS	   0.85	  BL0002	   60	  kDa	  chaperonin	  GROEL	   NS	   NS	   NS	   1.09	  BL0010	   ATPases	  with	  chaperone	  activity,	  ATP-­‐binding	  subunit	   0.89	   NS	   NS	   NS	  BL0355	   Predicted	  nuclease	  of	  the	  RecB	  family	   -­‐0.82	   NS	   NS	   NS	  BL0517	   Molecular	  chaperone	  (small	  heat	  shock	  protein)	   NS	   0.92	   NS	   NS	  BL0519	   ATPases	  with	  chaperone	  activity,	  ATP-­‐binding	  subunit	   NS	   -­‐1.08	   NS	   NS	  BL0520	   DnaJ-­‐class	  molecular	  chaperone	   NS	   -­‐1.28	   NS	   NS	  BL0576	   Universal	  stress	  protein	  UspA	  (Hsp20	  Small	  Heat	  Shock	  Chaparone)	   0.98	   -­‐1.58	   NS	   NS	  BL1250	   Molecular	  chaperone	   NS	   -­‐1.72	   NS	   NS	  BL1558	   10	  kDa	  chaperonin	  GROES	   NS	   NS	   NS	   0.98	  BLD_0001	   Cold	  shock	  protein	   NS	   NS	   1.51	   1.06	  BL1664	   Universal	  stress	  protein	  UspA	  and	  related	  nucleotide-­‐binding	  proteins	   -­‐1.15	   -­‐1.74	   NS	   NS	  BLD_1771	   Stress-­‐responsive	  transcriptional	  regulator	  PspC	   0.84	   NS	   NS	   NS	  Signal	  transduction	   	   	   	   	  BL1152	   LuxS	  protein	  involved	  in	  autoinducer	  AI2	  synthesis	  (quorum	  sensing)	   0.76	   1.52	   NS	   NS	  Cell	  secretion	   	   	   	   	  BL0709	   Preprotein	  translocase	  subunit	  SecG	   1.21	   1.26	   1.25	   1.05	  BL0730	   Protein	  translocase	  subunit	  YajC	   1.49	   1.61	   NS	   1.54	  BL0982	   Type	  II	  secretory	  pathway,	  pullulanase	  PulA	  and	  related	  glycosidases	   1.24	   NS	   NS	   NS	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  BL1287	   Protein	  translocase	  subunit	  secE	   0.84	   NS	   NS	   NS	  BL1600	   Preprotein	  translocase	  subunit	  SecY	   0.70	   NS	   NS	   NS	  Ion	  transport	   	   	   	   	  BL0872	   ABC-­‐type	  transport	  system	  involved	  in	  Fe-­‐S	  cluster	  assembly,	  permease	  component	   1.28	   1.21	   NS	   NS	  BL1309	   Co/Zn/Cd	  efflux	  system	  component	   0.77	   1.30	   NS	   0.96	  BL1393	   K+	  transport	  systems,	  NAD-­‐binding	  component	   0.79	   NS	   NS	   NS	  BLD_0780	   Na+-­‐driven	  multidrug	  efflux	  pump	   NS	   NS	   NS	   1.02	  BLD_0789	   Cation	  transport	  ATPase	   -­‐0.82	   NS	   NS	   NS	  BLD_1457	   Kef-­‐type	  K+	  transport	  systems,	  predicted	  NAD-­‐binding	  component	   -­‐0.73	   NS	   NS	   NS	  Cell	  envelope	  biogenesis	   	   	   	   	  BL0157	   Lipopolysaccharide	  biosynthesis	  proteins,	  LPS:glycosyltransferases	   -­‐0.89	   -­‐1.03	   NS	   NS	  BL0488	   Isopropylmalate/homocitrate	  /	  citramalate	  synthases	   0.75	   NS	   NS	   NS	  BL0672	   Glycosyltransferases	  involved	  in	  cell	  wall	  biogenesis	   -­‐0.75	   NS	   NS	   NS	  BL0796	   Choloylglycine	  hydrolase	  (Bile	  Salt	  Hydrolase)	   NS	   NS	   NS	   1.62	  BL0826	   Glycosyltransferase	   0.80	   NS	   NS	   NS	  BL0858	   Long-­‐chain	  acyl-­‐CoA	  synthetases	  (AMP-­‐forming)	   1.09	   NS	   NS	   NS	  BL1215	   Membrane	  carboxypeptidase	  (penicillin-­‐binding	  protein)	   0.84	   1.19	   NS	   NS	  BL1356	   UDP-­‐N-­‐acetylmuramyl	  tripeptide	  synthase	   0.84	   NS	   NS	   NS	  BL1424	   1-­‐acyl-­‐sn-­‐glycerol-­‐3-­‐phosphate	  acyltransferase	   1.15	   1.20	   NS	   NS	  BL1501	   Long-­‐chain	  acyl-­‐CoA	  synthetases	  (AMP-­‐forming)	   0.78	   NS	   NS	   NS	  BL1575	   Alcohol	  dehydrogenase	  /	  Acetaldehyde	  dehydrogenase	  [acetylating]	   NS	   1.19	   NS	   NS	  Cell	  division,	  chromosome	  partitioning	   	   	   	   	  BL0118	   Cell	  division	  GTPase	   0.73	   NS	   NS	   NS	  BL0121	   Cell	  division	  initiation	  protein	   1.24	   NS	   NS	   NS	  BL0322	   Cell	  division	  initiation	  protein	   1.79	   1.52	   NS	   NS	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  BL0646	   Predicted	  S-­‐adenosylmethionine-­‐dependent	  methyltransferase	  involved	  in	  bacterial	  cell	  division	   -­‐0.70	   NS	   NS	   NS	  BL1011	   Cell	  division	  transcription	  factor	  WhmD	   NS	   NS	   1.27	   1.66	  BL1682	   Cell	  division	  protein	  ftsH	   NS	   NS	   NS	   1.16	  
Poorly	  characterized,	  general	  function	  only	   	   	   	   	  BL0005	   Predicted	  esponse	  regulator	   1.91	   1.14	   NS	   NS	  BL0041	   Predicted	  membrane	  protein	   0.88	   NS	   NS	   NS	  BL0042	   Predicted	  RNA-­‐binding	  protein	  containing	  KH	  domain,	  possibly	  ribosomal	  protein	   0.81	   NS	   NS	   NS	  BL0306	   Predicted	  RNA-­‐binding	  protein	  	   0.73	   NS	   NS	   NS	  BL0690	   Short-­‐chain	  alcohol	  dehydrogenase	  of	  unknown	  specificity	   1.31	   1.12	   0.95	   NS	  BL0721	   Uncharacterized	  bacitracin	  resistance	  protein	   0.82	   NS	   NS	   NS	  BL0743	   putative	  membrane-­‐associated	  GTPase	   1.09	   1.00	   NS	   NS	  BL0765	   Acetyltransferase	  	   -­‐1.47	   NS	   NS	   NS	  BL0782	   Virulence	  protein	   NS	   0.78	   NS	   NS	  BL0863	   Hit	  Family	  Protein	   NS	   NS	   0.96	   0.95	  BL0885	   Predicted	  acyltransferases	   -­‐0.80	   -­‐1.08	   NS	   NS	  BL0986	   Response	  regulator	  with	  putative	  antiterminator	  output	  domain	   1.04	   NS	   NS	   NS	  BL1000	   Response	  regulators	  /	  Two-­‐component	  response	  regulator	   1.12	   NS	   NS	   NS	  BL1016	   FKBP-­‐type	  peptidyl-­‐prolyl	  cis-­‐trans	  isomerases	  1	   1.54	   NS	   NS	   NS	  BL1053	   Hydrolase	  (HAD	  superfamily)	   NS	   NS	   1.03	   NS	  BL1192	   Metal-­‐dependent	  hydrolase	  	   NS	   NS	   NS	   1.12	  BL1181	   Surface	  antigen	   0.88	   NS	   NS	   NS	  BL1234	   Abortive	  infection	  phage	  resistance	  protein	   -­‐0.79	   -­‐0.77	   NS	   NS	  BL1278	   Transporter	   NS	   1.12	   NS	   NS	  BL1379	   Predicted	  membrane	  GTPase	  involved	  in	  stress	  response	   0.95	   NS	   NS	   NS	  BL1430	   Multidrug	  resistance	  protein	   NS	   NS	   NS	   0.83	  BL1575	   NAD-­‐dependent	  aldehyde	  dehydrogenases	   1.07	   NS	   NS	   NS	  BL1627	   Rrf2	  family	  protein	   1.05	   NS	   NS	   NS	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  BL1725	   Dioxygenase	   -­‐1.87	   -­‐2.03	   NS	   NS	  BLD_0185	   Hypothetical	  cytosolic	  protein/	  putative	  addiction	  module	  killer	  protein	   -­‐1.42	   -­‐1.71	   NS	   NS	  BLD_0254	   Transporter	   1.24	   NS	   NS	   NS	  BLD_0989	   Membrane-­‐bound	  transglycosylase	   NS	   NS	   NS	   1.16	  BLD_0502	   Carbon-­‐nitrogen	  hydrolase	  family	  protein	   0.85	   NS	   NS	   NS	  BLD_0970	   ACT	  domain-­‐containing	  protein	   0.72	   NS	   NS	   NS	  BLD_1036	   Predicted	  membrane	  protein	   0.59	   NS	   NS	   NS	  
Uncharacterized,	  hypothetical	  proteins	   	   	   	   	  BL0090	   Hypothetical	  protein	   0.86	   NS	   NS	   0.78	  BL0095	   Hypothetical	  protein	   0.76	   0.85	   NS	   NS	  BL0099	   Hypothetical	  protein	   NS	   NS	   NS	   1.35	  BL0120	   Hypothetical	  protein	   1.28	   1.26	   NS	   NS	  BL0121	   Hypothetical	  protein	   NS	   NS	   NS	   1.41	  BL0192	   Hypothetical	  protein	   -­‐1.10	   -­‐1.03	   NS	   NS	  BL0214	   Hypothetical	  protein	   -­‐0.69	   NS	   NS	   NS	  BL0353	   Hypothetical	  protein	   -­‐0.69	   NS	   NS	   NS	  BL0401	   Hypothetical	  protein	   1.58	   1.10	   0.89	   0.88	  BL0496	   Hypothetical	  protein	   -­‐0.80	   NS	   NS	   NS	  BL0497	   Hypothetical	  protein	   -­‐0.81	   NS	   NS	   NS	  BL0561	   Hypothetical	  protein	   -­‐0.81	   NS	   NS	   NS	  BL0562	   Hypothetical	  protein	   NS	   -­‐1.24	   NS	   NS	  BL0599	   Hypothetical	  cytosolic	  protein	   1.03	   0.80	   0.98	   NS	  BL0606	   Hypothetical	  protein	   -­‐0.72	   NS	   NS	   NS	  BL0624	   Hypothetical	  protein	   -­‐0.74	   NS	   NS	   NS	  BL0639	   Hypothetical	  protein	   -­‐0.76	   NS	   NS	   NS	  BL0665	   Hypothetical	  protein	   -­‐0.87	   NS	   NS	   NS	  BL0677	   Hypothetical	  protein	   -­‐0.75	   NS	   NS	   NS	  BL0726	   Hypothetical	  protein	   1.08	   NS	   NS	   0.89	  BL0811	   Hypothetical	  protein	   -­‐0.78	   NS	   NS	   NS	  BL0812	   Hypothetical	  protein	   -­‐0.73	   NS	   NS	   NS	  BL0827	   Hypothetical	  protein	   1.38	   NS	   NS	   NS	  BL0913	   Hypothetical	  protein	   1.30	   NS	   NS	   NS	  BL0952	   Hypothetical	  protein	   1.75	   1.48	   NS	   NS	  BL1033	   Hypothetical	  protein	   0.71	   NS	   NS	   NS	  BL1084	   Hypothetical	  protein	   1.24	   NS	   NS	   NS	  BL1094	   Hypothetical	  membrane	  protein	   -­‐1.98	   -­‐2.48	   NS	   -­‐1.70	  BL1134	   Hypothetical	  protein	   0.77	   NS	   NS	   NS	  BL1139	   Hypothetical	  protein	   1.10	   0.92	   NS	   NS	  BL1235	   Hypothetical	  protein	   -­‐0.91	   -­‐0.79	   NS	   NS	  BL1236	   Hypothetical	  protein	   -­‐0.81	   NS	   NS	   NS	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